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Microorganisms, such as the anaerobic bacterium Desulfovibrio alaskensis, have 
evolved various mechanisms to resist high concentrations of toxic heavy metals; one 
of these mechanisms involves the synthesis of nanoparticles (NPs). It may be 
possible to utilise this ability to both reclaim heavy metals from contaminated 
effluents and to convert them into industrially useful NPs. By engineering a 
genetically modified D. alaskensis, through synthetic biology, cell surface 
engineering and by designing a modular cloning (MoClo) toolkit, there is a further 
opportunity to tailor nanoparticle synthesis.  
DNA assembly techniques have revolutionised biotechnology research and 
innovation. However, despite many advances in molecular biology, the assembly of 
DNA parts into new constructs remains cumbersome and unpredictable. The 
innovation of cloning toolkits and standards such as MoClo have standardised the 
process of DNA assembly, making it easier, faster, modular and cost-effective. The 
D. alaskensis MoClo toolkit developed in this work consists of characterised oxygen-
independent reporters, synthetic promoters and ribosome binding site (RBS) 
libraries.  
The D. alaskensis MoClo toolkit was utilised to assemble a combinatorial library of 
transcriptional units (TUs) expressing the NiFe hydrogenase small subunit. Platinum 
NPs were synthesised by the combinatorial library, and examined for their oxidative 
and reduction catalytic activities were tested.  
To enhance D. alaskensis resistance to Cu, Pt and Pd, cell surface engineering was 
used to express synthetic phytochelatin EC20 on the outer membrane. Tests of 
Escherichia coli expressing EC20/IgA to Cu, Pt and Pd concluded that EC20 confers 









Desulfovibrio alaskensis is a microorganism that survives unfavourable 
environments highly enriched with metals; it survives such environments because it 
possess qualities to resist toxic concentrations of metals. One of these qualities is 
their ability to turn toxic metal concentrations into a non-toxic form, called 
nanoparticles. These qualities can be utilised to help us capture metals from 
contaminated land, water, and industry waste, to make nanoparticles, which are of 
value in industry. Genetic engineering tools that enable the fast and cost-effective 
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ng           Nanogram  
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OE-PCR    Overlap extension polymerase chain reaction 
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PCR          Polymerase chain reaction  
PdNP     Palladium nanoparticle 
PGM     Platinum group metals 
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PtNP     Platinum nanoparticle 
RBS     Ribosome binding site 
rpm          Rotations per minute  
RT-PCR    Real-time polymerase chain reaction 
SOC         Super Optimal Broth  
SRB     Sulphate-reducing bacterium 
ssDNA    Single stranded deoxyribonucleic acid 




TEM         Transmission Electron Microscopy 
TIR     Translation initiation rate 
TU     Transcriptional Unit 
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Chapter 1: Introduction 
1.1. Desulfovibrio alaskensis Nanoparticle synthesis and its role in sustainability  
Nanoparticles (NPs) are particles having one or more dimensions below 100 nm 1. 
Heavy metal NPs possess unique physical, chemical, photo electrochemical, 
mechanical, electrical, magnetic, optical and biological properties 1. The NPs size 
plays a critical role in those properties, particularly their catalytic activity. 
Decreasing the NP’s size to a smaller nano-scale, increases the physical surface 
interaction of atoms, increasing its surface energy and decreases its imperfections 1. 
Potential applications of biogenic metal NPs range from biomedical purposes (e.g. 
antiviral, antibacterial, antiparasitic, medical imaging, drug delivery, cancer 
treatments and medical diagnostics), through environmental remediation purposes 
(e.g. pollutant degradation and catalytic treatments), to industrial purposes (e.g. 
catalytic organic chemistry and nanoelectrochemistry) 2. 
Metals play an integral role in the life processes of microorganisms. Some metals 
such as Cr, Ca, Mg, Mn, Cu, Na, Ni and Zn are essential micronutrients for various 
metabolic activities and for redox processes 3. Microorganisms have the ability to 
discern between these essential metals and those that are toxic, and have the ability to 
tightly regulate their transport in and out of the cell 3. Microorganisms have evolved 
various mechanisms to resist higher concentrations of toxic heavy metals, such as 
exclusion by permeability barrier, active transport of metals out of the cell, 
intracellular sequestration (protein binding), extracellular sequestration, enzymatic 
detoxification, reduction in metal sensitivity 4 and the ability to convert heavy metals 
into less toxic nanoparticles (NPs) 5. Examples of microorganism capable of 
synthesising NPs include: Desulfovibrio desulfuricans, Bacillus subtilis, Cupriavidus 
metallidurans, Escherichia coli, Candida glabrata, Thermomonospora sp., 
Rhodopseudomonas capsulate, Pseudomonas aeruginosa, Shewanella sp., 
Rhodococcus sp., and Verticilliium sp. 6, 7. While, currently the range of metal NPs 
(in its elemental state) that are able to be synthesised by microorganisms include (but 
is not limited to) As, Ag, Al, Au, Cd, Cr, Cu, As, Pb, Pd and Pt 7-10.  
Biogenic metal nanoparticles are produced by the microorganisms’ natural metal 




mechanism 11. The intracellular mechanism occurs in the cytoplasm of the cell and 
involves the reduction of metals to their elemental form through electrostatic and 
enzymatic interactions, forming NPs that are held within the cell 11. The extracellular 
mechanism is mediated either through enzymatic reduction at the cell surface or by 
secreted molecules that reduce metals ions into their elemental form 12. 
The focus of this thesis is dedicated to Desulfovibrio alaskensis a Gram-negative 
anaerobic sulphate-reducing bacterium (SRB) that is exceptionally well adapted to 
survive environments with high concentrations of heavy metals, converting them to 
NPs 4. Desulfovibrio sp. have been shown to be able to reduce Cr, Mg, Fe, Te and 
even U to nanoparticle forms 13-17. Desulfovibrio sp. such as D. alaskensis G20 have 
been most studied because they are able to reduce Pt and Pd to zero-valent NP 5, as 
they are highly tolerant to Pt and Pd ions, able to survive up to 2 mM and 5 mM, 
respectively 5. D. alaskensis G20 is a spontaneously nalidixic acid-resistant 
derivative of Desulfovibrio desulfuricans G100A 18, a deltaproteobacterium that was 
isolated from a producing oil well in Ventura County, California 19.  Its complete 
genome has been sequenced 18, and it provided great insight into its energy 
conversion through sulphate respiration, fermentation of organic acids and living in 
microbial syntrophy. Moreover, recent proteomic analysis of D. alaskensis G20 in 
response to platinum and palladium highlighted those proteins involved in both the 
reductive pathways and the wider stress-response system to this metals 20. Both 
accomplishments will help elucidate D. alaskensis sp. metal NP synthesis, and the 
future possibility to tailor NPs’ size to acquire a desirable catalytic activity.  
Biogenic platinum and palladium NPs have been found to be useful in a number of 
cases; for example biogenic palladium NPs synthesised by Desulfovibrio sp.  have 
been shown to be an effective catalyst in hydrogen fuel cells 21, while Desulfovibrio 
sp. cells synthesise palladium NPs which are bound to the cell surface which have 
been used in chromium (IV) decontamination 22. These palladium NPs proved to be 
considerably stable, and lasting over eleven times longer that it’s industrially 
produced counterpart 22. The reduction of platinum group metals (PGMs, Rh, Ir, Ru, 
and more importantly Pt and Pd) by Desulfovibrio sp is hypothesised to occur due to 
the bacteria incorporating the metals into their electron transfer pathways 5. Pt and Pd 




respiration, causing those metal ions to be reduced to a zero valence state 23, 24. The 
reduction of such metals occurs in the periplasm, where hydrogenases and 
cytochromes, such as NiFe hydrogenase are able to reduce them. NPs are exported 
outside of the cell and subsequently attached to the cell surface 5. The newly cell-
attached NPs act as a catalyst for further metal reduction 25. An illustration of the 
reduction of Pd ions to NPs is in Figure 1.1. Platinum group metals ions have been 
observed to cause DNA lesions and inhibit growth in other bacteria such as E. coli 
and Pseudomonas sp. 26, 27. Desulfovibrio sp. experience DNA lesions when exposed 
to higher concentrations of platinum group metals in comparison to E. coli and 
Pseudomonas sp. 5, since the attachment of metal NP to the cell surface and the 






















Figure 1. 1. Proposed mechanism of palladium reduction to nanoparticle in the 
periplasm of Desulfovibrio. Pd2+ ions are taken up by Desulfovibrio across the outer 
membrane into the periplasm, where they are hypothesised to be reduced by 
cytochromes and/or hydrogenases to form NPs. The NP is exported outside the cell, 
where they are attached to the cell surface, to act as a catalytic site for increased Pd 
reduction. Schematic taken from ‘Nickel and platinum group metal nanoparticle 






The use of D. alaskensis for the reclaiming of PGMs is of great importance as they 
play a key role in modern society, as PGMs possess a range of unique chemical and 
physical properties and are of specific importance for clean technologies and other 
high tech equipment 28. PGMs have applications as chemical processes catalysis, 
catalytic converters, consumer electronics, and fuel cells 28. Metals including PGMs 
are not consumed, instead they become dispersed into the environment in many 
ways, e.g. mines’ run-offs, waste from metal processing, and automobiles’ catalytic 
converters 29. Heavy metal pollution degrades the quality of soil and water, rendering 
them unsustainable and of little or no use, while also negatively affecting the 
biological health of ecosystems. It is imperative to develop technologies that will 
enable a more sustainable reclamation of metals, and enable to clean polluted land 
and water. Such sustainable technologies are imperative because a growing world 
population crucially drives the scarcity of metals, and has caused the global supply 
and demand of metals to be of importance in the developed world 28, 29.  
Attempts to develop technology and research to achieve sustainability through the 
means of recovering metals have been devised using physical, chemical and 
biological approaches. Physical and chemical approaches are proven to remove a 
broad spectrum of contaminants, but these methods rely on high consumption of 
energy and the use of additional chemicals 30, therefore proving not to be sustainable. 
Unlike such methods, bioremediation (biological approach) uses microorganisms to 
reclaim, immobilize and detoxify metal pollutants without the use of excessive 
energy and additional chemicals 11, 29, 31. 
Genetic and molecular biology technologies are available for D. alaskensis sp. 
Genetic tools to engineer Desulfovibrio sp have been developed 32, transposon 
mutant libraries have been generated 33 and systems biology tools have been applied 
34, but all available tools and technologies were developed to study D. alaskensis sp, 
energy metabolism and not their NP synthesis. No synthetic biology or genetic tools 
are available to specifically engineer genetically modified strains of D. alaskensis for 
bioremediation purposes. However, synthetic and genetic tools abound for the model 
organisms E. coli, a gammaproteobacterium closely related to D. alaskensis sp, a 
deltaproteobacterium. Proteobacteria compromise of the largest and phenotypically 




led to the identification of numerous conserved inserts and deletions that are shared 
among proteobacterial species. These findings provide the molecular means to 
understand their evolutionary relationships between proteobacterial species. Species 
belonging to the deltaproteobacteria subdivision are more closely related to the 
alpha, beta and gammaproteobacteria, in view of the paucity of sequence data on 
these subdivisions in comparison to other proteobacteria 35. The close relationship 
between E. coli and D. alaskensis sp, can be indicative that the tools available for 
E.coli can potentially be used to engineer D. alaskensis for bioremediation purposes. 
One of the objectives of this project is to engineer genetically modified strains of D. 
alaskensis as a bioremediation technology, to reclaim metals such as Pt and Pd, in 
the form of NPs. Not only is this practice sustainable, it also adds value to Pt and Pd 
recovery 36, as they are recovered as industrially useful NP 11.   
 
 
1.2. Synthetic Biology Tools 
1.2.1. Broad Overview of Synthetic Biology and its Applications 
Synthetic biology is an exciting and rapidly evolving scientific field that merges 
engineering principles and practices with modern molecular biology and 
biotechnology techniques.  This focus on engineering principles is what distinguishes 
synthetic biology from more traditional biological techniques,  emphasising the 
design and construction of core biological parts, that can be modelled, understood 
and engineered to meet a specific outcome 37.  
One of the driving forces in synthetic biology is the desire to make biological design 
and implementation easier and more predictable for biotechnology applications 38. 
Conceptual engineering frameworks underpin the research basis of synthetic biology. 
Modularisation, standardisation and characterisation are key engineering principles 
used within synthetic biology for the systematic design of biologically-based devices 
and systems. The modularity concept is when a device, pathway or system is reduced 
to a number of components parts, where each component part is characterised in 




standardised in order that, in principle, a combination of standard parts can be 
assembled to create a pathway. This approach, thoroughly used within engineering, 
is an important enabler because an entire biological device then does not have to be 
created from scratch, rather it can be assembled from existing standard parts 38. This 
synthetic biology design approach is known as parts, devices (genes) and systems 
(pathways) 38. Parts or bioparts (most notably synthetically designed DNA) encode 
biological functions. Devices are made from a collection of bioparts. Systems 
perform tasks to control or obtain a desired biological function or output. In 
principle, to construct the most simple device, comprised of a promoter, ribosome 
binding site (RBS), protein coding sequence (CDS), which contains the open reading 
frame (ORF) necessary for translation, and terminator, it will consist of joining four 
different bioparts to assemble a device (gene or transcriptional unit, TU). Multiple 
devices assembled together work as a system (pathway), designed for a desired 











Figure 1. 2. Illustration of the terms used in synthetic biology. Adapted from 
‘DNA Assembly for synthetic biology: from parts to pathways and beyond’, by T. 













Synthetic biology strategies and tools are being applied to facilitate the engineering 
of tailor-made microorganisms capable of tackling some of society’s toughest 
challenges. Synthetic biology relies on the gathering of bioinformatics data, coupled 
with engineering principles where the assembly of devices and systems is 
streamlined, and has broadened the possible applications of this new scientific field. 
Within industrial biotechnology, synthetic biology has enabled the development of 
new biosynthetic pathways for the production of renewable fuels and chemicals, 
programmable logic controls to regulate and optimize cellular functions, and robust 
microorganisms for the accumulation and removal of harmful environmental 
contaminants 40. Synthetic biology has expanded the diversity of chemical products 
that can be synthesised biologically. These molecules serve important industrial roles 
as monomers for producing bioplastics (potential replacements to many conventional 
plastic materials)41, bulk and fine chemicals, as well as long-chain alcohols (usually 
not efficiently synthesised by microorganisms) 42, and other biofuels with improved 
compatibility (increasing the yield of biofuel production) 43.  
Within a biomedical setting, synthetic biology has tackled key challenges, like the 
need for drug-target specificity, precise drug-dosing regimens, minimising side 
effects, better diagnostics, and the avoidance of drug-resistance pathogens 44. 
Synthetic biology has enabled scientists to research and understand a disease by 
synthetically emulating a pathogen mechanism, for example the H1N1 virus was first 
sequenced and then synthesised to provide information of its enhanced viral 
replication 45. Synthetic biology has recently provided new insights into immune 
disorders, for example, the functional reconstitution and analysis of the human B cell 
antigen receptor signalling cascade in insects revealed that human B cell antigen 
receptors are not activated by antigen-specific crosslinking 46.  Synthetic biology has 
also been applied to the suppression of insect vector transmission of infectious 
diseases, such as malaria and dengue virus, where transgenic mosquitoes prevent the 
propagation and proliferation of vectors 47. Notably synthetic biology has also 
propelled drug discovery and development efforts; the novel use of mammalian 
synthetic biology has enabled scientists to identify new antimicrobial peptides like 
MSI-78 48, and discover small molecules responsible for overcoming pathogenic 




precursor compounds and secondary metabolites, has been advanced with the advent 
of synthetic biology; a notable examples of such is the production of the anti-malaria 
drug Artemisinin 50 and the anti-cancer drug Taxol 51. Drug delivery systems 
developed using synthetic biology, for example the use of synthetic protein-
polyacrylamide and DNA-polyacrylamide monomers that release a trigger dependent 
subcutaneous dosage have been developed52. Anti-cancer devices that provide 
precise timing, location and dosing of drug production by external cues have recently 
been designed using synthetic biology tools, an example of such are engineered 
bacteria that selectively invade and proliferate in tumour tissue and release cytotoxic 
compounds 53.  
Within environmental biology, synthetic biology applications such as biosensors, 
bioaccumulation of metals, and bioremediation have been researched. The detection 
and quantification of pollutants in the environment is essential due to the threat they 
pose to the balance of the ecosystem and to human health 54. The design of whole 
cell microbial biosensors to sense and quantify arsenic have been used 55, for 
example the design of an amplified arsenic biosensor that can quantify arsenic 
concentrations, by calculating the fluorescent emission expressed form a bacterial 
biosensor using a microfluidic device 56. The use of microbial biomass as a platform 
for heavy metal ion accumulation and removal are being studied 57. Nonetheless, the 
use of wild type microorganisms to accumulate heavy metals from wastewater 
effluent has its limitations. The uptake of metals into the cytoplasm of Gram-
negative bacteria and their narrow tolerance to toxic metals are both limiting factors; 
therefore, it requires synthetic biology to optimise the heterologous expression of 
metal-binding proteins, or metal ion import systems 57. Bioremediation may use 
microorganism to degrade toxic chemicals via complete mineralisation or co-
metabolism 58, and synthetic biology has considerably helped advance efforts in this 
scientific field. For example, a co-culture of engineered E. coli SD2 and 
Pseudomonas putida KT2440 was used successfully to mineralize parathion 
(insecticide) 59.  
This work utilises synthetic biology technologies to enable the modularisation, 
standardisation and characterisation of bioparts, for the facile engineering of D. 




1.2.2. DNA Assembly Techniques and the Modular Cloning (MoClo) 
Toolkit 
The ability to reliably assemble and test DNA components in a high throughout 
manner is essential in the use of synthetic biology. This can be achieved through the 
standardisation and modularisation of the essential parts that make up a biological 
device or system. However, even with the simplicity of a standardised assembly, the 
DNA assembly process is still a limiting factor within research, hampering rapid 
prototyping of many devices 39, because the engineering design principles are too 
simplistic to efficiently create complex biological systems 60. Nowadays, DNA 
assembly techniques abound, but in the advent of synthetic biology, the need for a 
universal connecting method to facilitate the construction of progressively complex 
parts was appeased with the development of the Biobricks ™ standard. This standard 
is based on the cloning of parts via restriction digestion and ligation, a digestion 
resultant with sticky ends that are accordingly ligated, re-forming the prefix sequence 
and leaving a ‘scar’ between parts. BioBricks™ relies on the XbaI, SpeI and PstI 
restriction enzymes where a sequential, ordered assembly of parts into a device is 
easily achieved. The BioBricks™ method has a downside, that it leaves the same 8 bp 
scar sequence between parts 39. This scar can be problematic on certain locations, 
notably before the RBS and when assembling fusion proteins, because it encodes an 
in-frame stop codon 39. Similar to BioBricks™, another DNA assembly technique 
standard is BglBricks, which replaced restriction enzymes used on BioBricks™ with 
BglII, BamHI and XhoI and has a smaller 6 bp scar in between parts 61. Neither 
BioBricks™ nor BglBricks methods can assemble a scarless sequence from parts. 
However, scarless assembly can be achieved using another DNA assembly method 
called overlap extension polymerase chain reaction (OE-PCR). OE-PCR uses PCR 
primers to create homologous ends between different DNA molecules, homology 
then allows the extension of both parts in a second PCR, therefore allowing the 
scarless DNA assembly of devices without the use of restriction enzymes 62. Another 
scarless assembly method is circular polymerase extension cloning (CPEC), utilises a 
primer-less single cycle of PCR to circularise a gene into a linearised plasmid 63. 
However, these methods are limited in their ability to scale up, where plasmid 




date remains problematic for a reliable amplification of large constructs 39. The 
aforementioned DNA assembly methods, particularly the BioBricks ™ and BgIBricks 
standards are becoming less relevant in light of new technology, specifically the 
Gibson and Golden Gate assembly methods 64. Gibson assembly is an isothermal, 
single-reaction, ligation-independent assembly method that relies on the use of a high 
fidelity DNA polymerase, T5 exonuclease and Taq DNA ligase, were the assembly 
of multiple overlapping DNA molecules is achieved 65. This method utilises a slow 
chew back mechanism resulting from the 3’-5’ proofreading exonuclease activity, 
which generates long overhangs of overlapping DNA fragments, and instead of using 
a ligation enzyme to assemble parts, Gibson assembly relies on the in vivo DNA 
repair 65. This method is particularly attractive due to its simplicity and use of 
common lab enzymes 39. DNA assembly methods that rely on Type IIs restriction 
enzymes were developed to assemble DNA at larger scales. Type IIs restriction 
enzymes cut outside of their recognition site, leaving 4 bp overhangs, which can be 
customised and thus the assembly of devices can be scarless. The Golden Gate 
assembly method is one that uses this technique. It enables the sequential, 
combinatorial and scar-free assembly of parts into devices in a one-pot reaction 66-68. 
Golden Gate assembly is a rapid DNA assembly technique, but it may require the 
removal of any internal Type IIs restriction sites, since it prevents the correct DNA 
assembly. Another scarless DNA assembly technique is PaperClip, which relies on 
the use of double stranded bridging oligonucleotides (clips). For each DNA part to be 
joined four short oligonucleotides (that can be reused) are designed and assembled to 
join parts via PCR 69. Order of the parts in the assembly is controlled by the order of 
the oligonucleotides ligated to create the clips 69. A comparative schematic of the 




Figure 1. 3. Overview of DNA assembly techniques. A) BioBricks TM, cloning parts via restriction 
digestion and ligation of resultant compatible sticky ends. B) OE-PCR, where complementary 
overhangs attached to DNA targets anneal during PCR. C) Gibson isothermal assembly technique, 
where parts have a 30 + bp overlap, and ends are processed and fused together using an exonuclease, a 
ligase and a polymerase. D) Golden Gate, a one-pot assembly reaction reliant on Type IIs restriction 
enzymes. E) PaperClip, with the use of double stranded bridging oligonucleotides (clips) constructs 




The Golden Gate assembly method was chosen because this particular method, 
unlike BioBricks™, BglBricks, OE-PCR, CPEC, PaperClip and Gibson assembly, 
can assemble DNA in a single reaction. This method also allows a sequential and 
combinatorial assembly of parts, genes and pathways, in a cost effective and 
streamlined manner that better fits with synthetic biology’s cycle of design, build and 
test (and learn) 70. More specifically, a type of Golden Gate assembly method called 
Modular Cloning or MoClo was used throughout this research. MoClo tools were 
designed and engineered specifically for D. alaskensis, with an aim to assemble and 
test DNA components in a fast and facile manner. To date multipart modular 
assembly libraries have been developed for use in yeast 71, 72, E. coli 66, 73-75, plant 76, 
mammalian 77 and microalgae 78 based systems; however, to our knowledge, no such 
library has been reported for D. alaskensis or any other SRB.  
From the MoClo toolkits available for E. coli, Table 1.1 summarises each MoClo 
toolkit. At the time of the conception of this project, only two MoClo toolkits were 
available, CIDAR MoClo and EcoFLEX. The CIDAR MoClo toolkit, was selected 
here because it had more parts available, the reported assembly method is very 
straightforward and shorter than EcoFLEX, and because most of the parts contained 
in the CIDAR toolkit are derived from the Biobricks Registry of Standard Biological 
Parts, which were selected for their functional reliability and utility in synthetic 
biology designs 66. With CIDAR MoClo as our chosen toolkit, new CIDAR 
compliant bioparts were designed and engineered for D. alaskensis. Provision of 
these new tools to the research community and alongside those already available for 
E. coli, will enable the prompt assembly of genes and pathways tailored for D. 
alaskensis. These tools will therefore not only advance scientific research into the 
use of sulphate-reducing bacteria as a chassis for biotechnology, but also inform their 
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1.2.3. Engineering and designing expression control elements 
Expression control elements are required for a functional gene in prokaryotes, they 
form a device and consist of a promoter, a RBS, a CDS and lastly a terminator. 
Functional devices require all these expression control elements to be assembled in 
order; those with known functional characteristics are important as they allow the 
rational modification of metabolic pathways and the assembly of synthetic and 
heterologous pathways 79.  
In synthetic biology, the expression control elements are DNA sequences 
characterised by precise functions in either transcription or translation. Promoters are 
DNA sequences where RNA polymerases recognise and bind at the -35 and -10 
regions of an E.coli σ70  promoter and initiate the DNA transcription to mRNA. RBSs 
are the place where ribosomes recognise the Shine-Dalgarno sequence found on their 
sequence and bind to it to initiate translation. CDS encodes ORFs or small RNAs, 
which go through transcription until reaching a terminator. Terminators are 
sequences that terminate transcription, are placed at the end of a TU, and contain G-
C rich motifs that during transcription they fold into a hairpin that slows down 
mRNA elongation by the RNA polymerase. Then a short U-A double stranded 
sequence is formed into the RNA polymerase active site to allow it to dissociate from 
the DNA 80. All these expression control elements can be assembled into biological 
devices, such as important tools in research, like TUs that express reporter proteins.  
This study will focus on the design and engineering of synthetic promoters and 
RBSs. There are two common types of promoters, constitutive and regulated. 
Constitutive promoters are not regulated by any DNA binding proteins, and are 
therefore always ‘on’ 38. They are useful in synthetic biology because they provide a 
mostly constant level of expression. Regulated promoters frequently contain 
additional DNA sequences, known as operators, which allow other protein factors to 
bind to the DNA and modulate the transcription rate 38. Therefore, in eukaryotic cells 
the transcription can be controlled by the addition of a small molecule that recruits 
transcription factors to the promoter regions, or utilising a second genetic circuit to 
produce the accessory proteins that activate the promoter. Regulated promoters can 




or negatively regulated (factors binding to DNA to decrease transcription rate) or 
both38.  
In prokaryotes, the RNA polymerase requires a specialised subunit, sigma factor (σ) 
to recognise promoter regions 81. The prokaryote σ performs all initiation functions, 
and promotes transcription of thousands of genes, and many alternative sigma factors 
(σ70, σ19, σ24, σ28, σ32, σ38 and σ54) each promoting transcription of specialised genes 
necessary to cope with cellular stress or development 81.  
In the gammaproteobacteria, E. coli the σ70 is the housekeeping σ factor, and 
performs two main functions: directs the RNA polymerase to the appropriate 
transcription sites, and initiates the strand separations of the double-helical DNA 81. 
In deltaproteobacteria such as D. alaskensis spp, research has shown that the 
recognition of the promoter sequences is done primarily by a different sigma factor, 
σ54 82. In comparison with all other known sigma factors, σ54 differs that it recognizes 
and binds characteristic promoters with GG -24 and TGC -12 motifs, and it strictly 
requires ATP hydrolysis activity for the activation of the promoter complex 82, 83.  
Due to the lack of a consensus σ54 promoter architecture, this study will focus on the 
design and engineering of E. coli σ70 promoters and test them in D. alaskensis. The 
E. coli σ70 core promoter structure and that of most prokaryotes, include a -35 motif 
and a -10 motif, which are separated and surrounded by nucleotide spacer regions in 
which little or no nucleotide homology has been deduced and has a consensus length 
of 17 bp 84-86. The bacterial transcription initiation is a multistep process that is 
regulated by the σ70 core promoter structure 87, 88. The first step is as previously 
mentioned, where the RNA polymerase recognises the -35 and -10 motifs. The 
sequence-specific recognition of these motifs within the dsDNA sequence 
contributes to the specificity of the promoter binding and orients the RNA 
polymerase with respect to the -10 motif, the most highly conserved and essential 
promoter motif 89, 90. In the second step the promoter isomerisation generates an open 
complex in which the DNA between -11 and +4 is melted 91. At the -10 motif, strand 
separation is triggered by the sequence-specific ssDNA binding activity, to continue 




It is well established that the length of spacer region is critical 92. Research suggests 
that alterations in the spacer region sequence can increase the promoter activity in 
E.coli 93. However, it has a limited effect over the transcription initiation in 
comparison with the -35 and -10 motifs 89. 
The core promoter region is considered a minimal promoter, since these are the 
minimal elements necessary to enable transcription initiation 85, (Figure 1.4). 
Promoter engineering is done by varying the sequence within the core promoter 
structure, particularly within the -35 and -10 motifs, making it possible to vary the 
strength of the promoter, either to increase or decrease the number of mRNA copies 
that are made from it per second. An upstream region called the up-element is 
present in some promoters, this region is typically adenine/thymine rich, and can 
boost transcription rate through interactions with the c-terminal domain of the RNA 

























Figure 1.4. Consensus promoter motifs and architecture for prokaryotic 
promoters; based on E.coli σ70 promoter architecture. Adapted from ‘Promoter 
engineering: Recent advances in controlling transcription at the most fundamental 










Promoter engineering is becoming an enabling technology that will facilitate the 
optimisation of metabolic pathways and fine-tune expression of heterologous 
proteins. The basis for promoter engineering is related to its architecture. By varying 
the DNA in these spacer regions, changing the motifs in already existing promoters, 
or designing new synthetic promoters (not found in nature) you can modulate the 
expression potential of such promoters. Many techniques exist to engineer the 
prokaryotic promoters. Error-prone-PCR (Ep-PCR) introduces random mutations 
into the DNA sequence of choice. An example of the use of Ep-PCR for promoter 
engineering is for the generation of an engineered promoter library of PL-λ 
constitutive E. coli of varying strengths 94. This technique led to the engineering of a 
promoter library with varied strength that were used to fine-tune the expression of 
heterologous proteins, such as GFP 94. Another promoter engineering technique is 
through the saturation mutagenesis of nucleotide spacer regions, while maintaining 
the -35 and -10 motifs intact. A promoter library of Lactococcus lactis was 
engineered using saturation mutagenesis to modulate its strengths 95. This finding is 
relevant because it highlights the importance of the spacer region’s sequence to 
modulate a promoter strengths. Not only was this research able to generate a 
promoter library with varying strengths for L. lactis, but this library was also proven 
to work in E. coli, but with different strengths. An additional promoter engineering 
technique is through hybrid promoter engineering, which entails the assembly of 
enhancer element-core promoter fusions to rationally enhance basal core 
transcriptional capacity or enable novel promote regulation 85. This technique led to 
the engineering of many commonly used promoters, including the tac promoter 
(hybrid of trp and lac promoters) 96 and the rhaPBAD’ (hybrid of arabinose and 
rhamnose regulated promoters) 97.  
To predict a promoter’s DNA sequences, or more importantly to predict the -35 and -
10 motifs, many bioinformatics tools could be used, each with a specific algorithm 
tailored for a specific organism or sigma factor. A list of bioinformatics tools  to 
predict bacterial promoters are: BPROM (Softberry) 98, finds potential promoters 
with significant features of conserved sequences of known promoters in E. coli. 
BacPP (Bacterial promoter prediction) 99 ,   predicts promoters from all know σ 




region predictor based on Drosophila melanogaster. PromoterHunter 101, a tool for 
promoter search in prokaryote genomes. PePPER 102, a mining and visualising 
software of prokaryote promoter elements. DOOR2 103, an online operon prediction 
on user-provided genomic sequences. Virtual Footprint 104, a pattern-matching tool 
for the prediction of promoter regions. CNNPromoter105, a prokaryote and eukaryote 
convolutional neural network promoter predictor. In this study, BPROM was used to 
predict the -35 and -10 motifs to design and engineer synthetic promoters, because at 
the time, this tool was cited on numerous publications of importance to this project 
106, 107.  
Modifying the RBS strength is an efficient approach to tune gene expression level in 
prokaryotic systems. Small changes in the RBS sequence can result in the up- or 
down- regulation of translation 108. RBS engineering tools are geared to change the 
translation initiation rate (TIR), because the TIR can be calculated solely from the 
RBS nucleotide sequence 108. The engineering of RBS nucleotide sequences relies on 
bioinformatics tools that predicts nucleotide sequence and their respective TIR, to 
generate libraries that can be characterised. Similarly, to the methods and 
technologies used to engineer promoters, engineering the RBS is mostly done by 
targeted mutagenesis and iteration of nucleotide sequences with a different predicted 
TIR 109.  
To predict the RBS’s nucleotide sequences and its respective TIR, many 
bioinformatics tools could be used, each with a specific algorithm tailored for a 
specific organism. A list of bioinformatics tools to predict bacterial RBS are: the 
RBS calculator 110, is a predictive design method for controlling translation initiation 
in bacteria. The ‘MAGE Oligo Design Tool’ (MODEST) 111,  allows the 
identification of most regulatory coding regions. The ‘Empiric Model and Oligos for 
Protein Expression Changes’ (EMOPEC) 112, a free tool that modulates the 
expression level of any E. coli gene. ‘Reduced Libraries’ (RedLibs) 113, algorithm 
that identifies globally optimal degenerate RBS. RBSDesigner 114, an algorithm that 
predicts the translation efficiency of an existing mRNA sequence and designs RBSs. 
The UTR Designer, a quantitative prediction method that predicts the translation 
efficiency and designs RBS’s sequences. In this study, the RBS calculator was used 




tool was cited on numerous publications of importance to this project 108, 110, 115, 116, it 
is also a proven reliable E. coli RBS predictor 110, and has the option to enter D. 
alaskensis G20 into the program as the organism of choice. 
 
1.2.4. Characterising expression control elements 
Synthetic biology aims to robustly characterise expression control elements, 
particularly promoters and RBSs, to aid the assembly of fine-tuned pathways and 
devices that give a predictable response 39. The utility of expression control elements 
will increase if their behaviour, both in isolation and in combination, were more 
predictable. The prediction of behaviour depends on the initial designs and 
refinement of the expression control elements, the characterisation of each is 
imperative. The proper characterisation of expression control elements is embedded 
in synthetic biology, since the standardisation and characterisation of parts has been 
instrumental in the managing of complexity in engineering fields 117.  
To ascertain a thorough characterisation of expression control elements, it is ideal to 
characterise them via quantitative methods. Not only it will enable to compare 
quantitative values but it can also establish their order within a synthetic library. 
Expression control elements such as promoters are characterised by the expression of 
a reporter gene that can be quantified, for example GFP (green fluorescent protein). 
Numerous promoter libraries from a variety of microorganisms have been 
characterised using fluorescent reporters, for example E. coli 112, 117-120 , B. subtilis 
118, Saccharomyces cerevisiae 94, 118, and Yarrowia lipolytica 72. An alternative 
quantitative method is through the measurement of a desired gene at the 
transcriptional level, by measuring its mRNA level relative to that of a gene 
expressed at a constant level using quantitative RT-PCR. Characterising expression 
control elements through RT-PCR has been undertaken with E. coli 112, 120 , and S. 
cerevisiae 94. Parts can also be characterised by assaying their resistance to 
antibiotics, by measuring the minimum inhibitory concentration among the libraries, 
expressing an antibiotic resistance cassette under different expression controls 94. 
Alternative measurement methods for the characterisation of parts are by using 




phosphatase  123 and chloramphenicol acetyltransferase  124. Additionally luminescent 
reporters such as luciferase, have been used to characterise expression control 
elements 122. The choice of reporter used to characterise expression control elements, 
however, will depend on the cell line used, the nature of the experiment, and the 
adaptability of the assay to the appropriate detection method 125, 126. 
Reporter genes are the most commonly used technology to characterise expression 
control elements. Reporter gene technology was first used as a method for analysing 
the activity of expression control elements such as enhancers and promoters in the 
upstream region of genes 127. The popular use of reporter genes as a technology to 
characterise expression control elements is because they have the advantage of low 
background activity in cells and in many cases, the activity can be amplified to 
produce a highly sensitive, and often easy to detect response 127. Table 1.2 
summarises some of the advantages and disadvantages of the most common reporter 
genes used to characterise expression control elements. The reporter gene used to 
monitor transcriptional activity in cells was chloramphenicol acetyltransferase 128 ; is 
a bacterial enzyme that can detoxify chloramphenicol, an inhibitor of prokaryotic 
protein synthesis, by catalysing the transfer of acetyl groups from acetyl CoA to the 
3-hydroxyl position of chloramphenicol 127. However, this method relied on 
radioisotopes and ELISA, the linear range and sensitivity of the assay is not as broad 
as other methods. β-galactosidase is a well-characterised bacterial enzyme and has 
been used as a simple colorimetric assay of poor sensitivity and narrow dynamic 
range to monitor transcriptional activity in cells. It has an advantage over 
chloramphenicol acetyltransferase in that the assay is simpler and does not involve 
the use of radioisotopes 127. Luciferase refers to a family of enzymes that catalyse the 
oxidation of various substrates (e.g. luciferin and coelenterazine), resulting in light 
emission, which can be quantified to monitor transcriptional activity in cells. The 
downside of using a luciferase reporter gene is that it requires a substrate and ATP 
and in most occasions, it requires oxygen. The secretable form of alkaline 
phosphatase (SEAP) is a reporter gene that quantifies transcriptional activity in cells 
through an inexpensive colorimetric assay. The protein is secreted from the cell and 
can be detected by sampling the culture medium, cells remain intact and viable.  




Aequorea victoria. GFP is autofluorescent and does not require the presence of any 
cofactors or substrates to generate light unlike Aequorin. The greatest advantage of 
GFP is that in the absence of cell lysis, noninvasive monitoring of living tissue is 
possible 127. However, it requires the presence of oxygen to successfully mature and 
fluoresce.  
Low oxygen environments are frequently a requirement in a broad range of 
biomedical and industrial bioprocesses, including bioremediation, fermentation of 
high-value biomolecules, and especially in biotechnology applications for obligate 
anaerobes 129. Methods to characterise expression control elements abound, however 
to rapidly measure and characterise them under anaerobic conditions, the options are 
limited. Most reporter genes require molecular oxygen 127, an important limitation 
that needs to be addressed, to enable further research of the anaerobic bacterium, D. 
alaskensis. Recently flavin-based fluorescent proteins (FbFPs), such as iLOV, which 
are derived from Light-Oxygen-Voltage (LOV) photoreceptor proteins 130, 131, have 
become the staple oxygen-independent fluorescent reporters. FbFPs have many 
advantages over GFP and its related analogues, for example, FbFPs have been shown 
to be expressed and to fluoresce anaerobically in multiple organisms such as 
Porphyromonas gingivalis, Saccharomyces cerevisiae and Candida albicans 132-136, 
while they are also thermostable and fast-maturing probes with a broad operational 
pH range (4 – 11) 137. CreiLOV, an FbFP with blue light LOV domains, found in 
Chlamydomonas reinhardtii has been demonstrated to be the brightest FbFP reporter 
to date 137. CreiLOV has a reported quantum yield ~1.5-fold larger than iLOV 130, 137, 
138.  
In this study, designed oxygen-independent fluorescent reporters were engineered 
and screened for fluorescence emission, and ultimately used to characterise 







Table 1. 2. Comparison of commonly used reporter genes. Adapted from 
‘Reporter Gene Technology: The Future Looks Bright’, by L.H. Naylor 127 
Reporter Gene Advantages Disadvantages 
Chloramphenicol 
acetyltransferase  
No endogenous activity. 
Automated ELISA available. 
Does not require presence of O2. 
Narrow linear range; use 
of radioisotopes; stable. 
Enzymatic reaction.  
β-galactosidase  Well characterised; stable; 
simple colorimetric readouts; 
sensitive bio- or 
chemiluminscent assays 
available. Does not require 




Luciferase (firefly) High specific activity; no 
endogenous activity; broad 
dynamic range; convenient 
assays.  
Requires substrate 
(luciferin) and presence of 
O2 and ATP. Enzymatic 
reaction. 
Luciferase (bacterial) Good for measuring/analysing 
prokaryotic gene transcription. 
Does not require presence of O2. 
Less sensitive than firefly 
luciferase; not suitable for 
mammalian cells. 
Enzymatic reaction. 
Alkaline phosphatase Secreted protein; inexpensive 
colorimetric and highly 
sensitive luminescent assays 
available.  
Endogenous activity in 
some cells, interference 
with compounds being 
screened. Enzymatic 
reaction. 
Green fluorescent protein (GFP) Autofluorescent (no substrate 
needed); no endogenous 
activity; mutants with altered 
spectral qualities available.  
Requires post-translational 
modification and presence 
of O2; low sensitivity (no 
signal amplification).  
FBFPs LOV  Autofluorescent (no substrate 
needed); no endogenous 
activity; works under anaerobic 
and aerobic conditions 130, 131. 
Requires post-translational 
modification; low 
sensitivity (no signal 






1.3. Cell-Surface Engineering 
1.3.1 Overview of Cell-Surface Engineering 
Microorganisms, such as D. alaskensis cannot grow without metal ions; however, 
some of these metal ions are toxic at high concentrations but are essential at trace 
concentrations 139. In addition, some metal ions have strong toxic activity at low 
concentrations. As previously mentioned, metal pollution has become an important 
environmental issue because of the non-degradable nature of metal ions 140. Not only 
will the recovery of metal ions from wastewater, contaminated land and discarded 
technology products be an invaluable future resource of these metal ions, but it will 
also help reach sustainability goals. Conventional methods and approaches 
traditionally used for the recovery of metal ions, rely on physicochemical techniques 
that include precipitation, ion exchange, electrochemical methods, solvent extraction, 
membrane filtration and reverse osmosis 139. However, these techniques lack 
specificity, are not environmentally friendly, not always cost-effective, and are 
inefficient when dealing with low concentrations 141. Potentially, a more 
environmentally friendly approach is through bioadsorption, or the innate ability of 
microorganisms, fungi, algae and plants to absorb metal ions 142.  
Microorganisms use two processes of metal ion adsorption. The first adsorption 
process is bioaccumulation, which is the active uptake of metal ions, where they are 
transported into the cytoplasm and then either sequestered into cellular compartments 
or detoxified by enzymatic reduction. However, it is hard to recover metal ions that 
have been bioaccumulated, because it requires a lysis step. The second adsorption 
process is a through the binding of metal ions to the cell surface by polysaccharides, 
adsorption associated proteins, and functional groups 139. Cell surface adsorption 
occurs in living and dead cells, because it is the cell surface that interacts with the 
surrounding material, which enables an easy recovery of metal ions. Cell surface 
engineering enables outer membrane expression of proteins and peptides by fusing 
these to anchoring proteins (transmembrane proteins), which enable the tethering of 
proteins on the outer membrane. This technique was used in this study, as a potential 
way to enhance D. alaskensis’ ability to thrive in environments highly enriched with 
heavy metals. The use of cell surface engineering for displaying proteins and 




various bacteria 143-145. Methallothioneins and phytochelatins are naturally occurring, 
cysteine-rich metal-binding peptides 145.  The expression of these metal-binding 
peptides on the outer membrane of microorganism may confer a higher tolerance to 
those metals and may improve heavy metal NP synthesis. Gram-negative bacteria 
such as D. alaskensis possess a complex cell envelope structure, meaning that the 
anchoring proteins require an efficient signal peptide, a strong anchoring structure, 
compatibility with the host cell, and be protease resistant 143. Anchoring proteins 
such as IgA protease (subunit, no protease activity), Ice Nucleation Protein (INP), 
OmpA, Lpp-OmpA are anchoring motifs that are regularly used in cell surface 
engineering of Gram-negative bacteria 143, 146, 147. An illustration of the depiction of 
































Figure 1. 5. Illustration of cell surface engineering in D. alaskensis. Metal binding 
proteins (EC20 and MT) are tethered to the cell membrane using anchoring proteins 






The synthetic phytochelatin EC20 has previously been used to enhance the 
bioaccumulation of heavy metals in Gram-negative bacteria 148. Moreover, it has 
been shownthat the expression of phytochelatin synthase and metallothionein 
conferred to E. coli the ability to synthesize different metal NPs such as Cd, Se, Zn, 
Te, Fe, Co, Ni, Mn, Cs, Sr, Au, Ag, Pr and Gd6. Recently, recombinant E. coli strains 
expressing either phytochelatoin synthase, phytochelatins or metallothionein, were 
reportedly able to synthesize EuSe NPs, which exhibited high fluorescence, magnetic 
and anticancer properties 149. The successful expression of synthetic phytochelatin 
EC20 in other Gram-negative microorganisms such as Moraxella sp 145, 
Pseudomonas putida 150  and Ralstonia eutropha 151 sets precedent for the possibility 
to express EC20 on the outer membrane of the Gram-negative bacteria D. alaskensis. 
The expression on EC20 on the outer membrane of D. alaskensis to our knowledge 
has never been attempted, and since it has been shown that EC20 has metal-binding 
properties, it was hypothesised that if expressed by D. alaskensis it may increase its 
affinity to metals, confer better metal-binding capacity and/or specificity and 
selectivity 152.  
 
1.4 Aims of Research in Presented Thesis 
The interest in carrying out this project was led by the lack of synthetic biology tools 
available for non-model organism D. alaskensis. This research aims to adapt already 
existing tools to D. alaskensis, engineer new tools for it, and to design the necessary 
parts for a complete MoClo toolkit, which includes libraries of characterised oxygen-
independent fluorescent reporters, and synthetic promoter and RBS libraries. With 
the ultimate aim to accelerate the research into heavy metal bioremediation and NP 
synthesis, the newly engineered D. alakensis MoClo toolkit will enable the easy, 
time and cost effective DNA assembly of genes and pathways involved in the 
synthesis of NPs. These tools will be applied to tailor D. alaskensis NP synthesis and 
its applications within the bioremediation studies. 
As a proof of concept, the D. alaskensis MoClo toolkit was used to tailor NPs 
synthesis. Using a NiFe hydrogenase small subunit (KEGG, Dde_2137), a 




library was assembled using this toolkit; their Pt NP synthesis were assessed and 
compared to controls, and their oxidative and reducing catalytic activities were 
tested. This accomplishment showed that the application of these synthetic biological 
tools could be used to study NP synthesis in D. alaskensis.  
Moreover, a cell-surface engineering study was undertaken for D. alaskensis, to test 
if the expression of the synthetic phytochelatin (EC20), affects its tolerance to Cu, Pt 




















Chapter 2: Materials & Methods 
2.1. Materials and Reagents 
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO): ampicillin, 
chloramphenicol, spectinomycin, sodium chloride, isopropyl-β-D-
thiogalactopyranoside (IPTG), 5-bromo-4-chloro-3-indolyl β-D-galactopyronaside 
(X-GAL), Methylene-blue and 2,6-Dimethoxyphenol (2,6-DMP). PCRs were 
performed using Phusion polymarease, New England Biolab (NEB Cat #M0530S). 
Restriction enzymes, polymerases, ligases, and 1 Kb DNA ladders were purchased 
from NEB. Transformations were performed with NEB 5-alpha competent cells 
(NEB). Agarose gel DNA Extraction, PCR Purification, Plasmid Isolation kits were 
purchased from QIAGEN. Primers were synthesised by Sigma-Aldrich. Plasmids 
with CreiLOV and E.coli CreiLOV genes were synthesised by Genewiz (South 
Plainfield, NJ). Gblocks were synthesised by Integrated DNA Technologies (IDT). 
 
2.2. Molecular Biology Methods 
2.2.1. Polymerase Chain Reaction (PCR) 
All PCR reactions were carried out using commercially available reagents from New 
England Biolabs, following the manufacturer’s protocol with the Phusion High-
Fidelity DNA Polymerase(NEB). PCR conditions were tailored to the size of PCR 
product and the annealing temperatures of the primers used in each reaction as 
instructed by the provided kit. All PCR reactions were performed using a Bio-Rad 
T100 Thermal Cycler.  
2.2.2. Restriction Digestion and Ligation 
Restriction digestion reactions were carried out using commercially available 
reagents from NEB. Reaction volumes were adjusted accordingly to 50 µL or 25 µL, 
depending on their purpose, following the manufacturer’s protocol.   
Ligation reactions were performed in 20 µL total volume reactions, using T4 DNA 
Ligase, NEB Cat#M0202S. Following the manufacturer’s protocol, the vector to 




2.2.3. DNA Sequencing 
DNA sequencing was performed by DNA Sequencing & Services (MRC I PPU, 
School of Life Science, University of Dundee, Scotland, www.dnaseq.co.uk) using 
Applied Biosystems Big-Dye Ver 3.1 chemistry on Applied Biosystems model 3739 
automated capillary DNA sequencer.  
2.2.4. Site-Directed Mutagenesis 
Mutations to plasmids were performed using QuikChange Lighting Site-Directed 
Mutagenesis Kit, Agilent Technologies, and Cat#210518.  DNA primers were 
designed using Agilent’s primer design program. Primers were synthesised by 
Sigma-Aldrich. Verification of the mutations was carried out by sequencing.  
2.2.5. Agarose Gel Electrophoresis 
Agarose gels were made to a concentration of 0.8% by adding agarose to 1X TAE 
buffer (Table 2.4). The solution was then heated to boiling temperature until the 
agarose was completely dissolved. A volume of 0.005% mL SYBR Safe DNA Gel 
Stain was added to the dissolved solution. The gel was poured onto the casting stand 
(Geneflow electrophoresis tank) and allowed to cool. The gel was submerged into a 
gel tank filled with 1X TAE buffer (Table 2.4). Electrophoresis was performed with 
a voltage ranging from 90 -110 V and for 40 – 60 min. Electrophoresis was 
performed using a Bio-Rad PowerPac HC. Visualisation of DNA in agarose gels was 
performed using a Syngene, G:Box with a SYBR Safe detection filter. 
2.2.6. Plasmid isolation and sequence analysis 
All plasmid extractions were carried out using a commercially available plasmid 
extraction kit (QIAGEN, QIAprep Spin Miniprep Kit, Cat#27104) following the 
manufacturer’s protocols. Sequences were analysed using the Electronic Lab 
Notebook software Benchling (San Francisco, CA, USA).  
2.2.7. Agarose gel DNA extraction 
DNA extractions and purifications from agarose gels were carried out using the 
QIAGEN, QIAquick Gel Extraction Kit, Cat#28704.  
2.2.8. PCR purification 
PCR DNA amplified products were purified using the commercially available kit 




2.2.9. MoClo Assembly Reaction 
The MoClo assembly reaction was performed by adding equimolar amounts of 10-60 
fmol of each DNA component and acceptor vector to a 0.2 mL tube (ΔpMOMoClo, 
DVA_AB, DVA_BC, DVA_CD and ΔpMOMoClo_AF). To the same tube, 10 U of 
BsaI (NEB), 20 U of Quick T4 DNA Ligase (NEB), 1x T4 DNA Ligase Buffer 
(NEB) and sterile deionized water to a total volume of 20 µL was added. Reactions 
were performed using the following parameters: 16 cycles at 37°C for 1.5 min, then 
16°C for 3 min, followed by 50°C for 5 min and 80°C for 10 min and were then held 
at 4°C. 
2.3. E. coli culturing 
2.3.1. Growth and transformations of E. coli  
E. coli strains were grown in LB broth (Table 2.4) at 37°C with rotary shaking at 250 
rpm, or LB agar plates. All transformations were performed with 2-5 µL of the 
desired reaction into 50 µL of NEB 5- alpha Competent E. coli (NEB). For 
heterologous protein expression in E. coli, transformations were performed with 2-5 
µL of the desired reaction into 50 µL of E. coli JM109 cells. Cells were plated on 
appropriate antibiotic selection LB agar (See Table 2.3).  For blue-white screening, 
plates were supplemented with 20 mg/µL 5-bromo-4-chloro-3-indolyl β-D-
galactopyronaside (X-GAL) and 0.1 M isopropyl-β-D-thiogalactopyranoside (IPTG), 
Sigma-Aldrich (St. Louis, MO). Blue-white screening was used to select colonies 
which were grown overnight at 37°C in LB supplemented with the appropriate 
antibiotic (See Table 2.3). 
2.3.2. Frozen stock preparation 
E. coli cultures were grown for 24 hours at optimum growth conditions. A volume of 
0.5 mL of bacterial culture was transferred to a screw top microcentrifuge tube. A 
volume of 0.5 mL of 50% glycerol was added to each tube to obtain a 25% glycerol 
stock of each bacterial culture. Glycerol stocks were stored at -80°C.  
2.4. D. alaskensis culturing 
2.4.1. Growth of D. alaskensis 
Growth of D. alaskensis G20 (purchased from DSMZ, DSM No. 17464) was 




carbon. Growth and manipulations of D. alaskensis were carried out at 30°C in an 
anaerobic hood fed with 10% CO2 and 10% H2 in nitrogen. 
2.4.2. Preparing electrocompentent cells and Electrotransformation of 
D. alaskensis 
D. alaskensis competent cells were made by following a modified version of Li and 
Krumholz (2007) 153. Cultures of D. alaskensis G20 were grown to early stationary 
phase (OD600; 0.6 -0.8) under anaerobic conditions. Cells were centrifuged for 15 
minutes at 4000 rpm and resuspended in 10 mL ice-cold sucrose solution (400 mM 
Sucrose, 1 mM MgCl2, filtered and sterilized). The pellets were then resuspended 
and centrifuged twice more, with the final resuspension using 1 mL sucrose solution. 
To 100 µL, 1 µg of plasmid DNA was added and transferred into a 1mm 
electroporation cuvette (Eurogentec, Belgium). Cells were then shocked with 1.5 kV 
using a Micro-Pulser ™ (Bio-Rad, CA). Cell were recovered with 1 mL PGMC and 
transferred into microcentrifuge tubes, incubated anaerobically at 30°C and fed with 
10% CO2 and 10% H2 in nitrogen for 4 hours. Cells were spun down and 
resuspended in 100 µL of PGMC, then plated onto PGMC plates supplemented with 
the appropriate antibiotic (See Table 2.3).  
2.4.3. D. alaskensis frozen stocks preparation  
Bacterial cultures were grown anaerobically until cultures reached an OD600 0.6–0.8 
at optimum growth conditions. A volume of 0.5 mL of bacterial culture was 
transferred to a screw top microcentrifuge tube. A volume of 0.5 mL of 50% glycerol 
was added to each tube to obtain a 25% glycerol stock of each bacterial culture. 
Glycerol stocks were snap-frozen using liquid nitrogen and stored at -80°C. 
2.5. Tables of oligonucleotides, plasmids, reagents and strains used 
No.  Oligonucleotide Sequence 
1.  DaP01_pMO9075-F CGCAGTACTCCTTACGTAG 

























11.  FWD Kan Prom GTTCTAGAGGGTCTCAGGAGATCCGGAATTGCCAGCTGGGGC 
12.  REV Kan Prom CTGAATTCAGGTCTCTAGTAACCCCTGCGCCATCAGATCCTT 
13.  FWD mBFP pMO9-
10 
GTTCTAGAGGGTCTCAAATGATATGCAGAACCTGAATGGTAA 
14.  REV mBFP pMO9-10 CTGAATTCAGGTCTCTACCTACGGCCGCGAAGCCCCCGTCAA 
15.  FWD GFP pMO8-7 GTTCTAGAGGGTCTCAAATGATATGGTGTCCAAAGGGGAAGA 
16.  REV GFP pMO8-7 CTGAATTCAGGTCTCTACCTACTTTATAAAGCTCATCCATCC 
17.  Vector Forward VF2 TGCCACCTGACGTCTAAGAA 
18.  Vector Reverse VR ATTACCGCCTTTGAGTGAGC 
19.  Seq MoClo Fwd 2 GCGAAGTCGAGGCATTTCTGTC 
20.  Seq MoClo Rev 2 AAGAGCGCACTTATACATCG 
21.  AE_pMO9075 FWD TTCTACTAGTAGCGGCCGCTAACATGTGAGCAAAAGGCCA 
22.  AE_pMO9075 REV GTGCAGGTCTCTAAGCATGTCTTTCCTGCGTTATCCCCTG 
23.  DVK_AE FWD CAGGGGATAACGCAGGAAAGACATGCTTAGAGACCTGCAC 
24.  DVK_AE REV TGGCCTTTTGCTCACATGTTAGCGGCCGCTACTAGTAGAA 
25.  FWD_BbsIMutant 
pMO 
GAAAGGCTCAGTCGGCTGGGCCTTTCGTTT 
26.  REV_BbsIMutant 
pMO 
AAACGAAAGGCCCAGCCGACTGAGCCTTTC 
27.  FWD pMO8 
BbsIMutant 
AACTGAAAGGCATTGATTTCAAAGAGGACGGAAATATACTGGG 
28.  REV pMO8 
BbsIMutant 
CCCAGTATATTTCCGTCCTCTTTGAAATCAATGCCTTTCAGTT 
29.  FWD_2137 GTTCTAGAGGGTCTCAAATGAATGAAGTTTTCTGTGGGTCT 
30.  REV_2137  CTGAATTCAGGTCTCTACCTACCTACATTTCGTAGAACGGGC 
31.  FWD_SiteMut_2137  AAGTTTTCTGTGGGCCTCGGCAAAGAGGGC 
32.  REV_SiteMut_2137  GCCCTCTTTGCCGAGGCCCACAGAAAACTT 
33.  REV_phiLOV2 CTTCTAGAAGGTCTCTTACCTACGATCGTGATCACTAGTTTAC 
34.  FWD_phiLOV2 GTTCTAGAGGGTCTCAAATGATGCTAGCTCAGTCCTAGGTAT 
35.  FWD_DsLUC GTTCTAGAGGGTCTCAAATGATATGATCGAAAAGTCCTTCGT 
36.  REV_DsLUC CTGAATTCAGGTCTCTACCTACTTACACGTGGTCGGAGCCCA 
37.  FWD_BbsIMutant GAAAGGCTCAGTCGGCTGGGCCTTTCGTTT 
38.  REV_BbsIMutant AAACGAAAGGCCCAGCCGACTGAGCCTTTC 
39.  #EC20pHEB FWD TCTGATGGCGCAGGGGATCAATGAAATACCTATTGCCTACGG 
40.  #EC20pHEB REV GGGGGCTTGAATTCGCCCTTTTAGAAACGAATCTGTATTTTAAT
TTGT 
41.  #pMO9075 FWD AAATACAGATTCGTTTCTAAAAGGGCGAATTCAAGCCCCC 
42.  #pMO9075 REV GTAGGCAATAGGTATTTCATTGATCCCCTGCGCCATCAGA 
43.  Seq #pMO9075 FWD TTTTGAGACACGGGCCAGAGCTGC 
44.  Seq #pMO9075 REV CCCGATTCTCGACGAGCTGAAAGC 
45.  FWD PR-8 ACTAGGGGTCTCAGGAGATTTCAAAGGCATGCATAAGGCTCG 
CGTTACGAAATTACTAGAGACCATATCC 
46.  REV PR-8 TGATCCCCAGAGTCCTCTAAAGTTTCCGTACGTATTCCG 
AGCGCAATGCTTTAATGATCTCTGGTATAGG 
47.  FWD PR-10 ACTAGGGGTCTCAGGAGATTTCAGA GGCATGCATAAGGCTCG 
GGTTACCATATTACTAGAGACCATATCC 
48.  REV PR-10 TGATCCCCAGAGTCCTCTAAAGTCTCCGTACGTATTCCG 
AGCCCAATGGTATAATGATCTCTGGTATAGG 
 
Table 2. 1. List of oligonucleotides used in this work. Oligonucleotides designed for 
oxygen-independent reporter library cloning No. 1-10. Oligonucleotides to PCR-
amplify pMO9075 backbone for Gibson assembly No. 1-2. Golden Gate assembly 
oligonucleotides No. 3-8. Sequencing oligonucleotides No. 9 and 10. 




Sequencing oligonucleotides No. 17-20; No 17-18 correspond to oligonucleotides 
used to sequence new basic parts, No. 19 and 20 correspond to oligonucleotides used 
to sequence transcriptional units (TUs). No. 21-24 correspond to oligonucleotides 
used to amplify the insert and vector to assemble the acceptor vector ΔpMOMoClo. 
No. 25 and 26 correspond to oligonucleotides used to remove the BbsI recognition 
sites in ΔpMOMoClo through Site-Directed Mutagenesis. No. 27 and 28 correspond 
to oligonucleotides used to remove the BbsI recognition sites in DVa_pMO8 through 
Site-Directed Mutagenesis. No. 29 and 30 are oligonucleotides used to adapt the 
NiFe hydrogenase to MoClo. No. 31 and 32 correspond to oligonucleotides used to 
remove the BsaI recognition sites in pMO2137. No. 37 and 38 correspond to 
oligonucleotides used to remove the BbsI recognition site from DVa_LUC. No. 39 -
42 correspond to oligonucleotides to PCR the backbone and insert for Gibson 
assembly of pMOEC20. No. 43 and 44 are oligonucleotides used for the sequencing 
of pMOEC20. No. 45–48 correspond to the set of complementary oligonucleotides of 
the synthetic promoter PR-8 and PR-10.  
 
Table 2. 2. Strains used in the study.  
Strain  Characteristics Reference/Source 
E. coli NEB 5- alpha cloning strain New England Biolabs 
D. alaskensis G20 wild-type strain 153 
E. coli JM109 cloning strain New England Biolabs 
 
 
Table 2. 3. Plasmids used in the study.  
Plasmid Relevant details Antibiotic Used Reference 
pUC19 pMB1, lacZα 50 µg/mL Ampicillin NEB 
pMO9075 pBGI D. alaskensis plasmid backbone. 50 µg/mL Spectinomycin 
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ΔpMOMoClo pBGI D. alaskensis plasmid backbone, MoClo destination vector, lacZα and fixed illegal site. 
50 µg/mL 
Spectinomycin This study 
ΔpMO9075 pBGI D. alaskensis plasmid backbone, and fixed illegal site.  
50 µg/mL 
Spectinomycin This Study 
ΔpMOMoClo 
AF 
pBGI D. alaskensis plasmid backbone, MoClo 
destination vector, lacZα and fixed illegal site. 
40 µg/mL 




Fusion sites A and F 
pMOEC20 pBGI D. alaskensis plasmid backbone, EC20/IgA gene  
50 µg/mL 
Spectinomycin This Study 
pMO1 pBGI D. alaskensis plasmid backbone, BfgV D8 gene 
50 µg/mL 
Spectinomycin This Study 
pMO2 pBGI D. alaskensis plasmid backbone, Truncated BfgV D8 gene 
50 µg/mL 
Spectinomycin This Study 
pMO3 pBGI D. alaskensis plasmid backbone, Truncated BfgV D8 WR198NK gene 
50 µg/mL 
Spectinomycin This Study 
pMO4 pBGI D. alaskensis plasmid backbone, BsLOV gene 
50 µg/mL 
Spectinomycin This Study 
pMO5 pBGI D. alaskensis plasmid backbone, Truncated BsLOV C62A gene 
50 µg/mL 
Spectinomycin This Study 
pMO6 pBGI D. alaskensis plasmid backbone, PpLOV gene 
50 µg/mL 
Spectinomycin This Study 
pMO7 pBGI D. alaskensis plasmid backbone, AvGFP R10-3 gene 
50 µg/mL 
Spectinomycin This Study 
pMO8 pBGI D. alaskensis plasmid backbone, AvGFP R10-3 S66A gene 
50 µg/mL 
Spectinomycin This Study 
pMO9 pBGI D. alaskensis plasmid backbone, mBFP gene 
50 µg/mL 
Spectinomycin This Study 
pMO10 pBGI D. alaskensis plasmid backbone, mBFP G188S gene 
50 µg/mL 
Spectinomycin This Study 
pMO11 pBGI D. alaskensis plasmid backbone, PpLOV C53A gene 
50 µg/mL 
Spectinomycin This Study 
pMO12 pBGI D. alaskensis plasmid backbone, BsLOV C62A gene 
50 µg/mL 
Spectinomycin This Study 
 
 
Table 2. 4. Stock Solutions, Media and Buffers 
Solution/Media/Buffer Relevant details 
Agarose gel 0.8% Agarose, 0.005% SYBR Safe DNA Gel Stain 
LB Medium 1% w/v Tryptone, 0.5% w/v Yeast Extract, NaCL, NaOH 
LB Agar Medium LB Medium supplemented with 1.5% agar 
PGMC Medium 
0.5 g KH2PO4, 1 g NH4Cl, 4.5 g Na2SO4, 0.06 g CaCl2·6H2O, 
0.06 g MgSO4·7H2O, 10 mL/L Sodium lactate, 1 g Yeast 
Extract, 0.004 g FeSO4·7H2O, 0.3 g Sodium citrate, 1000 mL 
H2Odd – Adjust pH to 7.5 
PGMC Agar Medium PGMC Medium supplemented with 10g/L of agar  
Sucrose solution 400 mM Sucrose, 1 mM MgCl2 
SOC (Super optimal broth) 0.5% w/v Yeast Extract, 2% Trytone, 10 mM NaCl, 2.5 mM KCl, 20 mM MgSO4, 20 mM Glucose 
TAE Buffer (20x Stock) 96.8 g Tris base, 22.8 mL glacial acetic acid, 7.4 g EDTA disodium salt, H2Odd to 1 L.  
TE Buffer (10x Stock) 1 M Tris-HCl pH 7.5, 0.5 M EDTA pH 8.0, 880 mL H2Odd 
TPM Buffer 30 mM MgSO4, 10 mM KH2PO4, 10 mM Tris-HCl 







Table 2. 5. List of gBlocks used for cloning and CreiLOV sequences. RED: Flanking 















































































































































































































































































2.6. Adapting D. alaskensis to MoClo standards 
2.6.1. PCR amplification of A:LacZα:E insert and pMO9075 vector 
From the DVK_AE plasmid obtained from CIDAR MoClo Parts Kit (Cidar MoClo 
Parts Kit, Douglas Densmore, Addgene Kit # 1000000059) the LacZα gene fusion 
sites and BsaI and BbsI flanking recognition sites were PCR amplified. The 
pMO9075 backbone containing the pBGI and its multiple cloning site, was also PCR 
amplified. Primers were designed to uphold the Gibson Assembly standards (Table 
2.1, No. 21-24). The resulting PCR products were confirmed by electrophoresis on a 
0.8% agarose gel, then excised and purified. 
2.6.2. Gibson Assembly 
The DNA insert and backbone purified fragments were assembled by HiFi DNA 
Assembly® Reaction protocol, NEB, Cat#E2621S. Assembled plasmids were 
transformed into chemically competent E. coli NEB 5 - alpha.  
2.6.3. Confirmation through Blue-White Screening 
To confirm the successful cloning of LacZα from DVK_AE, the resulting colonies 
were restreaked onto a blue/white screening plate. Plates were supplemented with 1 
µL per 1 mL of Media of 100 mM IPTG and 20 µg/µl X-Gal, and its respective 
antibiotic.  
2.6.4. Insert specific PCR Confirmation 
Each blue colony was cultured overnight and their plasmids isolated. An insert 
specific PCR was performed for each plasmid using the primers 19 and 20 shown in 
Table 2.1, with an anneal temperature of 62°C. The resulting PCR products were 
confirmed by electrophoresis on a 0.8% agarose gel.  
2.6.5. Diagnostic Digest Reaction with BsaI 
To further confirm, a BsaI diagnostic digest reaction (NEB protocol) was performed 
followed by electrophotesis on a 0.8% agarose gel  was performed. The plasmid was 
then sequenced (see Table 2.2 for sequencing primers).  
2.6.6. Site-directed mutagenesis of BbsI recognition site 
The BbsI recognition site found in the pMO9075 backbone needed to be removed to 




recognition site was deleted from the MoClo adapted pMO9075 plasmid 
(ΔpMOMoClo). Primers for the deletion of the BbsI recognition site were designed 
(Table 2.1, No. 25 and 26) to delete the BbsI recognition site.  The QuikChange 
Lighting (Agilent) Site-Directed Mutagenesis kit protocol was followed. Mutant 
plasmids were transformed into chemically competent E. coli NEB 5- alpha cells. 
2.6.7. Diagnostic digestion reaction with BbsI 
To confirm the deletion of the BbsI recognition site a diagnostic digest reaction with 
BbsI (NEB protocol) was performed, followed by electrophoresis on a 0.8% agarose 
gel.  
2.6.8. MoClo Cloning Assembly Test 
To test the adapted MoClo construct ΔpMOMoClo the components J23100_AB, 
B0034m_BC, C0012m_CD, and B0015_DE from the CIDAR MoClo Parts Kit were 
cultured overnight and purified following previously mentioned E. coli methods. 
Using these components together with ΔpMOMoClo, a transcriptional unit (TU) was 
assembled through a MoClo assembly reaction. The resulting reaction was inserted 
into E. coli NEB 5-alpha competent cells and plated onto blue/white screening plates.  
pUC19 was used as a positive transformation control. Confirmation was done 
through a blue/white screening test on plates supplemented with 50 µg/mL 
Spectinomycin.   
2.6.9. Assembly of multi-gene expression acceptor vector ΔpMoMoClo 
AF 
To assemble ΔpMoMoClo AF, the Chloramphenicol resistance gene, with a T7 
bacterial promoter, strong bacterial RBS and lambda T0 terminator were synthesized 
as a gBlock (Table 2.5; LacAF_CmR). The gBlock also contained the essential lacZα 
gene from the acceptor vector DVK_AF and was flanked by a XhoI and XbaI 
recognition sites listed and described on Table 5. The gBlock was resuspended in TE 
buffer. gBlock and plasmid ΔpMO9075 were digested with XbaI and XhoI. 
ΔpMO9075 was ran prior to gel electrophoresis in a 0.8% agarose gel.  ΔpMoMoClo 
AF was assembled by ligating both digested parts. The resulting ligation reaction was 
inserted into E. coli NEB 5-alpha competent cells and plated onto blue/white 




onto fresh blue/white screening Chloramphenicol plates (40 µg/mL). Plasmids were 
extracted and sequenced for confirmation of correct assembly using sequencing 
primers (Table 1, No. 19 and 20). 
 
2.7. Designing and Engineering an Oxygen-independent reporter library for 
D. alaskensis 
2.7.1. Adapting CreiLOV, phiLOV and nanoLUC to MoClo standards 
To adapt the coding sequences of the oxygen-independent reporters phiLOV 
(plasmid was donated by Professor Susan Rosser, University of Edinburgh), and 
nanoLUC (NanoLUC®, Promega) to MoClo standards, the sequences of interest were 
amplified using the primers from Table 2.1, No. 33 – 36, with anneal temperatures of 
63°C and 65°C respectively. Primers were designed as follows: Forward primer, 9 
nucleotides; BsaI recognition site (GGTCTC), 1 nucleotide; Fusion site C (AATG), 2 
nucleotides, 15 nucleotides of sequence of interest. Reverse primer, 9 nucleotides; 
BsaI recognition site (GGTCTC), 1 nucleotide; Fusion site D (ACCT), 2 nucleotides, 
15 nucleotides of sequence of interest. PCR amplified DNA of interest was run on a 
0.8% agarose gel and extracted. Genes corresponding to the CreiLOV domains were 
codon optimised for expression in D. alaskensis (obtained using bioinformatics tool, 
JCat 154) and synthesized by Genewiz (South Plainfield, NJ). CreiLOV domains were 
flanked by BsaI recognition sites followed by fusion site C nucleotides (NTs) on the 
5’ end and by fusion site D nucleotides (NTs) on the 3’ end. Assembly of new 
MoClo parts was through a MoClo reaction as follows: Add to a 0.2 mL tube: 
equimolar 10 – 60 fmol of the DNA amplicons or CreiLOV plasmid and acceptor 
vector DVA_CD, 10 U of BsaI (NEB), 20 U of Quick T4 DNA Ligase (NEB), 1x T4 
DNA Ligase Buffer (NEB), and sterile deionized water to a total volume of 20 µL. 
Reactions were performed using the following parameters: 16 cycles (37°C for 1.5 
min, 16°C for 3 min), followed by 50°C for 5 min and 80°C for 10 min and were 
then held at 4°C until they were used in transformations. The resulting reaction was 
inserted into E. coli NEB 5-alpha competent cells and plated onto blue/white 
screening plates with Ampicillin (50 µg/mL). Multiple colonies that showed a white 




assembly of DVA_CreiLOV, DVA_phiLOV, and DVA_LUC was confirmed 
through sequencing using sequence primers (Table 2.1, No. 17 and 18). 
2.7.2. Site-directed mutagenesis of BbsI recognition site (DVA_LUC) 
The BbsI recognition site found on DVA_LUC plasmid needed to be removed to be 
compliant with MoClo standards. Through site-directed mutagenesis, the BbsI 
recognition site was deleted from DVA_LUC. Primers for the deletion of the BbsI 
recognition site were designed (Table 2.1, No. 37 and 38).  The QuikChange 
Lighting (Agilent) Site-Directed Mutagenesis kit manufacturer’s protocol was 
followed to mutate BbsI recognition site. Mutant plasmids were inserted into 
chemically competent E. coli NEB 5-alpha cells. 
2.7.3. Diagnostic Digest Reaction with BsaI 
To confirm if parts were adapted to MoClo a BsaI diagnostic digest reaction (NEB 
protocol) was performed followed by electrophoresis on a 0.8% agarose gel.  
2.7.4. Diagnostic Digest Reaction with BbsI 
To confirm the deletion of the BbsI recognition site, a diagnostic digestion reaction 
with BbsI (NEB protocol) was performed, followed by electrophoresis on a 0.8% 
agarose gel.  
2.7.5. Assembly of Transcriptional Units (TUs) for CreiLOV and 
phiLOV 
TUs were assembled by a MoClo assembly reaction. Different TUs were assembled 
for CreiLOV, E. coli CreiLOV and phiLOV. Each TU contains the following parts 
from the CIDAR MoClo Parts Kit; J23100_AB, J23106_AB, J23116_AB, 
B0034m_BC, B0015_DE, Kan promoter and acceptor plasmid ΔpMOMoClo. For 
phiLOV and E. coli CreiLOV only one promoter was used (J23100_AB). Assembled 
TUs were inserted into E. coli 5- alpha competent cells and plated onto blue/white 
screening plates  supplemented with 50 µg/mL spectinomycin. White colonies were 
restreaked onto fresh blue/white screening plates supplemented with spectinomycin 
(50 µg/mL). Plasmids were isolated and sequenced for confirmation of correct 




2.7.6. Fluorescence assay of E. coli expressing CreiLOV and phiLOV 
Overnight E. coli cultures of each TU were grown under aerobic conditions. OD600 
readings from E. coli expressing the TUs were measured using CO8000 Cell Density 
Meter (WPA, Cambridge, UK). In a Falcon® 96-well Black/Clear Flat Bottom 
(Corning, NY, USA) cultures were diluted with LB/Spectinomycin to an OD600 of 
0.15 in a total volume of 200 µL. Plasmid (pMO9075) in E. coli cultures was used as 
a negative control, and LB/Spectinomycin as the blank. Biological triplicates and 
technical triplicates were used per sample. Plates were incubated for 4 hours at 37°C. 
Readings were done with a Tecan M200 PRO, where the absorbance was measured 
at 600 nm (A600nm) and fluorescence for CreiLOV and phiLOV (Ex. 450 nm, Em. 
495 nm). 
2.7.7. Fluorescence assay of D. alaskensis expressing CreiLOV 
All TUs were inserted into D. alaskensis and cultured under anaerobic conditions. 
Cultures were grown to early stationary phase (OD600; 0.6 -0.8) under anaerobic 
conditions. OD600 readings from D. alaskensis expressing the TUs were measured 
using a CO8000 Cell Density Meter (WPA, Cambridge, UK). In a Falcon® 96-well 
Black/Clear Flat Bottom (Corning, NY, USA), cultures were diluted with 
PGMC/Spectinomycin to an OD600 of 0.15 to a total volume of 200 µL. Cells 
containing the plasmid pMO9075 was used as a negative control, and 
PGMC/Spectinomycin as blank. Biological triplicates and technical triplicates per 
sample and controls were used. Plates were incubated anaerobically for 72 hours at 
30°C. Readings were done with a Tecan M200 PRO, where the absorbance was 
measured at 600 nm (A600nm) and fluorescence (CreiLOV, Ex. 450 nm, Em. 495 nm). 
2.7.8. Genome mining, cloning and sequence design for increased 
oxygen-independent reporter library 
Biotangents (Edinburgh, UK), conducted the gene mining research and the assembly 
of the oxygen-independent fluorescent reporter library. Potential oxygen-independent 
fluorescent reporters were identified through a literature search focused on oxygen-
independent GFP, BFP and FbFP proteins and their variants. A total of 12 different 
oxygen-independent fluorescent reporters were found suitable for testing in D. 
alaskensis. The oligonucleotides and synthetic DNA fragments (gBlock linear 




2.5. Genes corresponding to the oxygen-independent reporters were synthesized as 
gBlocks, each containing an RBS, designed in silico using RBS Calculator 110 (to 
maximize initiation of translation) and an E. coli His terminator. To construct the 
oxygen-independent library, the pMO9075 plasmid backbone including the putative 
Kan promoter were PCR-amplified (Q5 High-Fidelity, NEB) and assembled with the 
gBlocks by HiFi DNA Assembly® Reaction Protocol (NEB). All plasmids with the 
exception of pMO11 and pMO12 were assembled by Gibson® assembly of the 
gBlocks with a PCR-amplified pMO9075 backbone. To assemble pMO11 and 
pMO12, their corresponding gBlocks and pMO9075 were PCR-amplified (Q5 High-
Fidelity, NEB) to Golden Gate standards for subsequent assembly. 
2.7.9. Screening for fluorescence excitation and emission 
For rapid screening of fluorescence emission, 50 ng of each plasmid DNA was 
inserted into E. coli JM109 competent cells and grown under aerobic conditions. 
Transformed cells were plated on LB/spectinomycin (100 µg/mL).  E. coli plates 
were incubated overnight at 37°C under aerobic conditions. Similarly, D. alaskensis 
plates were incubated at 30°C in an anaerobic hood for 7 days. Both the anaerobic 
and aerobic set of plates were exposed to black light for rapid screening of 
fluorescence emission.  
To test the oxygen-independent reporter library, 200 ng of each plasmid DNA were 
inserted into freshly made D. alaskensis competent cells following the 
aforementioned method (Section 2.3.2.). Transformed cells were plated on 
PGMC/spectinomycin (100 µg/mL). Plates were incubated at 30°C in an anaerobic 
hood for 7 days. Colonies were selected and grown in anaerobic conditions in 
PGMC/spectinomycin (100 µg/mL) broth and grown to an OD600 ~ 1.0. 50 ng of each 
plasmid DNA was also inserted into E. coli JM109 and plated on LB/spectinomycin 
(100 µg/mL). Plates were incubated overnight at 37°C, with the exception of pMO5 
and pMO6 (30°C), as it is their optimal growth temperature.  Colonies were selected 
and grown in aerobic conditions in LB/spectinomycin (100 µg/mL) broth for 16 
hours. D. alaskensis and E. coli cultures were diluted to an OD600 of 0.1 in PGMC 
and LB respectively with spectinomycin (100 µg/mL) and incubated for 4 hours 
under anaerobic (D. alaskensis) and aerobic (E. coli) conditions. On a Falcon® 96-




were dispensed. D. alaskensis and E. coli JM109 transformed with the plasmid 
pMO9075 were used as a negative control and PGMC or LB with spectinomycin as 
the blanks. Biological triplicates and per sample and controls were used. An oxygen 
free environment was maintained by sealing the 96 well plates with parafilm and 
tape. Plates were placed on a Tecan M200 PRO to measure absorbance OD600 and 
fluorescence at a range of wavelengths (Table 3.1, Chapter 3). To characterise pMO9 
and pMO10, an array of wavelengths were used: 350-410 nm for excitation and 420 
– 500 nm for emission altering each reading by 20 nm.  
2.7.10. Adapting the oxygen-independent reporter library to MoClo 
To adapt the coding sequences of the oxygen-independent reporters to MoClo 
standards, the sequences of interest were amplified using the primers in Table 2.1 
(No. 13-16), which were designed as mentioned in section 2.6.1. PCR amplified 
DNA of interest was run on 0.8% agarose gel and extracted (QIAGEN). 
2.7.11. Site-directed mutagenesis of BbsI recognition site (pMO8) 
The BbsI recognition site found on the pMO8 plasmid needed to be removed to be 
compliant with MoClo standards. The BbsI recognition site was deleted from 
DVA_pMO8 through site-directed mutagenesis. The QuikChange Lighting (Agilent) 
Site-Directed Mutagenesis kit manufacturer’s protocol was followed using primers 
designed to delete the BbsI recognition site (Table 1, No. 27-28). Mutant plasmids 
were transformed into chemically competent E. coli NEB 5-alpha cells.  
2.7.12. Diagnostic Digest with BbsI 
To confirm the deletion of the BbsI recognition site a diagnostic digestion reaction 
with BbsI (NEB protocol) was performed, followed by electrophoresis on a 0.8% 
agarose gel. 
2.7.13. Assembly of TUs for oxygen-independent fluorescent reporter 
library 
TUs for PMO7, PMO8, PMO9 and PMO10 were assembled via a MoClo assembly 
reaction. Each TU contained the following parts from the CIDAR MoClo Parts Kit; 
J23100_AB, J23106_AB, J23116_AB, B0034m_BC, B0015_DE, Kan promoter 
(only PMO7) and acceptor plasmid ΔpMOMoClo. Assembled TUs were inserted 




Plates were supplemented with 50 µg/mL spectinomycin. White colonies were 
restreaked onto fresh blue/white screening spectinomycin plates. Plasmids were 
isolated and sequenced for confirmation of correct assembly using sequencing 
primers (Table 2.1, No. 19 and 20). 
2.7.14. Fluorescence Assay of D. alaskensis expressing oxygen-
independent reporters library 
D. alaskensis was electrotransformed with all TUs and cultured under anaerobic 
conditions. Cultures were grown to early stationary phase (OD600; 0.6 -0.8) under 
anaerobic conditions. OD600 readings from D. alaskensis expressing the TUs were 
measured using CO8000 Cell Density Meter (WPA, Cambridge, UK). In a Falcon® 
96-well Black/Clear Flat Bottom (Corning, NY, USA) cultures were diluted with 
PGMC/spectinomycin to an OD600 of 0.15 in a total volume of 200 µL. D. alaskensis 
transformed with the plasmid pMO9075 was used as a negative control, and 
PGMC/spectinomycin as blank. Biological and technical triplicates per sample and 
controls were used. Plates were incubated for 72 hours at 30°C in an anaerobic hood 
fed with 10% CO2, 10% H2 in nitrogen. Plates were placed in a Tecan M200 PRO 
and absorbance was measured at 600 nm and fluorescence for PMO7 & PMO8 at Ex. 
525 nm, Em. 600 nm; PMO9 & PMO10, Ex. 410 nm, Em. 500 nm. 
2.7.15. Fluorescence Microscopy of D. alaskensis expressing CreiLOV 
and PMO7 
TUs for CreiLOV LS and PMO7 MS were inserted into D. alaskensis and cultured 
under anaerobic conditions. Cultures were grown to mid-exponential phase (OD600; 
0.4 -0.5) under anaerobic conditions. A modified protocol from Fievet et al 155 was 
followed; modified protocol does not use an agar pad. OD600 readings from D. 
alaskensis expressing the TUs were measured using CO8000 Cell Density Meter 
(WPA, Cambridge, UK). In a microcentrifuge tube, 200 µL of each D. alaskensis 
culture was added and centrifuged (13,000 rpm, 3 minutes). The pellet was 
resuspended with 100 µL of 10 mM TPM buffer (Table 2.4). Cells were incubated 
under anaerobic conditions for 20 minutes. On a circular microscope cover slide, 25 
µL of the sample was placed, followed by 500 µL of 2% liquid non-nutrient agar. 
The solution was covered with a circular microscope cover slide. Images were 




Laboratory, Edinburgh, UK). For pMO7 LS, the filters used were GFP (Ex 474/26 
nm, Em 525/40 nm) and for CreiLOV the filters used were GFP (Ex 474/26 nm, Em 
525/40 nm), Cy3 (Ex 554/23 nm, Em 596/83 nm) and CFP (Ex 438/24 nm, Em 
482/24 nm).  
2.7.16. Assembly of TUs expressing both PMO7 and CreiLOV 
Two multi-gene expression TUs were assembled (CR LS pMO7 MS and CR Kan 
pMO7 MS) for the orthogonal expression of PMO7 and CreiLOV via MoClo 
assembly. The following TUs were assembled first: CR LS, CR Kan, and EF pMO7 
MS. Each TU contained the following parts:  CR LS (DVA_CreiLOV, J2103_AB, 
B0034m_BC, B0015_DE and ΔpMOMoClo) CR Kan (DVA_CreiLOV, DVA_Kan, 
B0034m_BC, B0015_DE and ΔpMOMoClo) and EF pMO7 MS (DVA_pMO7, 
J23106_EB, B0034m_BC, B0015_DF and DVK_EF). Assembled TUs were inserted 
into E. coli NEB 5-alpha competent cells and plated onto blue/white screening plates. 
Plates were supplemented with 50 µg/mL spectinomycin (CR LS and CR Kan) and 
with 50 µg/mL kanamycin (EB pMO7 MS). White colonies were restreaked onto 
fresh blue/white screening spectinomycin (50 µg/mL) or Kanamycin plates (50 
µg/mL). Plasmids were isolated and sequenced for confirmation of correct assembly 
using sequencing primers (Table 1, No. 19 and 20). Using the assembled TUs, each 
multi-gene expression TU was assembled by MoClo assembly with BbsI digestion 
instead of BsaI. TUs contain the following TU components: CR LS pMO7 MS (TU 
CR LS and TU EF pMO7 MS) and CR Kan pMO7 MS (TU CR Kan and TU EF 
pMO7 MS). Assembled TUs were transformed into E. coli NEB 5-alpha competent 
cells and plated onto blue/white screening plates. Plates were supplemented with 
Chloramphenicol (100 µg/mL). White colonies were restreaked onto fresh blue/white 
screening Chloramphenicol plates (100 µg/mL). Plasmids were isolated and 
sequenced for confirmation of correct assembly using sequencing primers (Table 2.1, 
No. 19 and 20). 
2.7.17. Fluorescence assay of E. coli expressing PMO7 and CreiLOV 
orthogonally 
All TUs were inserted into E. coli and cultured under anaerobic and aerobic 
conditions respectively. Cultures grown to early stationary phase (OD600; 0.6 -0.8) 




Meter (WPA, Cambridge, UK). In a Falcon® 96-well Black/Clear Flat Bottom 
(Corning, NY, USA) cultures were diluted with LB/Chloramphenicol (100 µg/mL) to 
an OD600 of 0.2 to a final volume of 200 µL. E. coli transformed with the plasmid 
pMO9075 was used as a negative control, CR LS and EF PMO7 MS TUs were used 
as controls. LB/chloramphenicol (100 µg/mL) as the blank. Biological and technical 
triplicates per sample and controls were used. Plates were incubated for 4 hours at 
37°C. On a Tecan M200 PRO the absorbance at 600 nm and fluorescence were 
measured at the following wavelengths: PMO7, Ex. 525 nm, Em. 600 nm; CreiLOV, 
Ex. 450 nm, Em. 495 nm. Further orthogonality was examined by testing TUs to an 
emission screening with a fixed excitation (PMO7, Ex. 525 nm; CreiLOV, Ex. 450 
nm). Emission screening was conducted by iterating 5 nm, starting at their respective 
excitation wavelength.   
2.8. Designing and Engineering a Synthetic RBS library 
2.8.1. Design of a synthetic RBS library using RBS Calculator 
To design a synthetic RBS specifically for D. alaskensis the chosen sequences were 
predicted using the bioinformatics tool RBS Calculator 110. The information provided 
to the bioinformatics tool was the following protein coding sequences: PMO7, 
pMO8, pMO9, pMO10 and CreiLOV (Section 2.4., Table. 2.5). The organism D. 
alaskensis G20 was selected and maximised proportional scale was used (maximum 
translation initiation), to ensure the highest translation initiation rate.  
2.8.2. Adapting synthetic RBS library to MoClo 
The predicted synthetic RBS sequences were adapted to MoClo standards by adding 
flanking BsaI recognition sites (GGTCTC) followed by fusion site B (TACT) on the 
5’end and fusion site C (TTAC) on the 3’ end. The synthetic RBS from the library 
was synthesised in a single gBlock (Table 2.5) (Integrated DNA Technologies) and 
used for assembly in a MoClo acceptor vector. The library was adapted using the 
following protocol: To a 0.2 mL tube add equimolar 10 – 60 fmol of the gBlock and 
acceptor vector DVA_BC, 10 U of BsaI (NEB), 20 U of Quick T4 DNA Ligase 
(NEB), 1x T4 DNA Ligase Buffer (NEB), and sterile deionized water to a total 
volume of 20 µL. Reactions were performed using the following parameters: 16 




10 min and were then held at 4°C. The resulting reactions were inserted into E. coli 
NEB 5-alpha competent cells and plated onto blue/white screening plates. Plates 
were supplemented with ampicillin (50 µg/mL). Multiple colonies that showed a 
white phenotype were picked and grown overnight and subsequently used for 
plasmid purification. Plasmids were then sequenced to confirm RBS sequence for 
each plasmid (Table 2.1, No. 17 and 18).  
2.8.3. Assembly of TUs using synthetic RBS library 
To characterise the synthetic RBS library, TUs were assembled expressing oxygen-
independent reporters (PMO7 and CreiLOV), under the control of the same promoter 
(J23106_AB) and terminator (B0015_DE). The following components were used: 
J23106_AB, B0015_DE, ΔpMOMoClo, synthetic RBS library (RBS 7, RBS 8, RBS 
9, RBS 10 or RBS Cr), and an oxygen-independent reporter (PMO7 or CreiLOV). A 
total of 10 TUs were assembled through MoClo assembly. The resulting reactions 
were used in E. coli NEB 5-alpha transformatons and plated onto blue/white 
screening plates. Plates were supplemented with 50 µg/mL spectinomycin. White 
colonies were restreaked onto fresh blue/white screening spectinomycin plates. 
Plasmids were isolated and sequenced for confirmation of correct assembly using 
sequencing primers (Table 2.1, No. 19 and 20).  
2.8.4. Fluorescence assay of D. alaskensis expressing RBS library 
D. alaskensis was transformed with all 10 TUs and cultured under anaerobic 
conditions. Cultures were grown to early stationary phase (OD600; 0.6 -0.8) under 
anaerobic conditions. OD600 readings from D. alaskensis expressing the TUs were 
measured using CO8000 Cell Density Meter (WPA, Cambridge, UK). In a Falcon® 
96-well Black/Clear Flat Bottom (Corning, NY, USA) cultures were diluted with 
PGMC/Spectinomycin (100 µg/mL) to an OD600 of 0.15 in a total volume of 200 µL. 
D. alaskensis transformed with the plasmid pMO9075 was used as a negative 
control, and PGMC/Spectinomycin (100 µg/mL) as the blank. Biological and 
technical triplicates per sample were used. Plates were incubated for 72 hours at 
30°C in an anaerobic hood fed with 10% CO2, 10% H2 in nitrogen. On a Tecan M200 
PRO the absorbance at 600 nm and fluorescence of PMO7 at Ex. 525 nm, Em. 600 




2.9. Designing and Engineering a Synthetic Promoter library 
2.9.1. Designing a minimal and native synthetic promoter library using 
BProm 
To design synthetic promoters specifically for D. alaskensis the chosen sequences 
were predicted using the bioinformatics tool BPROM 98. A minimal promoter design 
of of the -10 and -35 hexamer boxes and the E. coli consensus spacer region 
(GGCATGCATAAGGCTCG) 156 was chosen for this study. The following 
housekeeping genes were used to predict the -10 and -35 hexamer boxes: Chaperone 
dnaK (PR-1), grpE (PR-3), groEL (PR-4), secE (PR-7), secY (PR-8), ntH (PR-9) and 
gyrA (PR-10). Sequences found 150 bp upstream of the housekeeping genes were 
used for to generate the -35 and -10 hexamer boxes. For a native promoter design, 
the design was the same as that of a minimal promoter design, but differed in that the 
spacer region consisted of the sequence between the -10 and -35 hexamer boxes. The 
native promoter tested in this study was predicted from the sequence of protein 
translocase subunit SecE (NPR-7).  
2.9.2. Adapting the synthetic promoter library to MoClo 
The predicted synthetic promoter sequences were adapted to MoClo standards by 
adding flanking BsaI recognition sites (GGTCTC) followed by a fusion site A 
(TACT) on the 5’end and a fusion site B (TTAC) on the 3’ end. The PR-1, PR-3, PR-
4, PR-7, NPR-7 and PR-9 from the library were synthesised in a single gBlock 
(Table 2.5) (Integrated DNA Technologies) and used for assembly in a MoClo 
acceptor vector. The library was assembled with the following protocol: Add to a 0.2 
mL tube: equimolar 10 – 60 fmol of the gBlock and acceptor vector DVA_AB, 10 U 
of BsaI (NEB), 20 U of Quick T4 DNA Ligase (NEB), 1x T4 DNA Ligase Buffer 
(NEB), and sterile deionized water to a total volume of 20 µL. Reactions were 
performed using the following parameters: 16 cycles (37°C for 1.5 min, 16°C for 3 
min), followed by 50°C for 5 min and 80°C for 10 min and were then held at 4°C 
until they were transformed. The resulting reaction was inserted into E. coli NEB 5-
alpha and plated onto blue/white screening plates. Plates were supplemented with 
Ampicillin (50 µg/mL). Multiple colonies that showed a white phenotype were 
picked and grown overnight for plasmid purification. Plasmids were then sequenced 




PR-8 and PR-10 were assembled by annealing complementary oligonucleotides 
(Table 2.1, No. 45-48). Oligonucleotides were synthesised by Sigma-Aldrich. Stock 
solutions of oligonucleotides were hydrated with TE buffer and diluted to 10 µM. In 
a 0.2 mL tube 10 µL of each complementary oligonucleotide was added along with 
30 µL of water. Oligonucleotides were incubated for 5 minutes in a water bath at 100 
oC after which the water bath was turned off and left to cool until it reached room 
temperature. Successful annealing was confirmed via a 0.8% agarose gel 
electrophoresis.  
2.9.3. Assembly of TUs with synthetic promoter library 
To characterise the synthetic promoter library, TUs were assembled expressing 
oxygen-independent reporters (PMO7 and CreiLOV), under the control of the same 
RBS (B0034m_BC) and terminator (B0015_DE). The following components were 
used: B0034m_BC, B0015_DE, ΔpMOMoClo, synthetic promoter library (PR-1, 
PR-3, PR-4, PR-7, PR-6, PR-9. NPR-7, Pr-8, PR-9 and PR-10), and an oxygen-
independent reporter (PMO7 or CreiLOV). A total of 16 TUs were assembled 
through MoClo assembly. The resulting vectors were inserted into E. coli NEB 5-
alpha competent cells and plated onto blue/white screening plates. Plates were 
supplemented with 50 µg/mL spectinomycin. White colonies were restreaked onto 
fresh blue/white screening spectinomycin plates. Plasmids were isolated and 
sequenced for confirmation of correct assembly using sequencing primers (Table 2.1, 
No. 19 and 20).  
2.9.4. Fluorescence assay of D. alaskensis expressing promoter library 
All 16 TUs were electrotransformed into D. alaskensis and cultured under anaerobic 
conditions. Cultures were grown to early stationary phase (OD600; 0.6 -0.8) under 
anaerobic conditions. OD600 readings from D. alaskensis expressing the TUs were 
measured using CO8000 Cell Density Meter (WPA, Cambridge, UK). In a Falcon® 
96-well Black/Clear Flat Bottom (Corning, NY, USA) cultures were diluted with 
PGMC/spectinomycin (100 µg/mL) to an OD600 of 0.15 in a total volume of 200 µL. 
D. alaskensis transformed with the plasmid pMO9075 was used as a negative 
control, and PGMC/spectinomycin as the blank. Biological triplicates and technical 
triplicates per sample and controls were used. Plates were incubated for 72 hours at 




PRO the absorbance at 600 nm and fluorescence for PMO7 at Ex. 525 nm, Em. 600 
nm; CreiLOV, Ex. 450 nm, Em. 495 nm were measured. 
2.10. Tailoring NPs synthesis using MoClo Toolkit  
2.10.1. Site-directed mutagenesis of BsaI recognition site 
The BsaI recognition site found on the pMO_2137 plasmid needed to be removed to 
be compliant with MoClo standards. Through site-directed mutagenesis, the BsaI 
recognition site was deleted from pMO_2137. Primers for the deletion of the BsaI 
recognition site were designed (Table 2.1, No. 31 and 32), and the QuikChange 
Lighting (Agilent) Site-Directed Mutagenesis kit manufacturer’s protocol was 
followed. Mutant plasmids were inserted into chemically competent E. coli NEB 5-
alpha cells. 
2.9.2. Diagnostic Digest Reaction with BsaI 
To confirm the deletion of the BsaI recognition site a diagnostic digest reaction with 
BsaI (NEB protocol) was performed, followed by electrophoresis on a 0.8% agarose 
gel.  
2.9.3. Adapting NiFe hydrogenase to MoClo  
To adapt the NiFe hydrogenase small subunit coding sequences to MoClo standards, 
the sequence of interest was amplified using the following primers (Table 2.1, No. 29 
and 30). Primers were designed as follows: Forward primer, 9 nucleotides (random); 
BsaI recognition site (GGTCTC), 1 nucleotide; Fusion site C (AATG), 2 nucleotides, 
15 base pairs of sequence of interest. Reverse primer, 9 nucleotides (random); BsaI 
recognition site (GGTCTC), 1 nucleotide; Fusion site D (ACCT), 2 nucleotides, 15 
base pairs of sequence of interest. PCR amplified DNA of interest was gel purified. 
To adapt the sequence to MoClo standards the following protocol was followed: Add 
to a 0.2 mL tube: equimolar 10 – 60 fmol of the DNA amplicon and acceptor vector 
DVA_CD, 10 U of BsaI (NEB), 20 U of Quick T4 DNA Ligase (NEB), 1x T4 DNA 
Ligase Buffer (NEB), and sterile deionized water to a total volume of 20 µL. 
Reactions were performed using the following parameters: 16 cycles (37°C for 1.5 
min, 16°C for 3 min), followed by 50°C for 5 min and 80°C for 10 min and were 
then held at 4°C until they were transformed. The resulting reaction was inserted into 
E. coli NEB 5-alpha competent cells and plated onto blue/white screening plates. 




showed a white phenotype were picked and grown overnight for plasmid 
purification. Correct assembly of DVA_2137 was confirmed via sequencing using 
sequence primers (Table 2.1, No. 17 and 18). 
2.9.4. Assembly of Combinatorial Transcriptional Units of NiFe 
hydrogenase 
TUs were assembled via MoClo assembly. Different TUs were assembled under the 
expression of the strongest characterised synthetic promoters and RBS. Each TU 
contained the following parts: J23106_AB, Kan promoter, PR-3, B0034m_BC, RBS-
CR, RBS-9, B0015_DE, DVA_2137 and acceptor plasmid ΔpMOMoClo. 
Assembled TUs were inserted into E. coli NEB 5-alpha competent cells and plated 
onto blue/white screening plates. Plates were supplemented with 50 µg/mL 
Spectinomycin. White colonies were restreaked onto fresh blue/white screening 
Spectinomycin plates. Plasmids were isolated and sequenced for confirmation of 
correct assembly using sequencing primers (Table 2.1, No. 19 and 20). 
2.9.5. Production of Pt NPs 
Cultures of D. alaskensis pMO9075 and D. alaskensis inserted with the 
combinatorial library were grown anaerobically to an OD600 of 1.0. OD readings of 
all cultures were measured, to make sure all samples had similar cell concentrations. 
Cells were centrifuged for 10 minutes at 4000 rpm. The pellet was washed with 1 mL 
of 10 mM MOPS (pH 7.5). These steps were repeated once more. The final pellet 
was resuspended in 1 mL of 10 mM MOPS (pH 7.5). Pt(IV)Cl4 solution was then 
added to the resuspended cells to a concentration of 2 mM. The solution was left for 
2 hours at 30°C under anaerobic conditions, then centrifuged for 10 minutes at 4000 
rpm. The pellet was resuspended in 1 mL of 50% acetone and centrifuged for 15 
minutes at 13,000 rpm. The supernatant was removed and the pellet was allowed to 
dry completely. Pellet was then resuspended in 1 mL dH2O.  
2.9.6. Transmission Electron Microscopy (TEM) 
A volume of 10 µL of purified NPs and NP/cell suspensions of each sample were 
spotted onto a 200 mesh copper grid (Agar Scientific) and allowed to dry. Any 
excess liquid was removed using filter paper. Samples were analysed using a JOEL 




using a GATAN OneView camera. Image post-processing was carried out using 
ImageJ software.  
2.9.7. Inductively Coupled Plasma Optical Emission Spectrometry 
(ICP-OES) 
Inductively Coupled Plasma Optical Emission Spectrometry ICP-OES was used to 
ascertain the amount of ions present in the nanoparticle samples. A sample of each 
suspension was sonicated for 30 minutes in a water bath, centrifuged for 1 hour at 
20,000 rpm. The supernatant was then added to 14% aqua regia and heated for 8 
hours at 80°C. The resulting suspension was diluted in H2O to a volume of 3 mL and 
subjected to ICP-OES analysis on a Perkin Elmer Optima 5300 DV ICP-OES.  
2.9.8. 2,6-DMP Colorimetric Assay 
All the reactions were carried out in a 96-well plate in a total volume of 300 µL. The 
colorimetric assay consisted of a final concentration of 1 mM 2,6-DMP (Sigma-
Aldrich),  and 50 mM N-(2-hydroxy-ethyl) piperazine-N’-(2-ethanesulfonic acid) 
(HEPES) at pH 7. Different concentrations of Pt nanoparticles and Pt ions were used. 
The optical density of 2,6-DMP in the presence of Pt nanoparticles and ions was 
measured over a time lapse of 10 minutes at 469 nm using a Thermo Scientific 
Multiskan GO (Cat#N10588).  
2.9.9. Methylene Blue Colorimetric Assay 
All reactions were carried out in a 96-well plate in a total volume of 200 µL. The 
colorimetric detection assay consisted of final concentrations of 40 µM methylene 
blue (MB), 10 mM Sodium Borohydride, and 10 mM N-(2-hydroxy-ethyl) 
piperazine-N’-(2-ethanesulfonic acid) (HEPES) at pH 7. Different concentrations of 
Pt nanoparticles and Pt ions were used. The optical density of MB in the presence of 
Pt nanoparticles and ions was measured over time at 665 nm using a Thermo 
Scientific Multiskan GO.  
2.11. Cell Surface Engineering of D. alaskensis 
2.11.1. PCR amplification of EC20/IgA insert and pMO9075 vector and 
Assembly 
The EC20/IgA fragment and pMO9075 plasmid backbone were amplified from 




Edinburgh) and pMO9075 respectively by PCR (Primers listed in Table 2.1, No. 39 - 
42), with annealing temperatures of 48°C and 67°C.  The resulting PCR products 
were confirmed by electrophoresis on a 0.8% agarose gel, then excised and purified. 
Insert and backbone purified fragments were assembled by HiFi DNA Assembly® 
Reaction Protocol (NEB). Assembled plasmids were inserted into chemically 
competent E. coli NEB 5-alpha cells.  
2.11.2. Diagnostic Digest Reaction with BamHI and BglI 
The engineered plasmid (pMOEC20) generated was confirmed through a BamHI and 
BglI diagnostic digest reaction (NEB protocol) followed by electrophoresis on a 
0.8% agarose gel electrophoresis. The plasmid was then sequenced with primers No. 
43 and 44 (Table 2.1) for confirmation.  
2.11.3. Copper, Platinum and Palladium Survivability Test of E. coli 
expressing EC20   
Overnight cultures of E. coli pMO9075 and E. coli pMOEC20 were grown (20 
hours, 37°C, 200 rpm) in 10 mL LB with 50 µg/mL spectinomycin. In a 96-well 
CytoOne® Plate 250 µL LB with 50 µg/mL spectinomycin and a range of 
concentrations of CuSO4 (0 mM, 0.5 mM, 1 mM, 2 mM, 4 mM and 5 mM), 
Pt(IV)Cl4 (0 mM, 0.5 mM, 1 mM, and 2mM) and Na2PdCl4 (0 mM, 1 mM, and 2 
mM). Overnight cultures were diluted with LB, to an adjusted OD600 of 0.1. On 
Thermo Scientific Multiskan GO, the absorbance at 600 nm were measured every 30 
minutes for 22 hours under controlled conditions of 37°C and 200 rpm.  
2.11.4. Copper Resistance in Copper containing agar plates 
Overnight cultures of E. coli pMO9075 and E. coli pMOEC20 were grown (20 
hours, 37°C, 200 rpm) in 10 mL LB with 50 µg/mL spectinomycin. Serial dilutions 
of the overnight cultures (10-2, 10-4, and 10-6) were done. A volume of 10 µL of all 
dilutions and undiluted cultures were spotted onto LB agar plates containing  
different concentrations of CuSO4 (0 mM, 0.5 mM, 1 mM, 2 mM, 3 mM, 4 mM, 4.3 
mM and 4.5 mM 4.7 mM and 5 mM), and supplementred with 50 µg/mL 




2.11.5. TEM imaging of D. alaskensis with copper 
Cultures of D. alaskensis transformed with pMO9075 and pMOEC20 were grown 
anaerobically to an OD600 of 1.0. Cells were centrifuged for 10 minutes at 4000 rpm. 
The pellet was washed with distilled water. These steps were repeated twice more. 
The final pellet was resuspended in distilled water. CuSO4 solution was then added 
to the resuspended cells to a concentration of 1 mM. The solution was incubated 
anaerobically for 1 hour at 30°C. TEM grids were prepared as follows; 10 µL of each 
sample was spotted onto a 200 mesh copper grid (Agar Scientific) and allowed to 
dry. Any excess liquid was removed using filter paper. Samples were analysed using 
a JOEL JEM 1400-Plus TEM with an accelerating voltage of 80 kV. Images were 
captured using a GATAN OneView camera. Image post-processing was carried out 
using ImageJ software. 
2.11.6. ICP-OES of the removal of copper by D. alaskensis  
Cultures of D. alaskensis transformed with pMO9075 and pMOEC20 were grown 
anaerobically to an OD600 of 1.0. Cultures were centrifuged at 4000 rpm, and washed 
in 1 mL of PGMC (to avoid copper precipitation) three times. CuSO4 solution was 
then added to the resuspended cells to a concentration of 1 mM. The cells  solution 
were incubated anaerobically for 2 hours at 30°C and then centrifuged at 4000 rpm. 
The supernatant was then filter sterilised through a 0.22 µm syringe filter and used 
for copper content measurement using ICP-OES (Perkin Elmer Optima 5300 DV 
ICP-OES). A minimum of 3 mL of each sample was transferred to a 15 mL Falcon 
tube. Samples were sonicated. Distilled water without any CuSO4 was used as a 
blank. A standard curve was made using three standard solutions of 0.1 mM, 1 mM 
and 5 mM copper in PGMC. 
2.12. Data Analysis 
All fluorescence assays, survivability assays and catalytic activity data were analysed 
by a one-way ANOVA, with a Shapiro-Wilk normality test and a Brown-Forsythe 
equal variance test. When this analysis was not feasible due to the failure of 
normality or equal variances tests (even after data transformation) an alternative test 




Chapter 3: MoClo Toolkit and Synthetic Biology Tools 
for D. alaskensis  
3.1.  Introduction 
DNA assembly techniques have revolutionised biotechnology research and 
innovation. However, despite many advances in molecular biology, the assembly of 
DNA remains cumbersome 68. Within synthetic biology research and industry, 
Modular Cloning (MoClo) is considered to be efficient and a versatile DNA 
assembly technology. MoClo is a golden gate, type IIS restriction endonuclease 
assembly technology that enables the sequential, combinatorial and scar-free 
assembly of parts in a one-pot reaction 66-68. Available toolkits and standards such as 
MoClo have streamlined the process of DNA assembly, and enabled the assembly of 
DNA parts, genes and pathways in a fast, cost-effective and high throughput manner. 
MoClo assembly libraries and toolkits are available for numerous model 
microorganisms, most importantly for E. coli 66, 73-75. However, no such library or 
toolkit has been reported for D. alaskensis or any other SRB. The design and 
engineering of MoClo tools for D. alaskensis will help accelerate research into heavy 
metal bioremediation and NP synthesis, allowing the quick design, assembly and 
testing of genes and pathways, tailored for D. alaskensis. This study aims to build 
two different acceptor vectors, one to express a single TU and another to express two 
TUs. These acceptor vectors are very important, because they will enable the MoClo 
assembly reactions to construct TUs that can be inserted into D. alaskensis, to 
streamline the easy to use, rapid design-build-test cycles.  
A MoClo toolkit would not be complete without the inclusion of reporter genes. The 
lack of a reporter specifically designed and engineered for D. alaskensis has hindered 
research and prevented the characterisation of expression control elements and 
bioparts. Reporter proteins have a wide range of applications within synthetic 
biology, from promoter and RBS variant analysis, as markers for monitoring gene 
transfer, for visualising gene expression, to drug discovery 127. Fluorescent proteins 
are the most common reporter proteins used to characterise synthetic bioparts. 
However, fluorescent reporter proteins such as green fluorescent protein (GFP) are 




maturation 157, 158. Low oxygen environments are encountered frequently in a broad 
range of biomedical and industrial processes, including bioremediation, fermentation 
of high value biomolecules, and in biotechnology applications of obligate anaerobes 
129. Currently, GFP is not the best fluorescent reporter used in research, as GFP’s 
relatively large size (~25 kDa) may cause constraints associated with dysfunctional 
GFP fusion proteins 155.  
The need to design and engineer a novel oxygen-independent reporter is imperative 
to enable researchers and industry stakeholders to study synthetic biology 
applications in anaerobic environments. Recently, flavin-based fluorescent proteins 
(FbFPs) such as iLOV (light, oxygen or voltage-sensing) fluorescent protein derived 
from LOV photoreceptor proteins 130, 131, have become the staple oxygen-
independent reporters. FbFPs have many advantages when compared to GFP, as they 
have shown to be expressed by multiple organisms and emit fluorescence under 
anaerobic conditions 132-136, while they can also act as thermostable and fast-maturing 
probes with a broad operational pH range 137. CreiLOV, an FbFP with blue light 
LOV domains, found in Chlamydomonas reinhardtii, has been demonstrated to be 
the brightest FbFP reporter to date 137. CreiLOV has a reported quantum yield ~1.5-
fold larger than iLOV 130, 137, 138. FbFPs are promising candidates to serve as a new 
class of fluorescent reporters in anaerobic conditions. However, the versatile 
application of FbFPs as robust reporters is currently hindered by their limited 
brightness 159. Fluorescence emission by an FbFPs are weak, and they need to be 
expressed at high levels. Through novel design and directed mutations of existing 
FbFPs, their fluorescence levels can be improved.  Novel oxygen-independent 
fluorescent reporters show considerable promise, therefore, this study aims to design 
and engineer an oxygen-independent reporter library specifically for D. alaskensis. 
The library will consist of reporters that work in more than one microorganism (D. 
alaskensis and E. coli), show a versatility to work in aerobic and anaerobic 
conditions and more importantly, will be able to be applied for the characterisation of 
expression control elements. 
3.2. Assembly of single TU acceptor vector ΔpMOMoClo 
The lacZα gene, fusion sites and the flanking BsaI and BbsI recognition sites from 




obtained via a blue/white screening test, insert-specific PCR, and a BsaI diagnostic 
digest reaction. Following assembly, the plasmid was transferred into chemically 
competent E. coli NEB 5-alpha cells. A total of 71 colonies grew overnight. Of these 
71 colonies tested, two (colonies 7 and 33) displayed a blue phenotype (Figure 3.1), 
indicating that the lacZα gene had been inserted into the construct. Plasmids from 
colonies 7 and 33 were extracted, followed by insert specific PCR. Both colonies 7 
and 33 were confirmed to have the correct size band by electrophoresis (Figure 3.1, 
C). To indicate that the BsaI sites needed for the MoClo reaction were present, a 
diagnostic digest reaction with BsaI was conducted (Figure 3.1, D). Further 
confirmation was conducted by sequencing. The sequencing results matched the 
desired sequence. 
To be compliant with the MoClo standards, the BbsI recognition site found on the 
pMOMoClo backbone needed to be removed, by site-directed mutagenesis. Specific 
primers for the deletion of the BbsI recognition site were designed to delete AAGA 
bases from the BbsI recognition site (GAAGAC). To confirm the successful deletion 
of the BbsI site, a diagnostic digestion reaction with BbsI was conducted on plasmids 
extracted from eight of the colonies which resulted from the mutagenesis.  The 
diagnostic digest was confirmed by electrophoresis (Figure 3.2). Further 
confirmation was conducted by sequencing. The sequencing results matched the 
desired sequence. 
The newly adapted plasmid ΔpMOMoClo was tested by performing a MoClo 
assembly reaction using the following components taken from the CIDAR MoClo 
Parts Kit: (J23100_AB; constitutive strong promoter, B0032m_BC; medium strength 
RBS, C0012m_CD; controller protein lacl, and B0015_DE; double terminator). 
When assembled correctly in the acceptor vector ΔpMOMoClo, these parts create a 
TU. ΔpMOMoClo contains a lacZα gene, which in turn contains the assembly 
insertion sequence, meaning successful insertion will disrupt transcription of the lacZ 
gene. A blue/white screening test was therefore performed with colonies containing a 
functional lacZ displaying a blue phenotype and those containing the assembled TU 
within the disrupted gene displaying a white phenotype. Following a transformation 
















Figure 3.1. Confirmations of the assembly of single TU acceptor vector pMOMoClo. A) Blue/White 
Screening Results Transformation positive control, E. coli (pUC19). B) Re-streaked colonies of Gibson assembly, 
colonies No. 7 and 33 have a blue phenotype. C) Insert Specific PCR: Agarose Gel electrophoresis. Plasmids 
purified from colonies C7 and C33 were tested for the presence of full-length insert (702 bp) D) Insert Specific 
PCR: Agarose Gel Electrophoresis. Diagnostic Digest Reaction with BsaI: Agarose Gel Electrophoresis. Colonies 













Figure 3.2. Diagnostic Digest Reaction with BbsI: Agarose Gel Electrophoresis. 
Eight colonies tested (C1 – C8) with two controls. C1 has the correct pattern of 
bands with only two bands (500 bp and 4736 bp) indicating that this mutant plasmid 
















Figure 3.3. Blue White Screening Test. A) Positive control, E. coli pUC19. B) 
MoClo assembly results with plasmid ΔpMoMoClo, 70 colonies in total (23 white 








3.3. Assembly of multi-gene expression acceptor vector ΔpMOMoClo_AF 
To assemble ΔpMOMoClo_AF, the Chloramphenicol resistance gene, the lacZα 
gene fusion sites and the flanking BsaI and BbsI recognition sites from DVK_AF 
were cloned into the D. alaskensis plasmid ΔpMO9075, with confirmation obtained 
via a blue/white screening test, and a BbsI and XhoI diagnostic digest reaction. A 
level 2 acceptor vector is required to have a different selection marker to the level 1 
acceptor vector (ΔpMOMoClo, Spectinomycin), therefore ΔpMOMoClo AF was 
assembled using a Chloramphenicol resistance gene.  
To be compliant with the MoClo standards, the BbsI recognition site found on the 
pMO9075 backbone needed to be removed, which was accomplished through site-
directed mutagenesis. Specific primers for the deletion of the BbsI recognition site 
were designed to delete AAGA bases from the BbsI recognition site (GAAGAC). To 
confirm the successful deletion of the BbsI site, a diagnostic digestion reaction with 
BbsI and XhoI was conducted on plasmids extracted from eight of the colonies that 
resulted from the mutagenesis. The diagnostic digest was confirmed by 
electrophoresis (Figure 3.4). Final confirmation was done by sequencing the 
plasmids. 
The gBlock (containing the Chloramphenicol resistance gene, Laczα gene from 
acceptor vector DVK_AF and flanked by XbaI and XhoI recognition sites) and 
ΔpMO9075 were digested with XbaI and XhoI. Correct bands were excised and 
purified after they were separated  on an electrophoresis gel. ΔpMoMoClo AF was 
assembled by ligating both digested parts. E. coli NEB 5-alpha was transformed with 
the resulting reaction and plated onto blue/white screening plates supplemented with 
Chloramphenicol. Blue colonies were restreaked onto fresh blue/white screening 
Chloramphenicol plates (Figure 3.5). Final confirmation was done by sequencing the 



















Figure 3.4. Diagnostic Digest Reaction with BbsI and XhoI: Agarose Gel 
Electrophoresis. Eight colonies tested (C1 – C8) with two controls. C5, C6 and C8 
have the correct band with only a single band (~4836 bp) indicating that this mutant 
plasmid no longer contains the undesired BbsI recognition site. Three bands appear 
































3.4. Adapting phiLOV, nanoLUC and CreiLOV to MoClo  
The CDS of phiLOV, nanoLUC and CreiLOV were successfully adapted to MoClo 
and each cloned into MoClo donor vector DVA_CD. For phiLOV and nanoLUC, the 
sequences of interest were amplified with sequence specific primers. These primers 
were designed to contain flanking BsaI recognition sites, followed by fusion site C  
(AATG, forward primer) and D (ACCT, reverse primer). Amplified sequences were 
cloned into DVA_CD through a MoClo assembly reaction. Assembled plasmids 
(DVA_phiLOV and DVA_LUC) were inserted into chemically competent E. coli 
NEB 5-alpha cells and plated onto blue/white screening plates with ampicillin. For 
DVA_phiLOV a white colony was chosen to perform an insert-specific PCR, to be 
confirmed by electrophoresis (Figure 3.6). The colony specific PCR gel showed the 
correct size band, concluding that DVA_phiLOV was successfully cloned. To further 
confirm the successful assembly of DVA_phiLOV, a diagnostic digest reaction with 
BsaI was performed. The diagnostic digest reactions were confirmed by 
electrophoresis (Figure 3.7). The diagnostic digest gel shows the correct size band, 
further indicating that DVA_phiLOV was successfully cloned. For DVA_LUC white 
colonies were purified and plasmid extracted. To confirm a successful assembly, 
diagnostic digest reaction with BsaI was performed on 7 different plasmids. Digest 
reactions were run on an electrophoresis gel (Figure 3.8). Gel results indicate that 
NanoLUC was successfully cloned into DVA_CD. DVA_LUC contained a BbsI 
recognition site within its CDS sequence, and to comply with MoClo standards, 
removal of this recognition site was required. This site was removed through site-
directed mutagenesis. Specific primers for the deletion of the BbsI recognition site 
were designed to change GAA to GAG in the restriction site whilst retaining the 
codon’s original coding for glutamine. To confirm the successful deletion of the BbsI 
recognition site in DVA_LUC a diagnostic digestion reaction with BbsI and BsaI 
was conducted. The diagnostic digest was confirmed through an electrophoresis gel 
(Figure 3.9). Both DVA_phiLOV and DVA_LUC were confirmed through 
sequencing.  
Plasmids with the CreiLOV gene (D. alaskensis codon optimised) and E. coli 




no need to clone these into the MoClo donor vector DVA_CD because the plasmids 


































Figure 3.6. Colony Insert Specific PCR: Agarose Gel Electrophoresis. A single 
colony was tested. DVA_phiLOV showed a single band between the 750 bp and 500 


















Figure 3.7. Diagnostic Digest Reaction with BsaI: Agarose Gel Electrophoresis. 
DNA extracted from a single culture was tested. Correct size bands are 344 bp and 


















Figure 3.8. Diagnostic Digest Reaction with BsaI: Agarose Gel Electrophoresis. 
Seven colonies was tested (DVA_LUC1 – DVA_LUC7). Only DVA_LUC1 has the 
correct results. Only two bands appear on DVA_LUC1 (2000 bp and 500 bp) 
indicating that this plasmid was correctly assembled. Three bands appear on 

























Figure 3.9. Diagnostic Digest Reaction with BbsI and BsaI: Agarose Gel 
Electrophoresis. Two colonies tested with one negative control (pMO9075). Both 
have the correct results. Only two bands appear on both plasmids (500 bp and 2000 








3.5. Fluorescence assay of E. coli expressing CreiLOV and phiLOV 
CreiLOV and phiLOV were assembled into different TUs using acceptor vector 
ΔpMOMoClo, each with the same strong promoter (J2100_AB), strong RBS 
(B0034m_BC) and terminator (B0015_DE) for each reporter. TUs assembled are as 
follows: phiLOV, CreiLOV and E. coli CreiLOV. TU’s were transferred into 
chemically competent E. coli NEB 5-alpha cells and were screened for fluorescence 
emission upon excitation at 450 nm and emission at 495 nm. Assay graphs are 
depicted in Figure 3.10. For the 1/100 and 1/5 dilutions all TUs emitted a higher 
fluorescence in comparison with the negative control (ΔpMOMoClo). For 1/10 
dilution, only CreiLOV emitted a higher fluorescence in comparison with the control. 
Values reported for CreiLOV under all dilutions were statistically significant (one-
way ANOVA, P value > 0.05) in comparison with the control.  
The statistically significant values obtained for CreiLOV, fluorescence allowed 
further investigations. TUs expressing CreiLOV were assembled, each with a 
different E. coli promoter strength, the same RBS (B0034m_BC) and the same 
terminator (B0015_DE), all parts obtained from CIDAR MoClo Parts Kit. TUs 
assembled are as follows: CreiLOV SS, CreiLOV MS, and CreiLOV LS (SS = 
strong promoter and RBS; MS = medium promoter and strong RBS; LS = low 
promoter and strong RBS). TU’s were transferred into chemically competent E. coli 
NEB 5-alpha cells and were screened for fluorescence emission upon excitation at 
450 nm and emission at 495 nm. Assay graphs are depicted in Figure 3.11. All TUs 
emitted a higher fluorescence emission in comparison with the negative control 
(ΔpMoMoClo). Values for cultures diluted in PBS (Figure 3.11A) are not 
statistically significant (one-way ANOVA, P value < 0.05) in comparison with 
control. By contrast, all TUs cultures diluted with LB showed values that are 
statistically significant (one-way ANOVA, P value > 0.05) in comparison with the 
control (Figure 3.11B).  
To visually confirm and to ascertain previous results in a qualitative manner, the 
fluorescence emission of CreiLOV, on a 96-well plate, several wells were filled with 
LB supplemented with Spectinomycin. Single colonies from CreiLOV SS, MS and 
LS were picked and used to inoculate individual wells. pMOMoClo was used a 




The plate was incubated overnight at 37°C and shaking at 300 rpm. Image of the 96-
well plate under blue light was taken (Figure 3.12). Figure 3.12 depicts all cultures 
emitting fluorescence under blue light, all to a similar intensity, except those wells 


























Figure 3.10. Fluorescence assay of E. coli expressing phiLOV or CreiLOV 
under aerobic conditions. Assays were conducted using PBS. All reporters tested 
are expressed under a strong promoter (J2100_AB), strong RBS (B0034m_BC) and 
terminator (B0015_DE). A) 1/100 dilution of cultures. B) 1/10 dilution of cultures. 








Figure 3.11. Fluorescence assay of E. coli expressing CreiLOV under aerobic 
conditions. TUs assembled for CreiLOV iterating promoter strength (Strong 
J23100_AB; Medium J23106_AB; Low J23116_AB), same RBS (B0034m_BC) and 
terminator (B0015_DE). TUs assembled (SS, MS and LS).  A) Cultures diluted with 

























Figure 3.12. Image of E. coli expressing CreiLOV under different promoter 
strengths under blue light. CreiLOV SS, CreiLOV MS, CreiLOV LS and negative 







3.6. Gene mining of the oxygen-independent library 
Biotangents (Edinburgh, UK), conducted the gene mining research and the assembly 
of the oxygen-independent fluorescent reporter library with the exception of 
CreiLOV.  
The oxygen-independent fluorescent reporter library was designed specifically to 
work under anaerobic conditions by D. alaskensis. Following a literature research 
and sequence homology of oxygen-independent GFP, BFP and FbFPs fluorescent 
proteins, 12 potential oxygen-independent fluorescent proteins were identified, and 
to be screened for fluorescence excitation and emission in E. coli and D. alaskensis 
under anaerobic and aerobic conditions (Table 3.1). Including within the reporter 
library were designed enhancements to result in higher fluorescence. For example, 
GFP-S65A (alanine substituted for serine at position 65) a mutated version of wild-
type GFP, has a red-shifted fluorescence excitation spectrum and higher fluorescence 
intensity than the wild-type 160. 
CDS of the oxygen-independent reporter library were codon-optimised for 
expression in D. alaskensis, commercially synthesised as gBlocks and inserted 
immediately downstream of a putative kanamycin promoter of plasmid pMO9075. 
Each insert CDS is preceded by a RBS and followed by an E. coli HisI terminator 
(Chapter 2, Table 2.5). Plasmids were assembled through Gibson assembly with the 
exception of pMO11 and pMO12, which were assembled through Golden Gate. All 












Table 3.1. Oxygen-independent reporter library tested in this study. 
Reporter
Name 





PMO1 CKM-1 BfgV D8 
(BfgV D8)  
BFP, from Vibrio 
vulnificus 
352 440 161 
PMO2 CKM-1 BfgV D8 
(Truncated BfgV 
D8) 
BFP, from Vibrio 
vulnificus 
352 440 161 




BFP, from Vibrio 
vulnificus 
352 440 161, 
162 
PMO4 LOV (BsLOV) FbFPs, from Bacillus 
subtilis 
449 495 163 
PMO5 LOV C62A 
(Truncated BsLOV 
C62A) 
FbFPs, from Bacillus 
subtilis 
449 495 163 
PMO6 LOV (PpLOV) FbFPs LOV gene, 
from Pseudomonas 
putida 
450 495 163 
PMO7 GFP from R10-3 
mutant (AvGFP 
R10-3) 
GFP mutant, from 
Aequorea victoria 
525 600 164 




GFP mutant, from 
Aequorea victoria 
525 600 164 





PMO10 BFP G188S (mBFP 
G188S)  






PMO11 LOV C53A 
(PpLOV C53A) 
FbFPs, LOV gene, 
from Pseudomonas 
putida 
450 495 163 
PMO12 LOV C62A 
(BsLOV C62A) 
FbFPs, LOV gene, 
from Bacillus subtilis 
449 495 163 
CreiLOV CreiLOV FbFPs LOV gene, 
from Chlamydomonas 
reinhardii  






3.7. Fluorescence screening of the Oxygen-Independent Library 
Dr Michael Capeness (Horsfall Laboratory) conducted the fluorescence screening of 
the oxygen-independent library in D.alaskensis under anaerobic conditions and the 
initial data analysis of such data. 
D. alaskensis and E. coli JM109 were inserted with the oxygen-independent library 
(Table 3.1). Cells were grown under anaerobic conditions until they reached the 
exponential phase. Fluorescence intensity was measured for E. coli (Figure 3.13) and 
D. alaskensis (Figure 3.14). All constructs with the exception of PMO1, PMO2, 
PMO3 and PMO6 were shown to be functional in E. coli, giving increased 
fluorescence intensities of approximately 2-fold and 15-fold above the background 
level for PMO7 and PMO5 respectively (Figure 3.15). BFP coding sequences from 
Vibrio vulnificus (PMO1, PMO2 and PMO3) did not result in detectable fluorescence 
by E. coli and D. alaskensis in comparison to the negative control (pMO9075), 
therefore no further test were done. All constructs with the exception of PMO4 and 
PMO9 were shown to be functional in D. alaskensis, giving increased fluorescence 
intensities of up to 2-fold and 3-fold for PMO7 and PMO12 respectively (Figure 
3.16). By comparing results between E. coli and D. alaskensis, a clear difference in 
reporter expression strength can be observed. LOV based FbFP from Pseudomonas 
putida (PMO6 and PMO11), and BFP from metagenomics (PMO10) in D. alaskensis 
reported a detectable fluorescence emission, in comparison with the negative control 
(pMO9075). Unlike results obtained for E. coli, where PMO6 and PMO10 showed 
fluorescence at basal levels, PMO10 resulted in a statistically significant (one-way 
ANOVA, P value < 0.05) fluorescence intensity value. However the BFP identified 
through metagenomics, (PMO9), yield fluorescence at basal levels in D. alaskensis, 
without the G1885 mutation designed to enhance fluorescence. Mutant GFP R10-3 
coding sequences from Aequorea victoria (PMO7 and PMO8), and LOV based 
FbFPs coding sequences from Bacillus subtilis (PMO5 and PMO12) when expressed 
in D. alaskensis and E. coli, all showed an increase in fluorescence emission in 
comparison with the negative control. Statistical analyses concluded that the detected 
values are significant (one-way ANOVA, P value < 0.05) in comparison to those of 
the negative control.  PMO8 differs from PMO7 in that it has an S66A substitution, a 




reporters167. When expressed in E. coli JM109 (Figure 3.13C), PMO8 has a higher 
fluorescence intensity in comparison with PMO7, with a statistically significant 
difference between reported values. Such results indicate that the S66A substitution 
in pMO8 indeed enhanced its reporter utility only in E.coli. However, when 
expressed in D. alaskensis, PMO7 has a higher fluorescence intensity than PMO8, 
and the reported values are statistically significant (one-way ANOVA, P value < 
0.05) (Figure 3.14C). The change in fluorescence emission capture between E. coli 
and D. alaskensis may be associated with the lack of correct protein folding. 
Recombinant proteins often fail to reach a native conformation when proteins are 
heterologously expressed by bacteria 168, which may result in  a diminished 
fluorescence emission. Bottlenecks in transcription and translation, under titration of 
chaperones and proteases, improper codon usage and inability of disulphide-bond 
formation are among the main causes of impaired protein folding 169, 170.  
For further examination of the BFP metagenome coding sequences (PMO9 and 
PMO10), each fluorescent reporter was tested within the wavelength range of 350 – 
410 nm 162. This screening was performed to determine the optimum excitation and 
emission wavelength for these fluorophores; reporters were tested by excitation and 
emission wavelengths, altering 20 nm for each attempt. The optimum 
excitation/emission wavelength was found to be 410/500 nm. Detectable 
fluorescence emission values were measured for E. coli (Figure 3.13D) with PMO9 
and D. alaskensis (Figure 3.14D) with PMO10. Statistical analyses concluded that 
captured values are not statistically significant (one-way ANOVA, P value > 0.05) in 
comparison the negative control. Unlike previous studies where the comparison of 
the expression of oxygen-independent fluorescent reporters between model-organism 
E. coli and other model-organisms reported that values expressed are higher under 
aerobic conditions, than anaerobic conditions 79. Fluorescence emissions captured for 
PMO8 and PMO7 in D. alaskensis had intensities of up to 7-fold and 15-fold above 
the intensities captured for their E. coli JM109 counterparts. These results indicate 
that the heterologous expression of PMO7 and PMO8 were more stable and their 
synthesis was more favourable when expressed in D. alaskensis. Results are not 
emulated by reporters PMO5 and PMO12, where fluorescence intensities captured 




Under anaerobic conditions both E. coli and D. alaskensis emitted autofluorescence. 
As seen on Figure 3.13A, B and D the autofluorescence reported is higher for E. coli 
(pMO9075) in comparison with values reported for D. alaskensis (pMO9075) on 
Figure 3.14A, B and D. Whereas, the autofluorescence reported on Figure 3.14C for 
D. alaskensis is higher in comparison with values reported for E. coli (Figure3.13C). 
These results indicate that both microorganism autofluorescence different intensities 
at different wavelengths, which can be associated with their own secretion of flavins 
into the external media 171.  
The versatility of the oxygen-independent reporter library was also tested under 
aerobic conditions in E. coli JM109 cells (Figure 3.15). All oxygen-independent 
reporters with the exception of PMO1, PMO9 and PMO10 emitted a detectable 
fluorescence in comparison with the negative control (pMO9075). Unlike with the 
anaerobic results captured for both strains, PMO2 and PMO3 reported higher 
fluorescence emission in comparison with the control, however the results were not 
statistically significant (one-way ANOVA, P value > 0.05). Similarly, to previously 
obtained results, PMO5 and PMO12 values statistically significant in comparison 
with to the negative control, suggesting these reporters have the versatility to emit 
fluorescence under both anaerobic and aerobic conditions. Moreover, PMO5 reported 
the highest fluorescence emission of the reporter library. PMO6 under aerobic 
conditions showed values over 15-fold and 9-fold of the values reported for D. 
alaskensis and E. coli respectively. A fluorescent reporter that is able to emit 
fluorescence under anaerobic and anaerobic environments, has useful properties to 
study gene expression of obligate anaerobes and facultative anaerobes 135. Results 











Figure 3.13. Fluorescence assay of E. coli expressing oxygen-independent 
library under anaerobic conditions. All culture cells with inserted plasmids tested 
were expressed under a constitutive kanamycin promoter and an E. coli His 
terminator. Assays were conducted after 4 hours of incubation under anaerobic 
conditions for E. coli JM109. A) Fluorescence assay expressing PMO4, PMO5 and 
PMO12. B) Fluorescence assay expressing PMO6 and PMO11. C) Fluorescence 
assay expressing PMO7 and PMO8. D) Fluorescence assay expressing PMO9, and 
PMO10. Error bars depict the standard deviation of the mean. Average absorbance 






Figure 3.14. Fluorescence assay of D. alaskensis expressing oxygen-independent 
library under anaerobic conditions. All cultured cells with inserted plasmids tested 
are expressed under a constitutive kanamycin promoter and an E. coli His terminator. 
Assays were conducted after 4 hours of incubation under anaerobic conditions for D. 
alaskensis G20. A) Fluorescence assay expressing PMO4, PMO5 and PMO12. B) 
Fluorescence assay expressing PMO6 and PMO11.  C) Fluorescence assay 
expressing PMO7 and PMO8. D) Fluorescence assay expressing PMO9, and 
PMO10. Error bars depict the standard deviation of the mean. Average absorbance 






Figure 3.15. Fluorescence assay of E. coli expressing oxygen-independent 
library under aerobic conditions. All cultured cells with inserted plasmids tested 
were expressed under a constitutive kanamycin promoter and an E. coli His 
terminator. Assays were conducted after 4 hours of incubation under aerobic 
conditions for E. coli. A) Fluorescence assay expressing PMO1, PMO2 and PMO3. 
B) Fluorescence assay expressing pMO4, pMO5 and pMO12. C) Fluorescence assay 
expressing PMO6 and PMO11. D) Fluorescence assay expressing PMO7 and PMO8. 
E) Fluorescence assay expressing PMO9 and PMO10. Error bars depict the standard 
deviation of the mean. Average absorbance values (OD600) are enlisted on the 




3.8. Adapting pMO7 and pMO8 to MoClo 
Sequences for PMO7 and PMO8, were adapted to MoClo standards, because they 
both are simple to quantify, and the excitation and emission wavelength generate a 
low background activity.  PMO12 was not chosen as it might cause a metabolic 
burden when overexpressed. Moreover, PMO12 may also not be suitable to 
characterise expression control elements with similar strength, as a high expression 
may cause a saturation of fluorescence, preventing an accurate characterisation. 
Using gene-specific primers to amplify sequence of interest, the reporters were 
cloned into donor vector DVA_CD through MoClo assembly reactions. Following 
assembly, the plasmids were transferred into chemically competent E. coli NEB 5-
alpha cells. White colonies were cultured and their plasmids were extracted. Further 
confirmed through sequencing the plasmids with results showing the presence of the 
desired sequence. To be compliant with MoClo standards, the BbsI recognition site 
found on the DVA_pMO8 needed to be removed, which was accomplished through 
site-directed mutagenesis. Specific primers for the deletion of BbsI recognition site 
were designed to change GAA to GAG in the restriction site whilst retaining the 
codon’s original coding for glutamine. To confirm the successful deletion of the BbsI 
recognition site on DVA_pMO8, a diagnostic digestion reaction with BbsI and BsaI 
was conducted on four colonies and visualised on an electrophoresis gel (Figure 






















Figure 3.16. Diagnostic Digest Reaction with BbsI and BsaI: Agarose Gel 
Electrophoresis. Four different colonies were tested (pMO8-1 – pMO8-4). All 
colonies  had conclusive results that the BbsI recognition site was successfully 







3.9. Fluorescence assay of MoClo adapted oxygen-independent library 
PMO7 from Aequorea victoria and CreiLOV were considered optimal due to its 
simple quantification, high fluorescence yield in D. alaskensis, its low background 
activity emitted from the negative control (pMO9075), and the fact that it does not 
cause a significant metabolic burden in D. alaskensis. All are necessary factors for 
accurate characterisation of synthetic expression control elements 79, 127.  
The MoClo adapted oxygen-independent reporters were assembled into different 
TUs, each with a different E. coli promoter strength, same RBS and same terminator. 
TUs assembled into ΔpMOMoClo are as listed on Table 3.2. Afterwards, all 
constructs were transferred into D. alaskensis competent cells and were screened for 
fluorescence emission upon excitation with the previously determined wavelengths 
(Figure 3.17). Values were depicted as fluorescence/OD since their growth and cell 
density had considerably different values among all fluorescent reporters, and 
fluorescence values were normalized by OD values. All TUs expressing PMO7 and 
CreiLOV emitted fluorescence at significant levels in comparison with the negative 
control (pMO9075). Importantly, 3 of the TUs, pMO7 MS, CreiLOV LS, and 
CreiLOV Kan reported statistically significant (one-way ANOVA, P value < 0.05) 
fluorescence emission in comparison with the negative control. The values obtained 
indicate that the use of different E. coli promoters does impact on the fluorescent 
emission captured for D. alaskensis, and these values differ among each reporter 
tested. For PMO7 the promoter strength order is as follows: M (J23106_AB) > L 
(J23116_AB) > Kan > S (J23100_AB). For CreiLOV the promoter strength order is 
as follows: Kan > L (J23116_AB) > M (J23106_AB) > S (J23100_AB). Our finding 
correlates previous research our findings of the order promoter strength changes 
when expressing different CDS 172. The expression of heterologous genes impedes a 
normal cellular growth rate, and regardless of the microorganism, such heterologous 
expression will cause a metabolic load or metabolic burden. This metabolic load can 
differ depending on the heterologous gene being expressed 172, 173. Results suggest 
that adapting the oxygen-independent reporters to MoClo standards, changes their 
relative fluorescence emission. All Golden Gate approaches require specific fusion 
sites to enable the sequential assembly of parts. These fusion sites are unavoidable 




sequence and the upstream sequence can have a substantial impact on the functional 






























Table 3. 2. PMO7, PMO8, PMO9, PMO10 and CreiLOV TUs assembled and 
tested in this chapter 
TUs Promoter RBS CDS Terminator 




pMO7 MS J23106_AB 
pMO7 LS J23116_AB 
pMO7 Kan Kanamycin 
promoter 
pMO8 SS J23100_AB 
PMO8 
pMO8 MS J23106_AB 
pMO8 LS J23116_AB 
pMO8 Kan Kanamycin 
promoter 
CreiLOV SS J23100_AB 
CreiLOV 
CreiLOV MS J23106_AB 
CreiLOV LS J23116_AB 









Figure 3.17. Fluorescence assay of TUs expressing anaerobe reporters in D. 
alaskensis. All assay were conducted after 72 hours. Four different TUs expressing 
the anaerobic reporters with different promoter strengths (strong, medium, low and 
Kan) and same RBS strength were tested in comparison with the negative control 
pMO9075. A) Fluorescence Assay of PMO7 reporter. B) Fluorescence Assay of 
PMO8 reporter. C) Fluorescence Assay of CreiLOV reporter on D. alaskensis. Error 
bars depict the standard deviation of the mean. Average absorbance values (OD600) 







3.10. Fluorescence Microscopy of D. alaskensis expressing pMO7 and 
CreiLOV 
From the TUs expressing pMO7 and CreiLOV previously assembled and 
characterised, those that reported the highest fluorescence emission values were 
chosen to be tested to be viewed under a fluorescence microscope. The TUs pMO7 
MS and CreiLOV LS were inserted into competent D. alaskensis cells and incubated 
under anaerobic conditions until they reached the exponential phase. A modified 
protocol version of Fievet et al 155 was followed to attempt to visualise D. alaskensis 
cells under a fluorescence microscope. The sole modification to the protocol was that 
instead of placing washed cells onto an agar pad, cells were mixed with lukewarm 
agar to prevent cell motility. A single sample was tested for each TU, and D. 
alaskensis (pMO9075) was used as the negative control. Images were taken using a 
Nikon Ti2 Live Imaging Microscope (Centre Optical Instrumentation Laboratory, 
Edinburgh, UK). For pMO7 a GFP filter was used (Figure 3.18). For CreiLOV,  GFP 
Cy3 and CFP filters were used, to test the entire range of excitation and emission 
wavelengths that could cause CreiLOV to emit fluorescence (Figures 3.19 and 3.20). 
Results were inconclusive due to excessive background noise and therefore no 
significant fluorescence emission was captured for either pMO7 or CreiLOV 
samples. D. alaskensis cells were not fluorescent under any of the filters used. The 
software used to analyse the images, increases the fluorescence of the background. 
The bright circular figures that appear in Figure 3.20 were agar bubbles due to air 
trapped when lukewarm agar was poured over the samples. From these attempts to 
visualise D. alaskensis under a fluorescence microscope it can be concluded that the 
protocol is not optimal and that the correct fluorescence filters need to be used to 
analyse the fluorophores used in this study. Since both fluorophores tested are novel, 
no filters were commercially available. Future fluorescence microscopy studies with 















Figure 3.18. Fluorescence Microscopy of D. alaskensis expressing pMO7. A) 
Fluorescence microscopy of D. alaskensis (pMO7 MS), DIC-camera image, GFP-
camera image and combined render of images. B) Fluorescence microscopy of D. 
alaskensis pMO9075 (negative control), DIC-camera image, GFP-camera image and 

















Figure 3.19. Fluorescence Microscopy of D. alaskensis expressing CreiLOV. A) 
Fluorescence microscopy of D. alaskensis (CreiLOV LS), DIC-camera image, GFP-
camera image, CFP-camera image and combined render of images. B) Fluorescence 
microscopy of D. alaskensis pMO9075 (negative control), DIC-camera image, GFP-
















Figure 3.20. Fluorescence Microscopy of D. alaskensis expressing CreiLOV. A) 
Fluorescence microscopy of D. alaskensis (CreiLOV LS), DIC-camera image, GFP-
camera image, Cy3-camera image and combined render of images. B) Fluorescence 
microscopy of D. alaskensis pMO9075 (negative control), DIC-camera image, GFP-







3.11. Orthogonal expression of oxygen-independent reporters CreiLOV and 
pMO7 
Using ΔpMoMoClo AF as an acceptor vector, two multi-gene expression TUs were 
assembled, CR LS pMO7 MS and CR Kan pMO7 MS, expressing CreiLOV and 
pMO7 orthogonally. Assembled TUs were transferred into electrocompetent D. 
alaskensis cells and into competent E. coli NEB 5-alpha cells. Tests with D. 
alaskensis were unsuccessful as no cells grew after the transformation, possibly 
because the chloramphenicol resistance gene was not expressed in D. alaskensis, 
which was needed for selection. Attempts to test CR Kan pMO7 MS in E. coli were 
unsuccessful as colonies did not grow in liquid media, unlike the previous TU, CR 
LS pMO7 MS fluorescence assay tests in E. coli using the aforementioned methods . 
This TU was screened for orthogonal fluorescence emission of both reporters, 
CreiLOV and pMO7. Values obtained for cultures incubated under anaerobic 
environments are shown in Figure 3.21, and under aerobic conditions in Figure 3.22.  
Similar to previously obtained results, high values were obtained for CreiLOV in 
both conditions (aerobic and anaerobic). Under both conditions, the values obtained 
for CreiLOV are statistically significant (one-way ANOVA, P value > 0.05) in 
comparison with the negative control (pMO9075). Values obtained for the 
expression of CreiLOV were higher than those obtained previously in Figure 3.11. 
What may have caused these results is that the plate reader is capturing both 
fluorophores’s emission. PMO7 is a GFP mutant from A. victoria that forms a red 
chromophore and is active with an excitation and emission of 525 nm and 600 nm 
respectively, under anaerobic conditions. PMO7 was stable in the presence and 
absence of oxygen, thus it emitted fluorescence under both conditions. PMO7 also 
had a green spectra emission in the presence of oxygen 164, which may have caused 
the capture of uncharacteristically high values. Since CreiLOV has an excitation and 
emission spectra (Ex 450 nm, Em 495 nm) within GFP’s spectra (Ex 485 nm, Em 
535 nm), it may explain the values captured. When assays are not conducted in 
anaerobic conditions, gas exchange occurs and the presence of oxygen may activate 
both reporters (CreiLOV and PMO7) to conformations active in aerobic conditions. 
Previous research on GFP reddening has concluded that some GFP variants, similar 




variants under hypoxic environments its GFP fluorescence shifts to a red 
fluorescence, but then it shifts back to green fluorescence after reoxygenation of the 
cells 167, 174.  
 
Ultimately, the successful orthogonal expression of both reporters under aerobic and 
anaerobic environments was not achieved. These tests prove that the expression of 
more than one protein in E. coli can be achieved using this multi-gene acceptor 
vector (ΔpMoMoClo AF). Attempts to express both reporters in D. alaskensis were 
unsuccessful. The lack of growth of the cells inserted with TUs was indicative that 
multi-gene acceptor vector ΔpMoMoClo AF was not suitable to work in D. 
alaskensis.  
 
To ascertain that PMO7 and CreiLOV are not orthogonal, a fluorescence assay with 
TUs expressing only CreiLOV and pMO7 (TUs that were assembled into CR LS 
pMO7 MS), the empty plasmid (pMO9075) and CR LS pMO7 MS were tested 
(Figure 3.23). In addition, an emission scan assay with a fixed excitation at 450 nm 
was conducted for all of the above (Figure 3.24). Both graphs (Figure 3.23 and 
Figure 3.25) conclude that CreiLOV and PMO7 expressed by CR LS pMO7 MS are 
not expressed orthogonally, because excitation and emission spectra between both 
reporters coincide and fluorescence is emitted on both accords. TU expressing solely 
CreiLOV has a fluorescence emission smaller that CR LS pMO7 MS, which 
correlates with fact that PMO7 is also expressed and therefore has a higher 
fluorescence. Also from Figure 3.23B, it can be concluded that reporter CreiLOV 
emits a fluorescence of similar intensity to that of pMO7 when excited at 525 nm. 
With such results in mind, an emission scan assay with a fixed excitation at 525 nm 
was conducted for all of the previously tested plasmids (Figure 3.25). These results 





Figure 3.21. Fluorescence assay of E. coli expressing multi-gene expression TU 
under anaerobic conditions. A) Fluorescence assay of reporter CreiLOV. B) 







Figure 3.22. Fluorescence assay of E. coli expressing multi-gene expression TU 
under aerobic conditions. A) Fluorescence assay of CreiLOV reporter. B) 






Figure 3.23. Fluorescence assay of E. coli expressing multi-gene expression TU 
under anaerobic conditions. A) Fluorescence assay at 450/495 corresponding to 
CreiLOV reporter and potential aerobic pMO7. B) Fluorescence assay at 525/600 






Figure 3.24. Fluorescence emission scan with fixed 450 nm excitation of E. coli 
expressing multi-gene expression TU under anaerobic conditions. A) CreiLOV 







Figure 3.25.  Fluorescence emission scan with fixed 525 nm excitation of E. coli 
expressing multi-gene expression TU under anaerobic conditions. A) PMO7 





D. alaskensis is a non-model organism and no synthetic biology tools have been 
specifically engineered for it. As described in the introduction, D. alaskensis is also a 
microorganism with great potential in bioremediation and biocorrosion, but the 
further understanding and applications of this bacterium can only be realised with the 
development of such synthetic biology tools. Many synthetic biology tools are 
available for researchers using model organisms such as E. coli and by exploiting 
and adapting these to D. alaskensis we can more easily engineer it to our 
specifications.  
Since most molecular biology manipulations are done in E. coli, due to the plasmid, 
pMO9075 having an E. coli origin of replication (pUC origin of replication), it was 
decided to adapt already existing E. coli synthetic biological tools to D. alaskensis. 
Synthetic biological tools e.g. Golden Gate tools such as MoClo are available for E. 
coli; CIDAR MoClo 66, EcoFLEX 73, Mobius Assembly 74  and newly created Start-
Stop Assembly 75. The CIDAR MoClo library bioparts were derived from the 
BioBricks™, Registry of Standards Biological Parts and were specifically selected to 
be functional and reliable in synthetic biology designs. For these reasons and the 
availability of only CIDAR MoClo and EcoFLEX toolkits at the time of conception, 
tools designed and engineered for D. alaskensis were made with the CIDAR MoClo 
specifications. 
The MoClo acceptor plasmid, ΔpMOMoClo is the essential plasmid for the use of 
any MoClo biopart to assemble TUs correctly. This tool has enabled the easy to use, 
rapid design-build-test iteration cycles in D. alaskensis. With this tool, the rapid and 
cost-effective DNA assembly of synthetic bioparts could form the foundation of the 
design-build-test paradigm. Genes responsible for the synthesis of heavy metal 
nanoparticles in D. alaskensis and other relevant genes can be rapidly assembled and 
tested.  
The final construct of ΔpMOMoClo was confirmed through insert-specific PCR, 
BsaI diagnostic digest, and further confirmation by sequencing. Ultimately, the 
feasibility and the proper use of ΔpMOMoClo as the acceptor vector in a MoClo 




blue/white screening test and further DNA sequencing. The multi-gene expression 
acceptor vector pMOMoClo_F was also successfully assembled in this study.  
The lack of reporter proteins specifically designed and engineered for D. alaskensis 
has hindered the research and prevented the characterisation of expression control 
elements and bioparts. This study provides a well-characterised library of oxygen-
independent fluorescent reporters. Previously researched reporters (CreiLOV, 
nanoLUC and phiLOV) were tested and only CreiLOV was found suitable for 
synthetic biology applications in D. alaskensis. From the results obtained, phiLOV 
was not an optimal reporter in comparison with CreiLOV, because CreiLOV showed 
a higher fluorescence emission. NanoLUC an enzymatic reaction that relies on a 
substrate to emit luminescence. For synthetic biology purposes, like those of 
characterising expression control elements, like promoters and RBS, the fluorescence 
quantification has a direct relation to the actual transcription and translation rate of 
heterologous proteins expressed. Whereas a luminescence quantification has an 
indirect relation, because it is reliant on an enzymatic reaction and the need of a 
substrate 127. Both CreiLOV and phiLOV work under the same wavelength spectrum, 
since both fluorophores are from the same family of LOV based FbFPs 166, but 
CreiLOV has been reported to be the brightest of the FbFPs 130, 138, 166. 
The versatility of fluorescent reporters is important. Properties that enable a 
fluorescent reporter to emit a fluorescent signal in aerobic environments and that is 
not affected by the lack of oxygen, makes this reporter a useful tool to study gene 
expression of obligate anaerobes 135. Reporters were tested in E. coli under aerobic 
conditions; significant different results were obtained from those reported under 
anaerobic conditions. It is known that most fluorescent reporters such as GFP require 
oxygen and are inactive under anaerobic conditions 157, 158. The reporters showed 
higher fluorescence emission values when expressed under aerobic conditions than 
anaerobic conditions. An oxidation step may be required for proper maturation of the 
chromophore as it helps with the overall correct folding of the structure of FbFPs and 
GFP-like chromophores, as well as to prevent the formation of inclusion bodies 175.  
The characterisation of oxygen-independent fluorescent reporters has been achieved 




its use in Clostridium difficile 176, FbFPs from P. putida (PpFbFP) 137, B. subtilis 
(EcFbFP) 137, C. reinhardtii (CreiLOV) 166 and Vaucheria frigida (VafLOV) 166 have 
been characterised in E. coli. Our research, found numerous possible oxygen-
independent reporters to characterise promoters, unlike another research where 
CreiLOV and phiLOV were not suitable for use in Clostridium acetobutylicum 79. 
Not only did our study concluded that CreiLOV was characterised to be suitable for 
synthetic biology applications in D. alaskensis, it was proven that five different 
oxygen-independent reporters are adequate (CreiLOV, PMO7, PMO8, PMO5, and 
PMO12). Whereas in the aforementioned research, both CreiLOV and phiLOV were 
found unsuitable reporters for synthetic biological applications in C. acetobutylicum.  
The use of well-characterised parts is an important aspect in synthetic biology. 
Synthetic biology relies on the assumption that the properties from such components 
in a certain context will be maintained the same in a different context 156. The 
characterised E. coli promoters (J23100_AB, J23106_AB, and J23116_AB from 
CIDAR MoClo Parts Kit) and Kan promoter, their expression strengths in D. 
alaskensis do not match the expression strengths in E. coli 66. Since promoters were 
designed specifically for each organism and are key for bacterial transcription, the 
values obtained indicate that indeed promoters designed for E. coli have a different 
strength order when expressed in D. alaskensis. The expression rate of heterologous 
proteins differs among organisms 177. Transcription factors differ between E. coli 
(Gamma proteobacterium) and D. alaskensis (Delta proteobacterium). Due to their 
unique evolutionary pathways each class of proteobacteria developed transcription 
factors with different DNA recognition motifs 177, resulting in a different expression 
strength of heterologous proteins between organisms. This study has conclusive 
results that the order of strengths of the promoters change when expressing different 
CDS. When different CDS are expressed under the same promoter, their order of 
strength changes. Such results are due to the different metabolic load depending on 
the heterologous gene being expressed 172, 173. 
The simultaneous expression of both CreiLOV and PMO7 in E. coli was achieved in 
this study, albeit their expression was not orthogonal, since they cannot be quantified 
independently. Values obtained for CreiLOV were different from those previously 




These results could be associated with the PMO7 fluorescence emission within GFP-
like spectra, like those of CreiLOV FbFPs wavelenghts. These results can be 
explained because the expression of more than one heterologous protein will cause a 
higher metabolic burden than when expressing just one. Moreover, the formation of 
inclusion bodies, and error prone protein folding of such proteins 169, 170, could 
explain the difference between the values obtained.  
Although the use of novel cloning methods such as MoClo can help streamline and 
speed up the DNA assembly of bioparts and genes, it may affect the overall 
expression rate of heterologous proteins. The assembly of genes via MoClo is easy, 
fast and cost effective in comparison with traditional DNA assembly methods, but 
the use of fusion sites between each expression control element may affect protein 
expression. Since these fusion sites (tetramer sequences) are transcribed to mRNA 
and then translated into proteins, their position may affect the mRNA transcribed and 
therefore have an effect on the expression rate of heterologous proteins 75.  
Ultimately, if you are looking for a DNA assembly method that is fast and reliable, 
and uses previously characterised expression control elements, MoClo is a very 
reliable DNA assembly method. For metabolic engineering, you require a predictable 
value or outcome. If using MoClo to test a metabolic pathway, it is imperative to 
characterise all the MoClo adapted expression control elements, to be able to predict 
an outcome, or to tailor a metabolic pathway to a desired outcome.  
To conclude, the oxygen-independent reporters that are adequate for synthetic 
biology applications and for its use as quantitative reporters to characterise 
expression control elements are PMO7 and CreiLOV. Both oxygen-independent 
reporters were chosen to be adequate because, both are simple to quantify, and the 
excitation and emission wavelength generate a low background activity. Moreover, 
the fact that both emit fluorescence at different wavelengths, and are different genes, 
will provide comparative results when characterising expression control elements 






Chapter 4: Synthetic Libraries of Expression Control 
Elements for D. alaskensis 
4.1. Introduction 
A functional prokaryotic gene requires the following expression control elements: a 
promoter, an RBS, a protein coding sequence (CDS) and a terminator. For a gene to 
be functional, it requires each individual part to be assembled in order. In synthetic 
biology, each of these expression control elements can be studied in isolation and 
characterised individually under defined conditions. Allowing the rational 
modification of native pathways and the construction of synthetic and heterologous 
pathways, leading to genetic devices that give a predictable response 39.  
A promoter can be defined as any DNA sequence that can independently facilitate 
the binding of transcription factors and enable transcription initiation 85. The 
consensus E. coli σ70 core promoter structure consists of a -35-hexamer and a -10-
hexamer motifs, and are separated by a spacer region with a consensus length of 17 
bp 156. This core promoter region is considered a minimal promoter 84-86, as these are 
the minimal elements necessary to enable transcription initiation 85. The synthetic 
promoters tested in this study were designed with a rational minimal design or 
minimal promoter. Moreover, the use of an E. coli 17 bp consensus sequence as the 
spacer region for a rational minimal design was used because a promoter with this 
design would be considered a synthetic promoter, whereas using the actual spacer 
region found in between the predicted -35 hexamer and -10 hexamer motifs, would 
be considered a native promoter. The prediction of both motifs was made using the 
bioinformatics tool BProm 98, which predicts the conserved core promoter elements 
regulated by σ70 factors. Conserved sequences are predicted by BProm’s algorithm 
that can discern between promoter and non-promoter sequences by using a collection 
of known E. coli promoter sequences 98. The rational design of constitutive minimal 
promoters was conducted by using housekeeping genes’ sequences to generate both 
motifs. Sequences were inputted into BProm to predict the core promoter motifs, and 
were separated by a consensus E. coli spacer region sequence 




The RBS is an ubiquitous genetic part that is located upstream of a protein CDS, 
usually beginning at least 35 nucleotides before the start codon of a protein CDS 110. 
The RBS is essential for the controlled expression of a heterologous protein as it 
regulates the translation initiation, which is a key rate-limiting step, because it 
controls how many ribosomes begin translation and how many of them finish it 110. 
In synthetic biology, being able to predict the function of parts is an important part of 
the design process, so the use of bioinformatics tools such as RBS Calculator 110 are 
useful when designing a synthetic RBS sequence. The RBS Calculator can be 
provided with a protein sequence and will generate a synthetic RBS sequence that 
will yield a user-desired translation initiation rate (TIR). The RBS calculator 
combines a biophysical model with stochastic optimization, to create a quantitative 
relationship between the nucleotides (A, G, C and U) and a potential TIR for a given 
protein CDS 110. It iterates all combination of sequences and predicts the best 
synthetic RBS sequence for the chosen TIR.    
This chapter will focus on the design and engineering of synthetic RBS and promoter 
libraries, specifically tailored for D. alaskensis. The synthetic RBS and promoter 
libraries consists of five and eight different characterised expression control elements 
respectively. Both synthetic libraries were characterised in D. alaskensis using two 
different oxygen-independent reporters, PMO7 and CreiLOV.  
 
4.2. Design of a synthetic RBS library using RBS calculator 
The bioinformatics tool RBS Calculator 110 was used in this study to design synthetic 
RBSs to allow control of the initiation of protein expression in D. alaskensis. The 
CDS sequences of CreiLOV, PMO7, PMO8, PMO9, and PMO10 were entered into 
the programme with a maximized proportional scale (maximum translation initiation) 
and organism of choice (Desulfovibrio alaskensis G20). The synthetic RBS 












Table 4. 1. Synthetic RBS sequences used in this study. 
Protein 
CDS 




















4.3. Adapting RBS library to MoClo 
The synthetic RBS sequences generated by RBS Calculator were adapted to MoClo 
standards through the addition of the required restriction sites and adapter sequences 
(Table 4.2). The resulting sequences were synthesised as a single gBlock (RBS 
Library, Chapter 2, Table 2.5) and cloned into the donor vector DVA_BC through a 
single MoClo assembly reaction. See Figure 4.1 for an illustration of the gBlock 
bioparts library assembly protocol. This assembly method uses a blue/white screen to 
allow for the easy identification of colonies containing the desired insert, in this case 
those being white colonies. Plasmids from multiple colonies were sequenced, with 
results showing all of the desired RBSs were covered by the library, with several 
variants appearing multiple times. Multiple results can be achieved in a single MoClo 
reaction, given that the gBlock contains multiple parts, and all are complaint with 
MoClo standards (contain flanking BsaI recognition sites, and fusion sites B and C), 
a single reaction can result in the successful assembly of the entire library. This 
method is cost and time effective, because the synthetic library assembly can be 
completed in a single reaction, unlike traditional cloning methods which requires 
PCR amplification, restriction digest and ligations steps with DNA clean-ups 


















Table 4. 2. Library of RBS sequences generated by RBS calculator and adapted to 
MoClo. RED: Restriction Sites; UNDERLINED: Adapted Sequence; BLUE: Fusion 
Site B; GREEN: Fusion Site C.  
MoClo 
adapted RBS  

































Figure 4. 1. gBlock bioparts’ library assembly protocol. MoClo adapted bioparts 
are commercially synthesised as a gBlock (may use more than 1 gBlock to assemble 
library). The bioparts library is assembled in a single MoClo reaction using the 
gBlock and the corresponding donor vector. Resulting assembled plasmids are 
inserted into competent cells and incubated overnight on blue/white screening plates. 
White colonies are selected, cultured overnight, plasmid extracted and confirmed 




4.4. Fluorescence assay of synthetic RBS library expressing PMO7 and 
CreiLOV 
The synthetic RBS library containing all five RBSs was assembled into different TUs 
expressing either PMO7 or CreiLOV, each with the same promoter (J23106_AB) 
and terminator (B0015_DE) obtained from the CIDAR MoClo Parts kit. The 
promoter J23106_AB was chosen because it has the highest order of strength 
(Chapter 3). TUs assembled are listed on Table 4.3. Afterwards, all TUs were 
inserted into D. alaskensis competent cells and were screened for fluorescence at the 
appropriate wavelengths (PMO7 ex 525 nm, em 600 nm; CreiLOV ex 450 nm, em 
495 nm) (Figure 4.2). Whilst all TUs had fluorescence values higher than that of the 
negative control (pMO9075) it was only statistically significant (one-way ANOVA, 
P value > 0.05) for one TU expressing PMO7 (RBS-CR) (Figure 4.2A) and for three 
expressing CreiLOV (RBS-8, RBS-9 and RBS-10) (Figure 4.2B).  From the values 
obtained, it does indicate that the same RBS sequences with different protein CDS 
sequences affect the protein expression levels. This results correlate with research 
that concluded that the TIR can potentially decrease by approximately 500-fold when 
reusing the same RBS sequence with different protein CDSs 108.  Here, the 
expression strength order of the synthetic RBSs changed when expressing a different 
protein CDS; for PMO7 the order of strength was RBS-CR > RBS-10 > RBS-9 > 
RBS-7 > RBS-8, while for CreiLOV it was RBS-9 > RBS-10 > RBS-8 > RBS-7 > 
RBS-CR. The synthetic RBS sequences obtained with the RBS calculator are 
generated based on a specific protein CDS, meaning that it would be expected that 
RBS-7 and RBS-CR should give the highest expression when expressing PMO7 and 
CreiLOV respectively. However, both are towards the lower end of their strength 
orders, indicating that the RBS Calculator algorithm used to generate the RBS 
sequences must be used with caution as a simple change of organism to generate 
sequences using the RBS Calculator may skew the predicted results and not be as 
accurate as those predicted with E. coli. As the RBS Calculator was built using E. 











Table 4. 3. TUs assembled using synthetic RBS library 






























Figure 4. 2. Fluorescence Assay of synthetic RBS library expressing oxygen-
independent reporters. A) Fluorescence assay of D. alaskensis expressing PMO7. 
B) Fluorescence assay of D. alaskensis expressing CreiLOV. Five different TUs 
expressing PMO7 and CreiLOV with the same promoter and different RBS (RBS- 7, 
RBS- 8, RBS- 9, RBS- 10 and RBS-CR) were tested in comparison to the negative 
control pMO9075. Experiments were performed in technical and biological 
triplicates. Error bars depict the standard deviation of the mean. Average absorbance 




4.5. Design of synthetic promoter library using Bprom 
The bioinformatics tool Bprom 98  can predict significant features of bacterial 
promoter regions based on conserved promoter sequences. To design minimal 
promoters the -10 and -35 motifs were predicted, by inputting sequences of 7 
different housekeeping genes up to 150 bp upstream of their CDS sequence (obtained 
from KEGG 178). Housekeeping genes were used because they maintain a constant 
expression and are used to generate constitutive promoters 179.  The design of the 
synthetic promoters used in this study utilised the predicted -10 and -35 motifs 
separated by the E. coli consensus spacer region (GGCATGCATAAGGCTCG) 156. 
The housekeeping genes, dnaK, grpE, groEL, secE, secY, ntH and gyrA were used in 
this study to predict the core promoter elements (Table 4.4). The sequences for the 
synthetic minimal promoters and native promoter (NPR-7) used in this study are 





























Predicted -35 Sequence  Predicted -10 Sequence 
1	 dnaK	 TTGCCC TCTTAATTT 
3	 grpE	 TTGACT TACTACATT 
4	 groEL	 TGGTCA GGCTATCAT 
7	 secE	 TTCACC AGGTAGTCT 
8	 secY	 TTCAAA CGTTACGAA 
9	 ntH	 TTCCTG ATGTACAGT 






















Table 4. 5. List of sequences of the synthetic minimal and native promoters design 
used in this study. RED: -35 Sequence; BLUE: -10 Sequence. **Note: the only 
native promoter design is NPR-7 
PR# Promoter Design 
1 TTGCCC GGCATGCATAAGGCTCG TCTTAATTT 
3 TTGACT GGCATGCATAAGGCTCG TACTACATT 
4 TGGTCA  GGCATGCATAAGGCTCG GGCTATCAT 
7 TTCACC  GGCATGCATAAGGCTCG AGGTAGTCT 
8 TTCAAA  GGCATGCATAAGGCTCG CGTTACGAA 
9 TTCCTG  GGCATGCATAAGGCTCG ATGTACAGT 
10 TTCAGA GGCATGCATAAGGCTCG GGTTACCAT 









4.6. Adapting the promoter library to MoClo 
The designed synthetic promoter sequences were successfully adapted to MoClo 
standards and cloned into the MoClo donor vector DVA_AB by synthesising the 
MoClo adapted promoter sequences (Table 4.6) into gBlocks (MIN PROM 
LIBRARY, Chapter 2, Table 2.5), with the exception of PR-8 and PR-10 which were 
assembled by oligonucleotide annealment. See Figure 4.1 for an illustration of the 
gBlock bioparts library assembly protocol. In the first instance, an attempt was made 
to assemble by oligonucleotide annealment. However since only PR-8 and PR-10 
were successful. A new method was devised using gBlocks with the library already 
adapted to MoClo. Most of the library was cloned into donor vector DVA_AB 
through a MoClo assembly reaction. In two reactions, the entire library was 
successfully adapted to MoClo. On the first attempt, not all synthetic promoters were 
successfully adapted to MoClo, as several colonies sequences’ chromatograms 
aligned with the same synthetic promoter. A new gBlock was designed (PROM 
Library 2, Chapter 2, Table 2.5), omitting the promoter sequences that were 
successfully assembled on the first attempt. The assembly of the remaining synthetic 
promoters was achieved with this gBlock. Although full library coverage required 
two assembly reactions, it was still an easy, cost and time effective method to 



















Table 4. 6. Designed synthetic promoter sequences adapted to MoClo. RED: 
Restriction Sites; UNDERLINED: Adapted Sequence; BLUE: Fusion Site A; 
GREEN: Fusion Site B. 
PR# MoClo adapted Promoter Sequence 
1 ACTAGGGGTCTCAGGAGATTTGCCC GGCATGCATAAGGCTCG 
TCTTAATTTATTACTAGAGACCATATCC 
3 ACTAGGGGTCTCAGGAGATTTGACT GGCATGCATAAGGCTCG 
TACTACATTATTACTAGAGACCATATCC 
4 ACTAGGGGTCTCAGGAGATTGGTCA  GGCATGCATAAGGCTCG 
GGCTATCATATTACTAGAGACCATATCC 
7 ACTAGGGGTCTCAGGAGATTTCACC  GGCATGCATAAGGCTCG 
AGGTAGTCTATTACTAGAGACCATATCC 
8 ACTAGGGGTCTCAGGAGATTTCAAA  GGCATGCATAAGGCTCG 
CGTTACGAAATTACTAGAGACCATATCC 
9 ACTAGGGGTCTCAGGAGATTTCCTG  GGCATGCATAAGGCTCG 
ATGTACAGTATTACTAGAGACCATATCC 
10 ACTAGGGGTCTCAGGAGATTTCAGA GGCATGCATAAGGCTCG 
GGTTACCATATTACTAGAGACCATATCC 








4.7. Fluorescence assay of the synthetic promoter library expressing 
PMO7 and CreiLOV 
The synthetic promoter library was assembled into different TUs expressing either 
PMO7 or CreiLOV, each with the same RBS (B0034m_BC) and terminator 
(B0015_DE) obtained from CIDAR MoClo Parts kit. RBS B0034m_BC was chosen 
because throughout this research it was used to characterise promoters (Chapter 3). 
TUs assembled are listed on Table 4.7. All TUs were inserted into D. alaskensis 
competent cells and transformed cells were then screened for fluorescence at the 
appropriate wavelengths (PMO7 ex 525 nm, em 600 nm; CreiLOV ex 450 nm, em 
495 nm) (Figure 4.3).  For PMO7, all TUs with the exception of PR-8 and PR-10 
emitted a higher fluorescence in comparison to negative control (pMO9075). PR-8 
and PR-10 were not assembled to express CreiLOV for this reason. For TUs 
expressing PMO7 all TUs with the exception of PR-8 and PR-10 reported values that 
are statistically significant, whereas all of the values reported for TUs expressing 
CreiLOV are not statistically significant (Figure 4.3B). Although most TUs report a 
higher value in comparison to control, by comparing all values for PMO7 TUs 
(Figure 4.3A) and CreiLOV TUs (Figure 4.3B), values are not statistically significant 
among when comparing each TU. Indicating there is no clear strength order of the 
synthetic promoters. Focusing only on the values captured, for PMO7 the promoter 
strength order is as follows: PR-4 > PR-3 > PR-1 > PR-7 > NPR-7. For CreiLOV the 
promoter strength order is as follows: PR-9 > NPR-7 > PR-7 > PR-4 > PR-3 > PR-1. 
From the values obtained, it does indicate that the same promoter sequences with 
different protein CDS affect fluorescence emission. Previous research correlates this 
finding, where promoter strength differs between the heterologous proteins being 
expressed 172. BProm predicts the conserved sequence motifs using an algorithm that 
discriminates between promoter sequences and non-promoter sequences, based on a 
set of known promoters from the E. coli genome 98, 180, and can be problematic when 
designing promoters for a different microorganism. The low levels of fluorescence 
observed across the library of promoters may be due to the BProm algorithm being 
based on E. coli promoters and its σ70 factors, meaning it may not be suitable for 












Figure 4. 7. TUs assembled using synthetic promoter library 

























Figure 4. 3. Fluorescence Assay of synthetic promoter library expressing 
oxygen-independent reporters. A) Fluorescence assay of D. alaskensis expressing 
PMO7. B) Fluorescence assay of D. alaskensis expressing CreiLOV. Each TU used 
the same RBS. The negative control was pMO9075. Experiments were performed in 
technical and biological triplicate. Error bars depict the standard deviation of the 






Expression control elements such as promoters and RBS are important targets for 
engineering as they allow for the rational modification of native pathways and the 
construction of synthetic and heterologous pathways. They need to be fully 
characterised so that their effects on native metabolic pathways and the expression of 
heterologous pathways are predictable, and therefore can be fine-tuned. This is 
especially important when using a non-model organism such as D. alaskensis. 
Metabolic engineering has not extensively been tried on D. alaskensis and where 
previous work on protein expression has relied upon natural, already existing 
promoter and RBS sequences, this study achieved its aim to design, engineer and 
characterise synthetic expression control elements for D. alaskensis.  
The synthetic RBS library was designed using the bioinformatics tool RBS 
Calculator, but the reliance on such a tool has its limitations; as it was designed for 
use with E. coli. Its predictions might not be accurate for all other organisms, but the 
algorithm was expected to have should have a close relationship with similar Gram-
negative bacteria, such as D. alaskensis. However, not only was the tool designed 
specifically for E. coli and all the environmental and growth factors related to this 
organism. For example, the RBS calculator considered interactions at 37°C, whereas 
throughout this research D. alaskensis was grown at a temperature of 30°C. Such 
temperature changes, are likely to have a significant effect on the RNA folding and 
its TIR 115. Previous research has ascertained that using the RBS Calculator and their 
predicted transcription initiation rates are not accurate in an wet lab experimental 
setting, where the in silico customised TIR values and experimental data are 
considerably different 116. Herein, our data suggest that the RBS calculator was 
useful for designing RBS parts in D. alaskensis; however, the fine control of the 
RBS strength was not possible with this prediction program 181. Characterised 
synthetic RBS libraries have been designed and tested in E. coli 108, 110, though not 
many synthetic RBS libraries have been designed using bioinformatics tools for other 
organisms, with the exception of the RBS library designed for Synechococcus sp. 
strain PCC 7002 116. Other RBS libraries have been designed without the use of 
bioinformatics tools, by locating a consensus RBS sequence of 15 bp upstream of the 




However, a synthetic RBS library specifically designed for an SRB or an anaerobic 
bacterium such as D. alaskensis, to our knowledge has never been reported. 
The synthetic RBS library was characterised with two different protein CDSs, PMO7 
and CreiLOV. The fluorescence assay results obtained show a clear difference 
strength in order between the protein CDS, which is in keeping with previous 
research stating that RBS sequences change its TIR depending on the protein CDS 
expressed 108. A clear order of strength among all elements of the RBS library, 
provide a great opportunity for future fine-tuned expression of heterologous 
pathways in D. alaskensis.  
The synthetic promoter library was designed using the bioinformatics tool BProm, 
which is a promoter sequence predictor that relies on predefined σ70 motifs from E. 
coli. BProm uses the homology of known promoters, specifically of those of E. coli, 
to predict potential promoter sequence motifs, that in occasions may not be accurate 
106. Again, there is no guarantee that the algorithm will have the same prediction 
performance with other organisms, such as D. alaskensis, and this tool is reported to 
to produce many false positives or show poor sensitivity when using long sequences 
of whole genomes 106, 183. An alternative experimental method has been 
demonstrated, in the identification of Helicobacter pylori promoters by primer 
extension with sequence-specific FAM-labelled primers 184. It is possible to confirm 
the actual transcription start point (promoter region) that the in silico analysis 
predicted. Published research ascertained in silico findings through primer extension 
analysis of RNA samples from Francisella tularensis 107. This research also 
concluded that of all the transcription start points experimentally determined were 
located within a range of 1 to 5 nucleotides of the promoter region predicted in silico 
107, which establishes the veracity of this approach. The in silico promoter region 
prediction has a small margin of error, but a margin error that is likely to be greater 
in a bacteria like D. alaskensis.  
The synthetic promoter library tested in this study was generated using housekeeping 
genes. Differences in promoter consensus found upstream of some housekeeping 




differences in their respective sigma factors, that will affect the predicted promoter 
sequence and its overall performance. 
The synthetic promoter library was also characterised with two different protein 
CDS, PMO7 and CreiLOV. Fluorescence assay results obtained do not have a clear 
strength order and no TU expressing CreiLOV had a statistically significant 
fluorescence emission in comparison with control. TUs with promoters PR-8 and 
PR-10 did not emit any fluorescence emission with PMO7. PR-1, PR-3, PR-4, PR-7, 
NPR-7 and PR-9 when expressing PMO7 all reported values that are statistically 
significant. The fact that all these promoters, were not statistically significant when 
expressing CreiLOV, indicates that the protein CDS significantly affects the 
promoter strength. Additionally, the use of bioinformatics tools for the promoter 
prediction may be problematic, because the specific interactions between proteins 
and DNA sequences are very complex 106. All expression control elements involved 
are highly degenerate, so recognition of characteristic sequences within promoter 
elements is difficult 106. However, a strength order among all elements of the library 
provide a great opportunity for the future metabolic engineering applications with D. 
alaskensis. Unlike our data, previous published work, obtained a defined order of 
synthetic promoters for Clostridium acetobutylicum 79, Synechococcus sp. strain PCC 
7002 116, E. coli 118, 156, 185-187, and F. tularensis 107. However, a synthetic promoter 
library specifically designed for an SRB or an anaerobic bacterium such as D. 
alaskesnsis, to our knowledge has never been reported. 
To conclude, the expression control elements specifically designed for D. alaskensis 
and those characterised on Chapter 3, which are adequate for metabolic engineering 
purposes, and further tested on Chapter 6 are as follow: promoters: J23106_AB, 
Kanamycin promoter and PR-3; RBS: B0032m_BC, RBS-CR and RBS-9. These 
expression control elements were chosen because they all reported high fluorescence 
over OD600 values.  
Our results also conclude that using bioinformatics tools and algorithms that were 
designed using E. coli as a model organism, are not as accurate to predict expression 
control elements for D. alaskensis. However, the prediction of the expression control 




(promoter and RBS). The predictions could’ve been different using other 
bioinformatics’ algorithms. For future reference, it is advised to use multiple 
bioinformatics’ algorithms to predict expression control elements. By entering the 
same sequence, predict the expression control elements using multiple algorithms, 
then enlist and compare them to generate a consensus sequence. This consensus 
sequence can then be adapted to MoClo standards and rapidly characterised.  
Synthetic biology aspires to bring predictable outcomes to biology, and one of the 
tools for this is the engineering of expression control elements. Moreover, the genetic 
tools presented here, enable the rapid construction of a finely controlled genetic 
circuit within D. alaskensis.  The tools have the potential to accelerate the field of 
synthetic biology within SRB and anaerobe microorganisms. While this study 
achieved the design and engineering of expression control elements, further research 
needs to be done to account for the lack of a clear strength order in the synthetic 
promoter library, this problem can potentially be solved by further characterising all 














Chapter 5: Cell Surface Engineering of D. alaskensis 
5.1. Introduction 
Metals play an integral role in the life processes of microorganisms; for example 
some metals such as copper and nickel are essential micronutrients for various redox 
processes 4,  and magnesium and zinc stabilise enzymes and DNA through 
electrostatic forces 4. However, some metals are nonessential and are potentially 
toxic to microorganisms at certain concentrations. Consequently, microorganisms 
evolved the ability to discern and uptake the essential metals, and utilise it as one 
mechanism to resist higher concentrations of toxic metals. Mechanisms of metal 
resistance in microorganisms are as follows: the metal exclusion by permeability 
barrier, active transport of metals away from cell/organism, intracellular 
sequestration (protein binding), extracellular sequestration, enzymatic detoxification, 
reduction in metal sensitivity 4 and the ability to convert heavy metals into less toxic 
nanoparticle form 5.  
Cell surface engineering can be used to harness applications such as the 
bioremediation and bioaccumulation of heavy metals. Bacteria can be used to display 
heterologous proteins on their outer membranes by fusing a trans-membrane protein 
as an anchoring motif to the desired protein to be displayed 143. It is hypothesised that 
the use of this technique can enhance D. alaskensis’ ability to thrive in environments 
with high concentrations of heavy metals by tethering metal-binding proteins to its 
outer membrane.  
The use of cell surface engineering for displaying naturally occurring, cysteine-rich 
metal-binding peptides such as methallothioneins and phytochelatins tethered to the 
microorganisms’ outer membrane has been performed in various bacteria 143-145, but 
it has never been reported for D. alaskensis. Recombinant E. coli strains co-
expressing phytochelatin synthase, an enzyme responsible for synthesizing 
phytochelatins from glutathione, and methallothionenin was able to synthesize 
different metal NPs 6. Synthetic chelatins such as EC20, are polypeptide chelators 
rich in metal binding amino acids, and have been used in cell surface engineering 
research, such as for the synthesis of metal NPs 11. The synthetic phytochelatin EC20 




microorganisms 148. More recently, recombinant E. coli strains expressing 
phytochelatin synthase, phytochelatins and metallothionein, were able to synthesize 
EuSe NPs, which exhibited high fluorescence, magnetic and anticancer properties 149. 
These achievements in E. coli set a precedent for attempts to express synthetic 
chelatins such as EC20 in D. alaskensis. The expression of EC20 has been reported 
for other Gram-negative bacteria microorganisms such as Moraxella sp 145, E. coli  6, 
188 Pseudomonas putida 150  and Ralstonia eutropha 151. These findings are indicative 
of the possibility of achieving the expression of metal-binding proteins to the outer 
membrane of D. alaskensis.  
EC20’s metal-binding properties offer an increased affinity, metal-binding capacity 
and/or specificity and selectivity for a target metal ion 152. A way to insert EC20 in 
the outer membrane is to add a signal peptide sequence to the EC20 gene, along with 
the sequence for the autotransporter β-domain of the Neisseria gonorrhoeae 
immunoglobulin A (IgA) protease precursor, which is a transmembrane domain 188.   
Expression of EC20 in D. alaskensis has not been reported, but it was thought that it 
may enhance its metal resistance and even its NP synthesis capabilities. In this study 
the expression of EC20 in E. coli and D. alaskensis was tested to evaluate if such 
expression enhances their resistance to Pt, Pd and Cu. Pt and Pd were chosen because 
D. alaskensis has the innate ability survive in an environment highly enriched with Pt 
and Pd, and can also synthesize platinum group metal NPs 5. Cu was chosen because 
EC20 has a high affinity for Cu 189, and to identify if D. alaskensis has the ability to 
synthesize Cu NPs with or without the expression of EC20.  
 
5.2. Assembly of pMOEC20 
The EC20/IgA fusion gene was inserted into the D. alaskensis plasmid (pMO9075) 
by Gibson assembly, and confirmed by diagnostic digest with BamHI and BglI 
conducted on DNA extracted from four different colonies. Such diagnostic digest 
reactions were conducted to confirm the successful insertion of EC20/IgA insert, 
which has an additional BamHI and BglI recognition site to those already present on 
the pMO9075 backbone (BamHI x1, BglI x2). The diagnostic digest was confirmed 




for BamHI digestion (band sizes: 366 bp and 5,979 bp) and three bands for the BglI 
digestion (Band sizes: 1,259 bp, 1,808 bp and 3,278 bp). Colony number 1 had the 
correct sized bands on both digestion reactions. To confirm the correct assembly, the 
plasmid from colony 1 was sent for sequencing. The sequencing results matched the 



























Figure 5. 1. Diagnostic Digest Reaction with BamHI and BglI: Agarose Gel 









5.3. Survivability test of E. coli expression EC20/IgA to Pt 
To test if the heterologous expression of EC20 on the outer membrane of a 
microorganism will influence its tolerance to platinum concentrations, cultures of E. 
coli pMO9075 and pMOEC20 were grown in a 96-well plate in the presence of 
different concentrations of platinum. OD600 values were captured every hour to 
assess how platinum may affect the growth of the bacteria with and without the 
expression of EC20. Growth was compared for each strain at 0 mM, 0.5 mM, 1 mM 
and 2 mM Pt (Figure 5.2). Growth curves with no Pt have the characteristic 
sigmoidal shaped curve. When Pt is present, the sigmoidal shape of the curve is lost, 
as the growth rate during the exponential phase is reduced. No apparent growth at 2 
mM Pt in E. coli pMO9075 was observed. At the higher Pt concentrations (1 and 2 
mM) the overall OD600 values are higher for pMOEC20, than those of the control 
strain (pMO9075). Values for E. coli pMOEC20 with 1 and 2 mM are of 
approximately 0.05 and 0.04 respectively, unlike values observed for E. coli 
pMO9075 (0.025 and 0.023 respectively). At 1 mM 2 mM Pt E. coli pMOEC20 
appears to grow under such conditions, but never reached a distinguishable 
exponential phase of growth. Contrary, at 0.5 mM Pt both E. coli with different 
plasmids behaved very similarly, two different exponential phases occurred (2-5 
hours and 20 -25 hours), and between exponential phases the graph depicts a 
stationary phase (5-15 hours). At 0.5 mM Pt, E. coli pMO9075 appeared to reach a 
higher OD600 in comparison with pMOECC20. However, no statistical difference 
was found while comparing the OD600 values of pMO9075 and pMOEC20, which 
can be associated with the standard deviation values, suggesting results are error 













Figure 5. 2. Survivability test with different concentrations of Pt. A) Growth 
curves of control E. coli pMO9075. B) Growth curves of E. coli pMOEC20. LB was 
supplemented with 0 mM, 0.5 mM, 1 mM, and 2 mM Pt. Error bars depict the 




5.4. Survivability test of E. coli expression EC20/IgA to Pd 
Similarly to the previously discussed Pt tests, the growth of cells was also compared 
at different Pd concentrations. Growth curves of E. coli pMO9075 and E. coli 
pMOEC20 at different Pd concentration are depicted on the following figures: 0 mM, 
0.5 mM, 1 mM and 2 mM Pd (Figure 5.3). The growth curves without Pd have the 
characteristic sigmoidal shape curve. At higher concentrations (1 and 2 mM), the 
sigmoidal shape of the curve is lost during the timeframe of the experiment, where 
the growth rate during the exponential phase is reduced compared to no Pd; no 
apparent growth at 2 mM Pd in E. coli pMOEC20. At higher Pd concentrations (1 
and 2 mM) the overall OD600 values are higher for pMO9075, than those of the strain 
expressing EC20 (pMOEC20). At the stationary phase (25 hours), the values at those 
concentrations for pMOEC20 are of approximately 0.04 and 0.02 respectively. 
Whereas for pMO9075 OD600 values are 0.05 and 0.1 respectively. When in the 
presence of 1 mM or 2 mM Pd, E. coli pMO9075 grew. Conversely, at 0.5 mM Pd, 
both E. coli (pMO9075 and pMOEC20) behaved very similarly, but there is no 
apparent exponential phase. E. coli pMO9075 reached a higher OD600 in comparison 
with pMOECC20, and no statistical difference was found while comparing OD600 
values of pMO9075 and pMOEC20, which can be associated with the standard 

















Figure 5. 3. Survivability test with different concentrations of Pd. A) Growth 
curves of control E. coli pMO9075. B) Growth curves of E. coli pMOEC20. LB was 
supplemented with 0 mM, 0.5 mM, 1 mM, and 2 mM Pd. Error bars depict the 




5.5. Survivability test of E. coli expression EC20/IgA to Cu 
Similarly to the previously described experiments conducted with Pt and Pd, the 
growth of cells was compared at different Cu concentrations. Overnight cultures of 
E. coli JM109 containing pMOEC20 were spotted onto agar plates, which had 
varying concentrations of copper added. These plates were then incubated overnight. 
Figure 5.10 compares the growth of E. coli pMO9075 and E. coli pMOEC20. E. coli 
pMO9075 grew relatively well in the presence of copper, but ceased to grow at 4.7 
mM. This strain also displayed a reduced colony density at 4 mM. The relative 
resistance to copper of such strain could be associated with the fact that E. coli has 
some tolerance to copper 190, 191. Since pMOEC20 has bacterial growth up to 5 mM, 
the results show that the heterologous expression of EC20 conferred a higher 
bacterial resistance to copper. However, pMOEC20 growth on the 5 mM plate 
showed a reduced or stunted growth in diluted samples, most likely due to the 
reduced cell density in diluted samples. Cell density may affect the culture’s 
resistance to higher concentrations of copper, something that has been observed with 
resistance to antibiotics, where studies have reported a higher resistance to antibiotics 
at higher cell density 192, 193. This can be explained by an accumulation of cells on the 
border of the colony, at higher cell densities, that hinder the entrance of harmful 
compounds and thus present a defence mechanism.  
E. coli variants containing pMO9075 and pMOEC20 were also cultured in liquid 
media in the presence of different concentrations of copper and their OD600 measured 
for 23 hours to assess the metals impact on growth. (Figure 5.11). The resultant 
curves with low concentrations of copper (0 mM, 0.5 mM, 1 mM, 2 mM and 3 mM) 
have the characteristic sigmoidal shape. At higher concentrations (4 mM and 5 mM), 
the sigmoidal shape of the curve is lost, meaning the growth rate during the 
exponential phases is reduced in comparison with other copper concentration tested, 
and no growth of E. coli pMO9075 was observed at 5 mM copper. At the higher 
copper concentrations (3, 4 and 5 mM) the overall cell density was higher for 
pMOEC20 than it was for the control strain (pMO9075) showing that E. coli 





Analyses were performed to determine the statistical significance between the 
strains. To evaluate whether the expression of EC20 had impact on the growth of 
bacteria in the presence of varying concentrations of copper, growth rates of the log 
phase (from 2 hours to 6 hours) were calculated (Table 5.1). The growth rate of the 
control E. coli pMO9075 was not affected at 0.5 mM and 1 mM copper. At the 
concentration of 2 mM copper E. coli pMO9075 growth rate is affected, conversely 
the growth rate of E. coli pMOEC20 is affected at 3 mM copper. When comparing 
growth rates between the two strains, it was apparent that pMOEC20 grew faster. 
Therefore, the results indicate that the heterologous expression of EC20 on the outer 
membrane confer to bacteria, specifically E. coli, a survivability advantage over the 










Figure 5.4. Copper survivability test in E. coli. Comparison of E. coli pMO9075 
and pMOEC20. Cultures were spotted at different cell dilutions on agar plates 






Figure 5.5. Survivability test with different concentrations of Cu. A) Growth 
curves of control E. coli pMO9075. B) Growth curves of E. coli pMOEC20. LB was 
supplemented with 0 mM, 0.5 mM, 1 mM, 2 mM, 3 mM, 4 mM and 5 mM. Cu. Error 






Table 5.  1. Growth rates of pMOEC20 and pMO9075 during the exponential 
growth phase at different concentrations of copper. Time points used to 
calculate growth rate: 3 hours and 15 hours. 







0 0.001575 0.001327 19 0.691 0.691 
0.5 0.001524 0.001233 24 0.735 0.678 
1 0.00149 0.001204 24 0.753 0.626 
2 0.001481 0.000988 50 0.719 0.504 
3 0.001103 0.000727 52 0.695 0.506 
4 0.000773 0.000116 566 0.500 0.228 
















5.6. Transmission electron microscopy of D. alaskensis G20 
D. alaskensis has the ability to synthesize nickel and platinum group metal NPs 5 and 
also has the ability to precipitate gold 194. It was hypothesised that D. alaskensis 
could able to synthesize Cu NPs, so TEM images of D. alaskensis G20 in 1 mM Cu 
were taken (Figure 5.6). As phytochelatins bind strongly to Cu ions, and have a 
greater affinity for Cu than other heavy metals 189, we also analysed D. alaskensis 
pMOEC20. NPs were observed on the distilled water and copper control (Figure 
5.12A). Images taken with the TEM gave inconclusive results, where D. alaskensis 
does not to produce Cu NPs, and the expression of EC20 does not enhance their 
production. The lack of Cu NP is likely to be because EC20 has a high affinity to 
copper ions, thus preventing them to enter the cell to be reduced into NPs. Another 
reason could be that D. alaskensis does not have a copper reduction mechanism. The 
morphology of D. alaskensis pMOEC20 cells in image 5.6D in the absence of copper 
were more irregular in comparison with cells grown in the presence of Cu (Figure 
5.12E). This is most likely due to the overexpression of EC20. Since EC20 is 
tethered to the outer membrane, its overexpression and transportation onto the outer 














Figure 5. 6. TEM images of D. alaskensis G20  pMO9075 and pMOEC20. A) 
Control of distilled water and 1 mM Cu. B) D. alaskensis pMO9075 with distilled 
water. C) D. alaskensis pMO9075 with 1 mM Cu. D) D. alaskensis pMOEC20 with 









5.7. Inductively coupled plasma- optical emission spectrometry analysis of 
removal of Cu by D. alaskensis 
In order to evaluate the amount of copper that D. alaskensis is able to remove from a 
solution of 1 mM Cu, ICP-OES analysis was carried out. Both strains of D. 
alaskensis (pMO9075 and pMOEC20) were able to remove all the copper from the 
solution (Figure 5.7). Results obtained show that the expression of the heterologous 
protein EC20 does not affect the ability of D. alaskensis to remove copper. This may 



























Figure 5. 7. ICP-OES Analysis. Percentage of copper removed by D. alaskensis, 
incubated with 1 mM Cu. WT: wild type D. alaskensis G20; pMOEC20: D. 




























Successful insertion of the EC20/IgA into pMO9075 and its confirmation through 
diagnostic digest reactions and sequencing validates the cloning of insert EC20/IgA, 
to assemble pMOEC20.  
Overall, the results obtained in E. coli indicate that the expression of EC20 does 
confer a certain heavy metal survivability advantage over the control. However, since 
EC20 has a higher affinity for Cu 189 than for Pt or Pd, it had a greater effect on E. 
coli’s tolerance to Cu concentrations higher than 2 mM in comparison to Pt and Pd, 
where E. coli did not survive concentrations higher than 2 mM . The expression of 
EC20 does not directly confer a higher resistance to Pd or Pt. Results observed for Pd 
and Pt are not significant since the error bars on Figure 5.2 and Figure 5.3 are 
considerable. Contrary to the Pt growth curve graphs, Pd growth curves show how 
the control (pMO9075) has a higher growth rate during the exponential phase in 
comparison to pMOEC20. In addition, results indicate that E. coli has a resistance 
mechanism to Cu and not to Pt or Pd. Control E. coli survived Cu concentrations of 3 
mM and E. coli pMOEC20 up to 4 mM. Whereas wild type and E. coli pMOEC20, 
did not survive concentrations higher than 0.5 mM of Pt and Pd, growth was stunted 
and never reached exponential phase. EC20 conferred a higher increase in resistance 
to Pt than it did to the other metals, because when expressed it enabled E. coli to 
increase its resistance from 0.5 mM to 2 mM Pt. Whereas, EC20 only conferred an 
additional 1 mM of Cu resistance, from 3 mM to 4 m. EC20 did not confer additional 
resistance to Pd.  
EC20 has previously been expressed in bacteria to chelate a number of heavy metals, 
including cadmium 145, mercury 145, 195,  zinc, lead, copper, nickel, and molybdenum 
196 and arsenic 188. No research has been published to suggest that the expression of 
EC20 on the outer membrane of a bacterium will be able to chelate Pt and Pd. 
However, EC20 is able to chelate Cu ions when expressed by Cupriavidus 
metallidurans. Although C. metallidurans is a different microorganism to D. 
alaskensis, it was hypothesised that the expression of EC20 on the outer membrane 




A previous study concluded that D. alaskensis is susceptible to low concentrations of 
Cu (16 µM) 197. The survivability to Cu, Pt and Pd growth curves previously done in 
this study for E. coli were attempted with D. alaskensis, but as the reading was done 
aerobically, D. alaskensis did not grow properly, and the values obtained were 
inconclusive, since data obtained is not reliable to a normal bacterial growth. 
Experiments were performed in a microplate reader that regulates temperature, but 
the area is oxygenated, and therefore not in anaerobic conditions. When D. 
alaskensis cultures were added to the media with Cu, Pd, and Pt, the metals 
precipitated. The precipitation of the metals prevented ions being available for the 
microorganism to uptake. To try to prevent the precipitation of the metals in the 
media and to avoid inaccurate readings, experiments were repeated with an added 
shaking step before the OD600 readings. This shaking step was added to prevent the 
effects of the metal precipitation on the OD600 readings. The formation of 
precipitated metal sediments, make it difficult to monitor cell growth  because it 
obscures the OD600 readings. Results were still inconclusive, for all set-ups where D. 
alaskensis was not growing at optimal conditions, and the shaking of the plate made 
no significant change on the values recorded. Optimisation of the protocol is 
required, but it will be very complicated to emulate the experiments and results 
obtained with E. coli in D. alaskensis because the of D. alaskensis anaerobic 
requirements.  A solution to this problem would be to take samples every 12 hours 
and take OD600 readings inside the anaerobic chamber, therefore the experiment 
conducted will be strictly in anaerobic conditions. Alternative methods to assess the 
effects of Pt, Pd and other heavy metals have on D. alaskensis can be used. The agar 
well diffusion and the tube dilution methods have previously been used to assess 
metal toxicity 198.  
The agar well diffusion method relies on the addition of a metal salt solution in a 
central well (1 cm in diameter and 4mm in depth) to a nutrient agar plate. Plates can 
be incubated at 37°C for 24 hours to allow the metal salt solution to diffuse into the 
agar, which will cause a concentration gradient of the metal 198. Under anaerobic 
conditions, D. alaskensis can be inoculated in radial streaks and in duplicate, to then 
be incubated at 30°C for 72 hours or more. After incubation, the area of growth 




calculated in terms of the ratio: length of the growth in mm versus length of the total 
inoculated streak.  
The tube dilution method relies on the addition of the desired metal salt 
concentration to the liquid nutrient media (final volume of 10 mL) and then sterilised 
at 110°C for 15 minutes. Under anaerobic conditions, previously cultured D. 
alaskensis is inoculated onto the tube and incubated at 30°C for 72 hours or more 198. 
Using controls as follows: positive control, metal-deficient medium with D. 
alaskensis; negative control, that consists metal-supplemented medium without D. 
alaskensis.  
The production of Pd and Pt nanoparticles by D. alaskensis is carried out in the 
presence of MOPS (3-(N-morpholino)propanesulfonic acid) buffer, pH 7.0. A similar 
protocol was used when investigating Cu NP production, but it resulted in the 
precipitation of copper prior to the addition of cells. Therefore, distilled water was 
substituted for MOPS. The results concluded that D. alaskensis is not able to 
synthesize NPs. This result was unexpected as D. alaskensis has been shown to be 
resistant to a wide range of metals and is able to synthesize a wide range of NPs from 
those metals. While it was hypothesised that D. alaskensis contains a pathway for the 
synthesis of Cu NPs it is also likely that the substitution of distilled water for MOPS 
means that a constant pH is not maintained, which could have a major influence on  
NP synthesis and the resulting morphologies of any NP produced 199.   
ICP-OES studies confirmed that the expression of EC20 by D. alaskensis does not 
affect the Cu removal from the media, since no difference between pMOEC20 and 
the control strain (pMO9075) was observed in these studies’ results. Furthermore, the 
lack of Cu NPs synthesis by D. alaskensis observed in the TEM image supports that 
EC20 acts just as a ‘holding area’ for metals. Meaning EC20 binds metals and 
prevents their uptake by the cell, ultimately reducing their toxic effect, but it does not 
play a role in metal removal or NP synthesis 188.  
CuNPs have been associated as antibacterial agents 200 , and in some cases capable of 
inhibiting SRBs such as Desulfovibrio marinisediminis 201. This last study screened 
for different biogenic CuONPs antibacterial activity on D. manirinisediminis. The 




was unable to synthesise CuNPs, but only accumulate/remove Cu ions from the 
solution. Moreover, no scientific research has been published to state that a 




























Chapter 6: Tailoring NPs synthesis using MoClo 
Toolkit 
6.1. Introduction 
This chapter will focus on the on a proof of concept application of all the previous 
efforts depicted on this thesis. The synthetic biology tools that were developed 
specifically for D. alaskensis, including the newly characterised synthetic promoters, 
and RBSs enabled the facile and cost-effective assembly of a combinatorial library of 
TUs, with the aim to the tailor nanoparticle’ size. It will also highlight the 
importance of the use synthetic biology tools, and how their applications help 
streamline the design, build, and test cycle of the biogenic nanoparticles synthesis 
research. 
Nanoparticles are currently being synthesised through chemical and physical 
methods on an industrial scale. However, traditional methods for the synthesis of 
NPs are not sustainable. Chemical and physical NP synthesis methods require high 
temperatures, and/or pressures resulting in high energy consumption and the 
generation of large amounts of waste 11. In recent years, research has shifted to 
harness biology to synthesise NPs. A biological approach has many advantages over 
chemical and physical methods. Reactions are catalysed in aqueous solutions at 
standard temperature and pressure (cost-effective and low energy syntheses) 11. It 
does not require solvents or harmful chemicals, making the NP biosynthesis a more 
sustainable method. Furthermore, NP synthesis by microbes does not require the use 
of a pure starting material; therefore, it can be used for the biosynthesis of NPs and 
for the bioremediation of contaminated water, land and waste 29, 31.  
The biogenic synthesis of metal NPs has drawbacks and problems that need to be 
addressed, in order for them to be comparable with monodispersed NPs synthesised 
chemically or physically. Amongst them, is that biogenic metal NPs may be 
produced with a broad morphology and size range 11, which could be problematic, 
because the  catalytic activity of NPs is size dependant 202. The ability to synthesis 
NPs with a monodispersed size is imperative.  Biogenic NPs require a homogeneous 
size in order to be successfully commercialised. In an effort to address this problem, 




improve and, most importantly, tailor NPs synthesis. Metal NPs’ size can be tailored 
using microbial nanocompartments called encapsulins. The defined size and shape of 
the encapsulins allows the size-constrained synthesis in their interior, resulting in a 
homogeneous and monodisperse population of NPs 203. A research study showed the 
synthesis of monodispersed biogenic magnetite (Fe3O4) NPs, using Dps proteins 
(DNA binding proteins, bear a strong similarity to ferritins) from starved Listeria 
innocua cells 204. An alternative method for the synthesis of a monodispersed 
magnetite was reported using bacterial organelles called magnetosomes, such as the 
magnetosome protein Mms6, a small protein embedded on the interior of the 
magnetosome membrane associated with the synthesis of magnetite 205.  Mms6 is 
produced by magnetotactic bacterium Magnetospirilum magneticum AMB-1 205. 
These examples highlight that research has successfully tailored biogenic NPs’ size 
by using nanostructures to constrain the NP size within a defined structure.  
Desulfovibrio sp mechanism for platinum group metals (more importantly Pt and Pd) 
reduction is hypothesised to occur due to the bacteria incorporating the metals into 
their electron transfer pathways 5. The reduction of Pt and Pd occurs in the 
periplasm, where hydrogenases such as NiFe hydrogenase are able to reduce Pt and 
Pd ions to NPs. The overexpression of key periplasmic proteins and enzymes, which 
play a part in the NP synthesis mechanism, may help elucidate how to tailor biogenic 
metal NPs’ size, without the use of nanocompartments. NiFe hydrogenase, is an 
enzyme present in D. alaskensis that plays an important role in the hydrogen 
metabolism of SRB 206, and a key role in the dissimilatory metal reduction by SRB 13, 
207. The involvement of a NiFe hydrogenase in Pd(II) reduction in Desulfovibrio sp, 
was proved by comparing hydrogenase-negative mutant strains to hydrogenase-
positive strains 208. The NiFe hydrogenase appeared to serve as a nucleation site for 
NP formation and also assisted in NP growth by supplying electrons for metal 
reduction 208. The overexpression of the NiFe hydrogenase may provide additional 
electrons for the reduction of heavy metals in D. alaskensis, therefore making it 
better at reducing metal ions to NPs. NiFe hydrogenase from Desulfovibrio spp are 
comprised of a small and large subunit, which are encoded in a single operon 209, 210. 
The small subunit of a NiFe hydrogenase contains a signal peptide consistent with 




overexpress the NiFe hydrogenase small subunit, resulted in the formation of larger 
Pt NPs in D. alaskensis 211. This proof-of-principle research showed the feasibility of 
genetically engineered D. alaskensis to alter NP sizes.  
Using the MoClo tools designed and engineered in this study, the D. alaskensis NiFe 
hydrogenase small subunit gene (KEGG, Dde_2137) was adapted to MoClo 
standards. A combinatorial library of TUs, expressing the NiFe hydrogenase small 
subunit under the control of the synthetic promoters and RBS previously 
characterised in this study, were assembled using MoClo. The design, build, test, 
analyse cycle was put into practice with the application of the MoClo synthetic 
biology tools now available for D. alaskensis. The aim of the study was to test if a 
controlled variation of expression of the NiFe hydrogenase small subunit, would 
affect the overall size of Pt NPs. Results demonstrate the importance of the NiFe 
hydrogenase in the mechanism of Pt reduction to NPs, and the fine tuning of NiFe 
hydrogenase expression can be harnessed to tailor NP size to a desired monodisperse 
size range. 
 
6.2. Adapting NiFe hydrogenase to MoClo 
The NiFe hydrogenase small subunit gene was cloned into the DVA_CD donor 
vector with confirmation obtained via a diagnostic digest reaction and sequencing. 
To be compliant with MoClo standards, the BsaI recognition site found in the NiFe 
hydrogenase gene needed to be mutated, which was accomplished through site-
directed mutagenesis. Primers for the deletion of the BsaI recognition site were 
designed to change GGT to GGC in the restriction site whilst retaining the codon’s 
original coding for glycine. To confirm the successful deletion of the BsaI site, a 
diagnostic digestion reaction with BsaI and EcoRI was conducted on plasmids 
extracted from six of the colonies obtained from the mutagenesis reaction. The 
diagnostic digestion was run on an electrophoresis gel (Figure 6.1). Colonies 1 - 3 
and 6 showed a correct digestion pattern, concluding that the BsaI recognition site 
was mutated. Final confirmation was done by sequencing. The sequencing results 













Figure 6. 1. Diagnostic Digestion Reaction with BsaI and EcoRI: Agarose Gel 
Electrophoresis. DNA extracted from six colonies were tested. Four lanes yielded 
bands at the correct size (5597 bp and 241 bp). Negative control is the non-mutated 










6.3. Assembly of combinatorial TUs of NiFe hydrogenase 
The NiFe hydrogenase combinatorial TU library was assembled to express NiFe 
hydrogenase small subunit under controlled expression, using previously 
characterised promoters and RBS. Each TU was assembled with the same terminator 
(B0015_DE), DVA_2137 (NiFe hydrogenase CDS), iterating promoters: Kan, PR-3 
and J2106_AB, and RBS: RBS-CR, RBS-9 and B0032m_BC. All these parts are 
necessary to assemble a TU with the acceptor vector ΔpMOMoClo. A total of 9 
different TUs were assembled: 2137_M S, 2137_M CR 2137_M 9, 2137_Kan S, 
2137_ Kan CR, 2137_ Kan 9, 2137_3 S, 2137_ 3 CR, and 2137_3 9. A detailed 
description of the TUs assembled and tested in this study are listed on Table 6.1. 
Since ΔpMOMoClo contains a lacZ-α gene, as part of the MoClo method, a 
blue/white screening test was performed. The successfully assembled plasmids were 
transformed into chemically competent E. coli NEB 5-alpha cells, DNA extracted, 


















Table 6. 1. TUs assembled and tested in this study. All promoters and RBS were 
previously characterised in this study.  





M-CR RBS -CR 





Kan-CR RBS -CR 




3-CR RBS -CR 
















6.4. Transmission electron microscopy of combinatorial library  
The NiFe hydrogenase combinatorial library was transformed into D. alaskensis 
competent cells and cultured until they reached an OD600 of 1.0. To observe how a 
controlled variation of expression rates of the NiFe hydrogenase small subunit affect 
the Pt NP synthesis,  TEM images were taken of D. alaskensis inserted with the 
combinatorial library and pMO9075 in presence of 2 mM Pt (Figure 6.2). NP sizes 
were measured using ImageJ software. The frequency of the NPs size was calculated 
in percentages, and illustrated as histograms on Figure 6.3. The negative control, 
pMO9075, showed Pt NPs dispersed across most size ranges, but 50% of NPs have a 
size between 201 – 300 nm. The combinatorial NiFe hydrogenase library, displayed 
a varied size range for Pt NPs, varying from 15 nm to 823 nm. Contrary to the 
control, most plasmids tested had a larger percentage of NPs within a smaller size 
range. Plasmids, 2137_3 CR (Figure 6.3 B), 2137_M 9 (Figure 6.3F) and 2137_M S 
(Figure 6.3G), respectively have a 29%, 27% and 29% frequency of NPs within the 
101 – 200 nm size range. Plasmids, 2137_3 9 (Figure 6.3C), 2137_3 S (Figure 6.3D), 
2137_M CR (Figure 6.3E) and 2137_Kan S (Figure 6.3J), respectively have a 45%, 
35%, 45% and 23% frequency of NPs within the 0 – 100 nm size range. The only 
plasmid with a relative similarity to negative control was 2137_Kan CR (Figure 
6.3H), which has a low 29% of NPs with a size range between 201 - 300 nm, but has 
a higher frequency of smaller and bigger NPs than the negative control. Plasmid 
2137_Kan 9 (Figure 6.3I), has a 36% NP size frequency of 301-400 nm, and 





Figure 6. 2. TEM Images of Pt NPs and D. alaskensis.  Representative electron 
micrographs Pt NPs produced by the NiFe hydrogenase combinatorial library. Scale 




Figure 6. 3. Pt NP Size Frequency Histograms Synthesised by D. alaskensis.  A) 
pMO9075 (negative control), N = 38. B) 2137_3 CR, N = 377.  C) 2137_3 9, N = 
258.  D) 2137_3 S, N = 100. E) 2137_M CR, N = 166.  F) 2137_M 9, N = 115.  G) 
2137_M S, N = 128.  H) 2137_Kan CR, N = 132.  I) 2137_Kan 9, N = 80. J) 
2137_Kan S, N = 100. The NiFe hydrogenase combinatorial library had a larger 





6.5. Inductively coupled plasma- optical emission spectrometry of 
combinatorial library 
In order to ascertain the total ionic concentrations of Pt NPs and Pt ions respectively, 
ICP-OES analysis was carried out for all samples obtained from the NiFe 
hydrogenase combinatorial library. All strains were able to produce considerable 
amounts of Pt NPs (Figure 6.4), some concentrations remained in ionic form (Figure 
6.5). Some strains from the NiFe combinatorial library synthesised higher 
concentrations of Pt NPs in comparison with the control (pMO9075 = 152.87 mg/L). 
The strain with the highest Pt NP synthesis was M-S (256.59 mg/L), and the lowest 
concentration synthesised was Kan-9 (159.16 mg/L), which had a value close to the 
control. Statistical analyses of all samples concluded that the values obtained were 
not statistically significant, which is indicative that the values obtained do not 
necessarily reflect the strains’ ability to synthesise Pt NPs. Some Pt ions are not 
reduced into nanoparticle form, and therefore remain as Pt ions in small 
concentrations. All strains including the control (pMO9075 = 6.17 mg/L) showed 
considerably small ionic concentrations of Pt. The strain reporting the highest ionic 
concentration was Kan-CR (14.47 mg/L; SD 13.7), construct under the expression 
control of a  Kanamycin promoter and a RBS-CR, and the lowest ionic concentration 
was 3-CR (2.09 mg/L; SD 0.104), construct expressing under the expression control 












Figure 6. 4. Total concentration of Pt NPs from NiFe hydrogenase 
combinatorial library. Average total values in mg/L are as follow: pMO9075 = 
152.87; 3-S = 253.38; 3- CR = 217.46; 3-9 = 174.86; Kan-S 213.56; Kan-CR; 
154.50; Kan-9 = 153.16; M-S = 256.59; M-CR = 237.92; M-9 = 159.02. Error bars 











Figure 6. 5.  Overall total concentration of Pt detected with ICP-OES. Pt ions are 
not reduced completely to Pt NPs, PT ions concentrations remain. This graph depicts 
and compares the total concentrations of Pt NPs in comparison with those that 






6.6. Colorimetric assays of the NiFe hydrogenase combinatorial library 
To investigate the catalytic activity of NPs synthesised by the NiFe hydrogenase 
combinatorial library, the NPs’ redox activity was quantified using methylene blue 
(MB) and sodium borohydride (NaBH4). When NPs are introduced to a MB-BH4 
solution, they act as a reducing agent 212. Reducing the dye from its oxidised state to 
its reduced state results in a colour change from blue (oxidised state) to colourless 
(reduced state). This colour change can be used to quantify the reduction rate by 
measuring the optical density of methylene blue in the solution at 665 nm. In an 
attempt to accurately measure the combinatorial library’s NP catalytic activity, 
assays were set up with different Pt NP concentrations. A clock reaction is happening 
for most assays, because the OD values are oscillating throughout time. Meaning in 
the presence of BH4 and Pt NPs, MB is rapidly reduced to leucomethylene blue 
(LMB) and then oxidised back to MB within seconds or minutes. The clock reaction 
of methylene blue, is due to the fact that LMB is prone to oxidation by oxygen in the 
air after a gentle shake 213. Many factors may affect the speed of the oscillating clock 
reaction of MB-BH4 in presence of Pt NPs. Factors such as: nanoparticle size, 
nanoparticle metal type, shaking time, MB concentration and nanoparticle 
concentration 213, 214.  The MB-BH4 colorimetric assay results are as follows: 6 ppm 
Pt (Figure 6.6), 5 ppm Pt (Figure 6.7), 4 ppm Pt (Figure 6.8), 2 ppm Pt (Figure 6.9) 
and 0.2 ppm Pt (Figure 6.10).  All graphs depict a nanoparticle-catalysed clock 
reaction. Most factors were controlled when attempting to quantify the catalytic 
activity of biosynthesised NPs, but it was not possible have a homogeneous NPs size, 
since the NiFe hydrogenase combinatorial library synthesised Pt NPs with a varied 
size dispersion. A size dispersion that is considerably varied among NPs synthesised 
by the entire combinatorial library.  By closely analysing the graphs, the higher the 
Pt concentration the less oscillation occurred, during which most reached an 
asymptotic value (value close to zero) for a prolonged time. NPs synthesised by 
plasmids expressing the NiFe hydrogenase under Kan-9 (Kan promoter and RBS-9) 
and Kan – CR (Kan promoter and RBS-CR) had a faster catalytic activity in 











Figure 6. 6. MB colorimetric assay at 665 nm of NiFe combinatorial library with 

















Figure 6. 7. MB colorimetric assay at 665 nm of NiFe combinatorial library with 


















Figure 6. 8. MB colorimetric assay at 665 nm of NiFe combinatorial library with 



















Figure 6. 9. MB colorimetric assay at 665 nm of NiFe combinatorial library with 


















Figure 6. 10. MB colorimetric assay at 665 nm of NiFe combinatorial library 










To further investigate the catalytic activity of NPs synthesised by the combinatorial 
library, the NPs’ oxidative activity was quantified using 2,6-dimethoxyphenol 
(DMP). When nanoparticles are introduced to a solution containing 2,6-DMP, they 
act as an oxidising agent 215. Due to their catalytic activity, biogenic Pt NPs can be 
assessed using this colorimetric assay. Unlike the MB-BH4 colorimetric assay, a 
clock reaction would not occur with the 2,6-DMP assay. The NiFe hydrogenase 
combinatorial library synthesised Pt NPs showed different oxidase activities (Figure 
6.11) at pH 7, with an increased relative oxidative activity at higher concentrations of 
Pt NPs. The oxidative activity order of all samples tested with 0.5 mM Pt 
concentration is as follows: Kan-CR > 3-9 > pMO9075 > M-CR > Kan-S > 3-S > M-
9 > Kan- 9 > M-S > 3-CR. The oxidative activity order of all samples tested with 0.3 
mM Pt concentration is as follows pMO9075 > Kan-CR > Kan-S > M-CR > 3-9 > 3-
S > M-9 > M-S > Kan-9 > 3 – CR. Values obtained are not statistically significant, 
with the exception of Kan-CR vs 3-CR with 0.5 mM Pt and pMO9075/Kan-CR vs 3-
CR with 0.3 mM Pt. To ascertain that the Pt ion concentrations of all samples were 
not affecting their oxidative activity, the respective Pt ions concentrations (0.1, 0.25, 
0.3 and 0.5 mM) were tested. The low measurements recorded for all Pt ion 
concentrations, indicated that Pt ions are not very reactive in oxidative reactions at 
neutral pH. By analysing the values captured at 0.25 mM, 0.3 mM, and 0.5 mM Pt, 
their catalytic activity changed considerably between 0.25 mM to 0.3 mM, despite 
the small concentration change. The change was more apparent for Kan-S samples, 
as a change from 0.25 mM to 0.3 mM Pt, increased its catalytic activity 30-fold. 
Their oxidative catalytic activity did not have a considerable change from 0.3 mM to 
0.5 mM, as values were not statistically significant among each other. Such results 
are likely to be associated with the aggregation or agglomeration of NPs, which may 
mitigate their catalytic activity.  
In theory, the TUs with a smaller NP size distribution should have a higher oxidative 
activity. TUs synthesising the smallest Pt NPs were 3-9 and M-CR, both produced 
45% of their Pt NPs with a size distribution of 0-100 nm. However, 3-9 had the 
second highest oxidative activity and M-CR placed in the middle of the order. 




dispersed PT NPs size frequency (30% of Pt NPs with a size range of 201 -300 nm). 
The TU with the lowest oxidative activity was 3-CR, which has a dispersed Pt NP 
size distribution (30% of Pt NPs with a size range of 101- 200 nm), a higher 
percentage of smaller Pt NPs in comparison with the TU with the highest oxidative 
activity, Kan-CR. These results indicate the importance of the promoter, the only 
difference between 3-CR and Kan-CR is the promoter used. The controlled 
expression of NiFe hydrogenase small subunit by the Kanamycin promoter produced 
Pt NPs, which showed higher oxidative values in comparison with those produced by 





























Figure 6. 11. 2,6- DMP colorimetric assay at 469 nm of NiFe hydrogenase 
combinatorial library at different Pt concentrations. Error bars depict the 






The expression of the NiFe hydrogenase small subunit under the control of different 
expression control elements in D. alaskensis was successfully achieved in this study. 
The assembly of the combinatorial library was easily accomplished in a facile, cost 
and time-effective way, which surpasses the effectiveness of what can be done by 
using traditional DNA assembly methods. Traditional DNA assembly methods are 
cumbersome and often time consuming, but with the use of newly designed and 
engineered MoClo tools developed for D. alaskensis, the time required to generate a 
combinatorial library was considerably reduced and streamlined. From conception to 
completion, this project took less than 6 months, an achievement that couldn’t have 
been accomplished without the use of synthetic biology tools. This specific approach 
for the combinatorial synthesis of NPs, to our knowledge has never been reported, 
however NiFe hydrogenase libraries (lacking one or more of the NiFe hydrogenases) 
of recombinant E. coli have been assembled using traditional cloning methods 8. 
Libraries assembled to control the expression of NiFe hydrogenase, to our 
knowledge has never been reported, particularly because our study is using 
characterised expression control elements specifically designed for D. alaskensis.  
Studies have been published, where NiFe hydrogenase deficient strains of 
Desulfovibrio fructosivorans showed a different Pd NP synthesis to wild-type 208. 
Another research study successfully changed the expression of outer membrane 
cytochrome (MtrC), and soluble redox shuttled (flavins) to radically change the Pd 
NP phenotype in Shewanella oneidensis 216.  
All plasmids assembled when transferred to D. alaskensis were able to synthesise Pt 
NPs, with a significant NP size range in comparison with the control (pMO9075), 
notably synthesising a higher percentage of smaller NPs. Such results also indicate 
that NiFe hydrogenase plays a key role on the Pt NP synthesis, and that depending on 
the expression control elements used, the size of Pt NPs changes. Our results support 
published research, which reported that engineered E. coli lacking one or more of the 
NiFe hydrogenases exhibit altered phenotypes of Pd NPs and Pd depositions within 
the cells 8. Our results also support the aforementioned study with NiFe hydrogenase 
lacking mutant strains of D. fructosivorans, that also reported a variety of Pd NPs 




the periplasm 208. Our study of the combinatorial library of NiFe hydrogenase goes 
further to conclude that the different expressions rates of NiFe hydrogenase, affect 
the Pt NPs size, to the findings of published research with NiFe hydrogenase lacking 
strains 208.  
The expression of the NiFe hydrogenase small subunit did not hinder D. alaskensis’ 
ability to successfully reduce Pt ions to Pt NPs, but it also did not enhance its ability 
to synthesise NPs. ICP-OES results indicate that regardless of the plasmid inserted 
into D. alaskensis, the remaining Pt ion concentrations after NP synthesis are 
considerably lower than the Pt NP concentrations. Values obtained from testing the 
library were not statistically significant compared to each other, meaning that all 
plasmids equally reduced ions to similar amounts of Pt NPs.  
The biogenic Pt NPs synthesised by the NiFe hydrogenase combinatorial library 
were able to catalyse both reduction and oxidisation reactions with model substrates. 
Although their catalytic activities were not comparable, the Pt NPs tested proved to 
have better oxidative catalytic activities, than reducing catalytic activities. The MB-
BH4 colorimetric assays did not yield conclusive results; hence, it was not possible to 
assign an order depending on their calculated catalytic activities. Only Kan-9, Kan-
CR and 3-S showed a normal curve. Unlike our results, a research study proved that 
biogenic Au NPs and Ag NPs synthesised by Breynia rhamnoides are able to reduce 
4-NP (4-nitrophenol) to 4-AP (aminophenol) in the presence of a BH4 substrate 217. 
4-NP-BH4 is also a colorimetric assay, similar to the MB-BH4 colorimetric assay. 
However, this reaction is slower and is not a clock reaction, so conclusive catalytic 
rates were calculated.  
All Pt NPs synthesised by the NiFe hydrogenase combinatorial library exhibited an 
oxidative activity. The activity of Pt NPs was not significant across all samples 
tested, with the exception of Kan-CR (0.5 and 0.3 mM Pt) and pMO9075 (0.3 mM 
Pt) with 3-CR. When closely comparing results from the 2,6-DMP assays, catalytic 
activities reported with 0.3 and 0.5 mM Pt are not statistically significant to each 
other. The small catalytic activity changes between 0.3 mM and 0.5 mM Pt can be 
explained by the aggregation/agglomeration of NPs. Aggregation and/or 




their catalytic activity 211. Research shows that the further you increase the 
concentration of Pt NPs the more they will agglomerate and have different catalytic 
activities than isolated Pt NPs 218. The characterisation of Pt NPs with the 2,6-DMP 
assay was undertaken at a neutral pH of 7, because it was previously shown not to be 
as reactive at a lower pH, although Pt ions were shown to be highly reactive 211.  Our 
research obtained similar results to those previously reported, where all biogenic Pt 
NPs showed an oxidative activity of approximately 300 2,6-DMP nmol min-1 211. 
Unlike such research study, where only wild type D. alaskensis strains were used to 
synthesise Pt NPs, our study reported oxidative activities of Pt NPs synthesised by a 
NiFe hydrogenase combinatorial library.  
Pt NPs synthesised by plasmid Kan-CR showed the highest oxidation catalytic 
activity, and yielded a discernible curve with the MB-BH4 colorimetric assay. 
However the recorded values were not comparable among all the samples, hence it 
was not possible to confirm whether Pt NPs synthesised by Kan-CR had the highest 
reducing activity among the samples tested. Published studies on non-biogenic Pt 
NPs concluded that its oxidative catalytic properties are shape and size dependant 219. 
This study also emphasised the importance of testing NPs activities of 
monodispersed NPs, because the different size and shapes of NP will be variable 
within samples tested and will affect its oxidative catalytic activity.  
Alternative methods to understand and characterise heavy metal NPs are available. A 
study achieved to characterise single NP’s size and catalytic activity employing a 
method called, scanning electrochemical cell microscopy (SECCM) 220. SECCM, is a 
method that combines the electrochemical and physical characterisation at the single 
NP level, where the NP’s catalytic activity is studied on a TEM grid 220. The 
downside to this method is that it characterises a single NP, whereas the synthesis of 
biogenic NPs has an inherent variance in NP size and shape. Another method to 
characterise biogenic NP is by surface plasmon resonance (SPR). SPR is a powerful 
label-free method used to study the binding between two macromolecules, where one 
of the two is immobilised on a sensor chip surface and the other is interacting by 
lowing over it 220. This method was proven to be useful to characterise Pt NP’s 
catalytic activity 221 and its regarded as a rapid and accurate method to characterise 




To conclude, the NiFe hydrogenase combinatorial library synthesised Pt NPs with a 
wide NP size dispersion in comparison with the control (pMO9075). To be 
comparable with chemical synthesised NPs, biogenic NPs require a monodisperse 
size distribution. TUs, 3-9 and M-CR show the highest percentage (45%) of NPs 
within the 0 – 100 nm size range, a percentage that is considerably higher than the 
control (less than 5%). These results indicate that 3-9 and M-CR strains are at better 
suited at synthesising monodisperse NPs. Furthermore, the 2,6-DMP colorimetric 
assay also concluded that 3-9 has one of the best oxidative catalytic activity from the 
combinatorial library. Overall, 3-9 is the strain best suited for the synthesis of 
monodisperse Pt NPs and still has a high oxidative catalytic activity in comparison 
with control. Further characterisations studies need to be done to fully ascertain the 


















Chapter 7: Overall Discussion and Future Plans 
 
In this thesis, the lack of synthetic biology tools available for the non-model 
organism D. alaskensis is addressed. The main contribution of this work is the D. 
alaskensis MoClo Toolkit (See Figure 7.1), which consist of 19 bioparts. The toolkit 
contains an oxygen-independent reporter library (PMO7, CreiLOV, nanoLUC and 
phiLOV), a synthetic promoter library (PR-1, PR-3, PR-4, PR-7, NPR-7, PR-8, PR-9 
and PR-10), a synthetic RBS library (RBS-7, RBS-8, RBS-9, RBS-10, RBS-CR) and 
two acceptor vectors (pMOMoClo, and pMOMoClo_AF). The D. alaskensis MoClo 
Toolkit primarily enables the assembly of single-gene TUs, which can be inserted 
and tested in D. alaskensis and E. coli. Furthermore, with the array of bioparts 
available in this toolkit, allows the assembly of single-gene combinatorial libraries. 
In addition, if new bioparts are required, these can be easily synthesise as a gBlock 
and adapted to MoClo following the protocol used on Chapter 4, Figure 4.1. An 
already available sequence of interest (within a plasmid) can be MoClo adapted by 
following the protocol used on Chapter 2, Section 2.7.1.  
MoClo is a modular multi-part DNA assembly method, whose framework of 
specified steps, rules and design constrains including predefined fusion sites allow a 
highly efficient multipart assembly of individual constructs or combinatorial 
constructs. However, these benefits come with certain drawbacks like the fixed ‘scar’ 
sequences found in between parts in the assembled construct, the required used of 
suitable assembly donor and acceptor vectors, and to prepare the sequence of interest 
to the appropriate MoClo format. Whereas in comparison to modular DNA assembly 
methods, non-modular DNA assembly methods rely on sequence overlaps to direct 
assembly, and have a greater need for custom oligonucleotide primers (at least one 
pair per junction between part) and sequence verification (assembly is done via PCR, 
which is error-prone) and are less suitable for combinatorial assembly due to lower 
efficiency (low yield of clones are obtained following transformation so smaller 
libraries are generated) and a greater potential to bias particularly due to repetitive 













Figure 7. 1.  D. alaskensis MoClo Toolkit. The toolkit consists two D. alaskensis 
acceptor vectors (single and multi-gene acceptor vectors), an oxygen-independent 
reporter library, a synthetic promoter library and a synthetic RBS library.  The 
oxygen-independent reporter library consists of: PMO7, CreiLOV (both 
characterised in E. coli and D. alaskensis), nanoLUC and phiLOV (both only 
characterised in E. coli). The synthetic promoter library consists of: 8 different 
constitutive promoters characterised in D. alaskensis. The synthetic RBS library 





The ultimate aim of this thesis was to accelerate the research of heavy metal 
bioremediation and NP synthesis. The use of the D. alakensis MoClo toolkit as a 
method to assemble a NiFe hydrogenase combinatorial library was proven to be an 
easy, time and cost effective method, since the project took less than 6 months from 
conception to completion. This proof of concept project set the precedent for future 
similar projects, where multiple combinatorial libraries of NP synthesis genes can be 
assembled.  
Genes of interest were identified through proteomic analysis of D. alaskensis in 
response to platinum and palladium 20. This study highlighted proteins involved in 
both the reductive pathways and the wider stress-response systems of D. alaskensis  
to platinum and palladium 20. This same study found 7 proteins that were specific to 
either platinum or palladium (Protein ID: Pt, Dde_2642; Dde_2137; Dde_2138; 
Dde_0168; Dde_1279; Dde_1545; Dde_1214.  Pd, Dde_0444; Dde_2315; 
Dde_3028; Dde_1618; Dde_ 2641; Dde_2200; Dde_1699) 20. Great opportunity lies 
on the overexpression or deletion of these specific proteins, since a potential NP size 
and morphology change could occur when the above proteins’ expression rate or lack 
thereof changes in comparison to the wildtype. From the aforementioned proteins, it 
is advised to first test those with the highest reported protein abundance in presence 
of Pt, and Pd: (Protein ID: Pt, Dde_2642; Dde_0168. Pd, Dde_0444; Dde_2315.) 20.  
Following the synthetic biology’s cycle (design, build and test), insurmountable data 
and knowledge can be generated by utilising the D. alaskensis MoClo toolkit. In 
collaboration with research facilities specialised in the assembly of large plasmid 
libraries, that use highly automated platforms, like the Edinburgh Genome Foundry 
(EGF). Automated laboratories and facilities use acoustic droplet ejection (ADE) 
coupled with DNA assembly methods like Golden Gate Type IIs (MoClo). Acoustic 
droplet ejection is a liquid handling technology that uses acoustic sound waves to 
rapidly move low-volumes (nL – pL) without any physical contact 223. Liquid 
handling technologies like ADE, increase operational speeds, reduce the working 
volumes (particularly of enzymes and reagents, making it cost-effective), reduce the 
need for a generally error-prone human handling, and ultimately contribute to 




For this future project, plasmids containing the proteins of interest will be assembled 
under the control of different expression control elements. The combinatorial library 
sequentially can be transformed into D. alaskensis. Using D. alaskensis cultures 
inserted with the plasmids, biogenic NPs are synthesised and then characterised 
using TEM and colorimetric assays. The characterisation of biogenic NPs 
synthesised by D. alaskensis inserted with all the plasmids of a combinatorial library 
has a downside. As concluded on Chapter 7, the use of colorimetric assays to 
characterise biogenic NPs is not entirely accurate, since they are not monodisperse in 
size and values are not statistically significant among the samples tested. To 
characterise biogenic NPs synthesised using large combinatorial libraries it is 
imperative to use more accurate and rapid screening methods. These methods can 
help narrow the number of plasmids (in a large combinatorial library) to be further 
analysed (particularly for TEM imaging). The advised protocol for this project is 
illustrated on Figure 7.2. 
With the D. alaskensis MoClo toolkit, any future user can easily design and rapidly 
characterise new synthetic promoter, RBS and terminator libraries, that can be 
utilised in future for biogenic NP synthesis research. In this thesis, synthetic 
promoters with a rational minimal design were characterised and used for NP 
synthesis. In the future it is advised to design promoter libraries with other designs 
(native design, and different promoter architecture). Moreover, the design of 
positively and negatively regulated promoters can be achieved and tested, in an 
attempt to tightly regulate D. alaskensis NP synthesis.  
Additionally, this thesis provides a characterised oxygen-independent reporter library 
specifically engineered for D. alaskensis. Since there is a need of oxygen-
independent reporters, to enable researchers and industry stakeholders to study 
synthetic biology applications in anaerobic environments, the Horsfall Lab is further 
testing the oxygen-independent reporter library with other research and industrially 







Figure 7. 2.  Proposed protocol for rapid assembly and testing of combinatorial 
libraries. (1.) CDS of interest are adapted to MoClo standards following previously 
mentioned protocols (Chapter 2). (2.) Equimolar stocks of all necessary bioparts are 
made. (3.) Using automated laboratory facilities, and their nanoliquid dispensers 
assemble libraries, using the equimolar bioparts’ stocks and following the MoClo 
assembly protocol (Chapter 2, Section 2.2.9). (4.) White colonies are selected, 
cultured, plasmid extracted and confirmed by sequencing. (5.) One plasmid of each 
CDS (all with the same expression control elements) is electrotransformed into D. 
alaskensis, following the aforementioned protocol (Chapter 2, Section 2.4.2). (6.) 
Biogenic NPs are synthesised following the previously mentioned protocol (Chapter 
2, Section 2.9.5). (7.) Rapid and accurate screening of the catalytic activity of the 
biogenic NPs is done with the following methods: scanning electrochemical cell 
microscopy 220 and surface plasmon resonance 221.  Results are analysed and 
compared to select an ideal CDS. Repeat step 5 and 6 with the rest of the plasmids 
from expressing the selected CDS. (8.) NP size frequency is calculated using TEM 
images (Chapter 2, Section 2.9.6) (9.) Conduct a colorimetric assay to analyse the 
biogenic NPs catalytic activity. 
1. Adapt CDS parts to 
MoClo 
2. Make enough 
stocks of each biopart 







7. Screening Assay 






Appendix – Additional Data 
 
Table A-1. Chapter 3 Relevant Absorbance Values (Average OD600) 
Values Values Values Values
pMO9075 0.710 pMO9075 0.710 pMO9075 0.710 pMO9075 0.710
pMO4 0.693 pMO6 0.544 pMO7 0.516 pMO9 0.564
pMO5 0.557 pMO11 0.530 pMO8 0.552 pMO10 0.633
pMO12 0.628
Figure 3.13. Average Absorbance Values
 
Abs Abs Abs Abs
pMO9075 0.288 pMO9075 0.288 pMO9075 0.288 pMO9075 0.288
pMO4 0.199 pMO6 0.318 pMO7 0.317 pMO9 0.383
pMO5 0.276 pMO11 0.389 pMO8 0.335 pMO10 0.313
pMO12 0.342
Figure 3.14. Average Absorbance Values 
 
Abs Abs Abs
pMO9075 0.161 pMO9075 0.161 pMO9075 0.161
pMO4 0.165 pMO6 0.077 pMO1 0.139
pMO5 0.077 pMO11 0.070 pMO2 0.125
pMO12 0.097 pMO3 0.133
Abs Abs
pMO9075 0.161 pMO9075 0.161
pMO7 0.022 pMO9 0.171
pMO8 0.019 pMO10 0.043
Figure 3.15. Average Absorbance Values
 
Abs Abs Abs
pMO9075 0.180 pMO9075 0.106 pMO9075 0.204
pMO7 SS 0.184 CreiLOV SS 0.108 pMO8 SS 0.199
pMO7 MS 0.172 CreiLOV MS 0.102 pMO8 MS 0.214
pMO7 LS 0.178 CreiLOV LS 0.106 pMO8 LS 0.207
pMO7 Kan 0.170 CreiLOV Kan 0.265 pMO8 Kan 0.211







Table A-2. Chapter 4 Relevant Absorbance Values (Average OD600) 
A. Abs B. Abs
pMO9075 0.285 pMO9075 0.268
RBS-7 0.247 RBS-7 0.227
RBS-8 0.230 RBS-8 0.236
RBS-9 0.264 RBS-9 0.193
RBS-10 0.235 RBS-10 0.249
RBS-CR 0.279 RBS-CR 0.214
Figure 4.2. Average Absorbance Values
 
A. Abs B. Abs
pMO9075 0.345 pMO9075 0.154
PR-1 0.316 PR-1 0.192
PR-3 0.301 PR-3 0.165
PR-4 0.290 PR-4 0.150
PR-7 0.297 PR-7 0.143
NPR-7 0.314 NPR-7 0.150
PR-8 0.346 PR-9 0.121
PR-9 0.357
PR-10 0.278
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